SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
-------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) February 6, 1998
------------------------------
NUWAVE Technologies, Inc.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 000-28606 22-3387630
- -------------------- ------------------ -------------------
(State or Other (Commision (IRS Employer
Jurisdiction File Number) Identification No.
of Incorporation)
One Passaic Avenue, Fairfield, New Jersey 07004
- ---------------------------------------------------- -------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (973) 882-8810
----------------------------
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
1 of 5
<PAGE>
Item 4. Changes in Registrant's Certifying Accountant
---------------------------------------------
(a) Dismissal of Independent Accounting Firm
(i) Coopers & Lybrand L.L.P. ("Coopers"), the independent
accounting firm which audited the financial statements of
the registrant during fiscal year 1996, was dismissed by
the registrant on February 11, 1998.
(ii) Coopers' report on the registrant's financial statements
for either of the past two years did not contain an
adverse opinion or a disclaimer of opinion, and was
neither qualified nor modified as to uncertainty, audit
scope, or accounting principles.
(iii) The decision to change accountants was approved by the
Board of Directors of the registrant at the Meeting of the
Board of Directors of the registrant on February 4, 1998.
(iv) During the registrant's two most recent fiscal years and
any subsequent interim period preceding such dismissal,
there were no disagreements with Coopers on any matter of
accounting principles or practices, financial statement
disclosure, or auditing scope or procedure, which
disagreement(s), if not resolved to the satisfaction of
Coopers, would have caused it to make reference to the
subject matter of the disagreement(s) in connection with
its report.
(v) During the registrant's two most recent fiscal years and
any subsequent interim period preceding such dismissal,
the registrant has had no reportable events as defined in
Item 304(a)(1)(v) of Regulation S-K.
(b) Engagement of New Independent Accountants
The registrant has engaged Richard A. Eisner & Company,
LLP as its new independent accountants effective February
11, 1998. During the registrant's two most recent fiscal
years and any subsequent interim period prior to engaging
such accountants, the registrant has not consulted with
Richard A. Eisner & Company, LLP regarding any of the
matters specified in Item 304(a)(2) of Regulation S-K.
2 of 5
<PAGE>
Item 5. Other Events
------------
On February 6, 1998, the registrant entered into a Private Securities
Subscription Agreement (the "Subscription Agreement") with ProFutures Special
Equities Fund, L.P. (the "Investor") pursuant to which the registrant agreed to
(i) issue and sell to the Investor shares of common stock, par value $0.01 per
share (the "Common Stock"), of the registrant for an aggregate purchase price of
$1,000,000; (ii) issue and sell to the Investor, from time to time as provided
in the Subscription Agreement, up to an additional $5,000,000 of Common Stock;
and (iii) issue to the Investor certain warrants to purchase Common Stock in
accordance with the Subscription Agreement. See press release dated February 10,
1998 attached as Exhibit 99.1.
3 of 5
<PAGE>
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
------------------------------------------------------------------
(c) Exhibits
4.1 Registration Rights Agreement, dated February 6, 1998,
between NUWAVE Technologies, Inc. and ProFutures Special
Equities Fund, L.P.
10.1 Private Securities Subscription Agreement, dated as of
February 6, 1998, between ProFutures Special Equities
Fund, L.P. and NUWAVE Technologies, Inc.
10.2 Warrant, dated February 6, 1998, executed by NUWAVE
Technologies, Inc. in favor of ProFutures Special Equities
Fund, L.P., to purchase up to 50,000 shares of common
stock, par value $0.01 per share, of NUWAVE Technologies,
Inc.
16.1 Letter from Coopers & Lybrand L.L.P. to the Securities and
Exchange Commission dated February 16, 1998.
99.1 Press Release, dated February 10, 1998.
4 of 5
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NUWAVE TECHNOLOGIES, INC.
(Registrant)
Date: February 18, 1998 /s/ Gerald Zarin
--------------------------------------
Gerald Zarin
Chairman of the Board, Chief Executive
Officer and President
5 of 5
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description Page
- ------- ------------------------------------------------ ----
4.1 Registration Rights Agreement, dated February 6,
1998, between NUWAVE Technologies, Inc. and
ProFutures Special Equities Fund, L.P.
10.1 Private Securities Subscription Agreement, dated
as of February 6, 1998, between ProFutures
Special Equities Fund, L.P. and NUWAVE
Technologies, Inc.
10.2 Warrant, dated February 6, 1998, executed by
NUWAVE Technologies, Inc. in favor of ProFutures
Special Equities Fund, L.P., to purchase up to
50,000 shares of common stock, par value $0.01
per share, of NUWAVE Technologies, Inc.
16.1 Letter from Coopers & Lybrand L.L.P. to the
Securities and Exchange Commission dated
February 16, 1998.
99.1 Press Release, dated February 10, 1998.
REGISTRATION RIGHTS AGREEMENT
Between
PROFUTURES SPECIAL EQUITIES FUND, L.P.
And
NUWAVE TECHNOLOGIES, INC.
Dated as of February 6, 1998
This REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of
February 6, 1998, is made and entered into between NUWAVE TECHNOLOGIES, INC., a
Delaware corporation (the "Company"), and PROFUTURES SPECIAL EQUITIES FUND, L.P.
(the "Investor").
WHEREAS, the Company and the Investor have entered into that certain
Private Securities Subscription Agreement (henceforth the "Investment
Agreement"), dated as of the date hereof, pursuant to which the Company will
issue to the Investor $1,000,000 worth of shares of Common Stock on the
Subscription Date;
WHEREAS, pursuant to the Investment Agreement, the Company will issue,
from time to time after the Effective Date, to the Investor up to $5,000,000
worth of shares of Common Stock;
WHEREAS, pursuant to the terms of, and in partial consideration for,
the Investor's entering into the Investment Agreement, the Company has issued to
the Investor a warrant dated February 6, 1998, exercisable from time to time
within three (3) years following the six-month anniversary of the date of
issuance (the "Warrant") for the purchase of an aggregate of fifty thousand
(50,000) shares of Common Stock at a price specified in such Warrant;
WHEREAS, pursuant to the terms of, and in partial consideration for,
the Investor's entering into the Investment Agreement, the Company may issue to
the Investor an additional warrant (the "Supplemental Warrant"), exercisable
from time to time within five (5) years of the Effective Date, for the purchase
of an aggregate of fifty thousand (50,000) shares of Common Stock at a price
specified in such Warrant;
WHEREAS, pursuant to the terms of, and in partial consideration for,
the Investor's agreement to enter into the Investment Agreement, the Company has
agreed to provide the Investor with certain registration rights with respect to
the Registrable Securities;
NOW, THEREFORE, in consideration of the premises, the representations,
warranties, covenants and agreements contained herein, in the Warrant, in the
Supplemental Warrant, and in the Investment Agreement, and for other good and
valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, intending to be legally bound hereby, the parties hereto agree as
follows (capitalized terms used herein and not defined herein shall have the
meaning ascribed to them in the Investment Agreement):
<PAGE>
ARTICLE I
REGISTRATION RIGHTS
Section 1.1. FORM S-3 REGISTRATION STATEMENTS.
(a) Filing of Form S-3 Registration Statements. Subject to the terms
and conditions of this Agreement, the Company shall file with the SEC within
twenty-five (25) days following the Subscription Date (the "Filing Deadline") a
registration statement on Form S-3 under the Securities Act (the "Registration
Statement") for the registration of the resale by the Investor of the
Registrable Securities. In the event the Company fails for any reason to file
the Registration Statement by Filing Deadline, the Company shall pay $20,000 to
the Investor by wire transfer of immediately available funds into an account
designated by the Investor within three (3) Trading Days of the Filing Deadline.
(b) Effectiveness of the Registration Statement. The Company shall use
its best efforts to have the Registration Statement declared effective by the
SEC as soon as possible, but no later than April 10, 1998 (the " Effectiveness
Deadline"), and to insure that the Registration Statement remains in effect
throughout the term of this Agreement as set forth in Section 4.2, subject to
the terms and conditions of this Agreement.
(c) Failure to Obtain Effectiveness of Registration Statement. In the
event the Company fails for any reason to obtain the effectiveness of a
Registration Statement by the Effectiveness Deadline, the Company shall pay
$20,000 prorated over the thirty (30) calendar days following the Effectiveness
Deadline to the Investor by the sooner of three Trading Days after the Effective
Date or thirty-three (33) days after the Effectiveness Deadline. In the event
the Company fails for any reason to obtain the effectiveness of a Registration
Statement within thirty (30) calendar days after the Effectiveness Deadline, the
Company shall pay $20,000 to the Investor within thirty-three (33) calendar days
of the Effectiveness Deadline and an additional $1,000 for each successive
calendar day that the Registration Statement is not declared effective. All such
payments accruing during a calendar month shall be paid by wire transfer of
immediately available funds into an account designated by the Investor by the
third Trading Day of the subsequent calendar month.
(d) Failure to Maintain Effectiveness of Registration Statement. In the
event the Company fails, subsequent to the Effective Date, to maintain the
effectiveness of a Registration Statement (or the use of the underlying
prospectus) throughout the period set forth in Section 4.2, and the Investor
holds any Registrable Securities at any time during the period of such
ineffectiveness (the "Ineffective Period"), the Company shall pay to the
Investor by wire transfer of immediately available funds into an account
designated by the Investor an amount equal to two percent (2.0%) of the
aggregate Purchase Price of all of the Registrable Securities then held by the
Investor for each seven calendar-day period (or portion thereof) of such
Ineffective Period. Such amounts shall not be payable with respect to
suspensions of the effectiveness of a Registration Statement (or use of the
underlying prospectus). Such payments shall be made on the first Trading Day
after the earlier to occur of (i) the expiration of the
Page 2
<PAGE>
Commitment Period, (ii) the expiration of each twenty-eight calendar days of an
Ineffective Period, and (iii) the expiration of the Ineffective Period.
(e) If at any time subsequent to the Company's filing of the
Registration Statement, the Company receives a "no-review" letter from the SEC,
the Company shall take the Registration Statement effective within five (5)
Trading Days of receiving such approval (the "No-Review Deadline"). For each
seven calendar-day period or portion thereof after the No-Review Deadline after
which the Company does not take the Registration Statement effective, the
Company shall pay to the Investor by wire transfer of immediately available
funds into an account designated by the Investor an amount of $5,000. Such
amounts shall be payable within three Trading Days of the expiration of each
seven calendar day period during which such amounts accrue.
(f) The parties hereto acknowledge and agree that the sums payable
under Sections 1(c), 1(d), and 1(e) hereto shall constitute liquidated damages
and not penalties. The parties further acknowledge that (a) the amount of loss
or damages likely to be incurred is incapable or is difficult to precisely
estimate, (b) the amounts specified in such Sections bear a reasonable
proportion and are not plainly or grossly disproportionate to the probable loss
likely to be incurred by the Investor in connection with the failure by the
company to obtain or maintain the effectiveness of a Registration Statement or
the temporary suspension of the effectiveness of a Registration Statement, (c)
one of the reasons for the Parties reaching an agreement as to such amounts was
the uncertainty and cost of litigation regarding the question of actual damages,
and (d) the parties are sophisticated business parties and have been represented
by sophisticated and able legal and financial counsel and negotiated this
Agreement at arm's length. The rights and remedies in this subsection (f),
including the payment of liquidated damages, shall be in addition to the
provisions of Section 4.13 hereof.
ARTICLE II
REGISTRATION PROCEDURES
Section 2.1. FILINGS; INFORMATION. The Company will effect the registration and
sale of such Registrable Securities in accordance with the intended methods of
disposition thereof. Without limiting the foregoing, the Company in each such
case will do the following as expeditiously as possible, but in no event later
than the deadline, if any, prescribed therefor in this Agreement:
(a) The Company shall prepare and file with the SEC a registration
statement on Form S-3 (if use of such form is then available to the Company
pursuant to the rules of the SEC and, if not, on such other form promulgated by
the SEC for which the Company then qualifies and which counsel for the Company
shall deem appropriate and which form shall be available for the sale of the
Registrable Securities to be registered thereunder in accordance with the
provisions of this Agreement and in accordance with the intended method of
distribution of such Registrable Securities); use best efforts to cause such
filed Registration Statement to become and remain effective (pursuant to Rule
415 under the Securities Act or otherwise); prepare and file with the SEC such
amendments and supplements to such Registration Statement and the
Page 3
<PAGE>
prospectus used in connection therewith as may be necessary to keep such
Registration Statement effective for the time period prescribed by Section
1.1(b); and comply with the provisions of the Securities Act with respect to the
disposition of all securities covered by such Registration Statement during such
period in accordance with the intended methods of disposition by the Investor
set forth in such Registration Statement.
(b) The Company shall file all necessary amendments to the Registration
Statement in order to effectuate the purpose of this Agreement, the Investment
Agreement, the Warrant, and the Supplemental Warrant.
(c) If so requested by the managing underwriters, if any, or the
holders of a majority in aggregate principal amount of the Registrable
Securities being sold in connection with the filing of a Shelf Registration, the
Company shall (i) promptly incorporate in a prospectus supplement or
post-effective amendment such information as the managing underwriters, if any,
and such holders agree should be included therein, and (ii) make all required
filings of such prospectus supplement or post-effective amendment as soon as
practicable after the Company has received notification of the matters to be
incorporated in such prospectus supplement or post-effective amendment;
provided, however, that the Company shall not be required to take any action
pursuant to this Section 2.1(c) that would, in the opinion of counsel for the
Company, violate applicable law.
(d) In connection with the filing of a shelf registration, the Company
shall enter into such agreements and take all such other reasonable actions in
connection therewith (including those reasonably requested by the managing
underwriters, if any, or the holders of a majority in aggregate principal amount
of the Registrable Securities being sold) in order to expedite or facilitate the
disposition of such Registrable Securities, and in such connection, whether or
not an underwriting agreement is entered into and whether or not the
registration is an underwritten registration, (i) make such representations and
warranties to the holders of such Registrable Securities and the underwriters,
if any, with respect to the business of the Company (including with respect to
businesses or assets acquired or to be acquired by the Company), and in the
Registration Statement, prospectus and documents, if any, incorporated or deemed
to be incorporated by reference therein, in each case, in form, substance and
scope as are customarily made by issuers to underwriters in underwritten
offerings, and confirm the same if and when requested; (ii) if an underwriting
agreement is entered into, provide indemnification provisions and procedures no
less favorable to the selling holders of such Registrable Securities and the
underwriters, if any, than those set forth herein (or such other provisions and
procedures acceptable to the holders of a majority in aggregate principal amount
of Registrable Securities covered by such Registration Statement and the
managing underwriters, if any); and (iii) deliver such documents and
certificates as may be reasonably requested by the holders of a majority in
aggregate principal amount of the Registrable Securities being sold, their
counsel and the managing underwriters, if any, to evidence the continued
validity of their representations and warranties made pursuant to clause (i)
above and to evidence compliance with any customary conditions contained in the
underwriting agreement or other agreement entered into by the Company.
Page 4
<PAGE>
(e) Prior to filing a Registration Statement or prospectus, or any
amendment or supplement thereto (excluding amendments deemed to result from the
filing of documents incorporated by reference therein), the Company shall
deliver to the Investor and one firm of counsel representing the Investor, in
accordance with the notice provisions of Section 4.8, copies of such
Registration Statement as proposed to be filed, together with exhibits thereto,
which documents will be subject to review by such parties, and thereafter
deliver to the Investor and its counsel, in accordance with the notice
provisions of Section 4.8, such number of copies of such Registration Statement,
each amendment and supplement thereto (in each case including all exhibits
thereto), the prospectus included in such Registration Statement (including each
preliminary prospectus) and such other documents or information as the Investor
or counsel may reasonably request in order to facilitate the disposition of the
Registrable Securities.
(f) The Company shall deliver, in accordance with the notice provisions
of Section 4.8, to each seller of Registrable Securities covered by such
Registration Statement such number of conformed copies of such Registration
Statement and of each amendment and supplement thereto (in each case including
all exhibits and documents incorporated by reference), such number of copies of
the prospectus contained in such Registration Statement (including each
preliminary prospectus and any summary prospectus) and any other prospectus file
under Rule 424 promulgated under the Securities Act relating to such seller's
Registrable Securities, and such other documents, as such seller may reasonably
request to facilitate the disposition of its Registrable Securities.
(g) After the filing of the Registration Statement, the Company shall
promptly notify the Investor of any stop order issued or threatened by the SEC
in connection therewith and take all reasonable actions required to prevent the
entry of such stop order or to remove it if entered.
(h) The Company shall use its best efforts to (i) register or qualify
such Registrable Securities under such other securities or blue sky laws of such
jurisdictions in the United States as the Investor may reasonably (in light of
its intended plan of distribution) request, and (ii) cause such Registrable
Securities to be registered with or approved by such other governmental agencies
or authorities in the United States as may be necessary by virtue of the
business and operations of the Company and do any and all other acts and things
that may be reasonably necessary or advisable to enable the Investor to
consummate the disposition of the Registrable Securities; provided that the
Company will not be required to qualify generally to do business in any
jurisdiction where it would not otherwise be required to qualify but for this
paragraph (h), subject itself to taxation in any such jurisdiction, or consent
or subject itself to general service of process in any such jurisdiction.
(i) The Company shall promptly notify the Investor upon the occurrence
of any of the following events in respect of a Registration Statement or related
prospectus in respect of an offering of Registrable Securities: (i) receipt of
any request for additional information by the SEC or any other federal or state
governmental authority during the period of effectiveness of the Registration
Statement for amendments or supplements to the Registration Statement or related
prospectus; (ii) the issuance by the SEC or any other federal or state
governmental authority of any stop order suspending the effectiveness of the
Registration Statement or the initiation of any
Page 5
<PAGE>
proceedings for that purpose; (iii) receipt of any notification with respect to
the suspension of the qualification or exemption from qualification of any of
the Registrable Securities for sale in any jurisdiction or the initiation or
threatening of any proceeding for such purpose; (iv) the happening of any event
that makes any statement made in the Registration Statement or related
prospectus or any document incorporated or deemed to be incorporated therein by
reference untrue in any material respect or that requires the making of any
changes in the Registration Statement, related prospectus or documents so that,
in the case of the Registration Statement, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be
stated therein or necessary to make the statements therein not misleading, and
that in the case of the related prospectus, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be
stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; and (v) the Company's
reasonable determination that a post-effective amendment to the Registration
Statement would be appropriate; and the Company will promptly make available to
the Investor any such supplement or amendment to the related prospectus.
(j) The Company shall enter into customary agreements and take such
other actions as are reasonably required in order to expedite or facilitate the
disposition of such Registrable Securities (whereupon the Investor may, at its
option, require that any or all of the representations, warranties and covenants
of the Company also be made to and for the benefit of the Investor).
(k) The Company shall make available to the Investor (and will deliver
to Investor's counsel), subject to restrictions imposed by the United States
federal government or any agency or instrumentality thereof, copies of all
correspondence between the SEC and the Company, its counsel or auditors and will
also make available for inspection by the Investor and any attorney, accountant
or other professional retained by the Investor (collectively, the "Inspectors"),
all financial and other records, pertinent corporate documents and properties of
the Company (collectively, the "Records") as shall be reasonably necessary to
enable them to exercise their due diligence responsibility, and cause the
Company's officers and employees to supply all information reasonably requested
by any Inspectors in connection with such Registration Statement. Records that
the Company determines, in good faith, to be confidential and which it notifies
the Inspectors are confidential shall not be disclosed by the Inspectors unless
(i) the disclosure of such Records is necessary to avoid or correct a
misstatement or omission in such Registration Statement or (ii) the disclosure
or release of such Records is requested or required pursuant to oral questions,
interrogatories, requests for information or documents or a subpoena or other
order from a court of competent jurisdiction or other process; provided that
prior to any disclosure or release pursuant to clause (ii), the Inspectors shall
provide the Company with prompt notice of any such request or requirement so
that the Company may seek an appropriate protective order or waive such
Inspectors' obligation not to disclose such Records; and, provided further, that
if failing the entry of a protective order or the waiver by the Company
permitting the disclosure or release of such Records, the Inspectors, upon
advice of counsel, are compelled to disclose such Records, the Inspectors may
disclose that portion of the Records which counsel has advised the Inspectors
that the Inspectors are compelled to disclose. The Investor agrees that
information obtained by it solely as a result of such inspections (not including
any information obtained from a third party who, insofar as is known to the
Investor after reasonable inquiry, is
Page 6
<PAGE>
not prohibited from providing such information by a contractual, legal or
fiduciary obligation to the Company) shall be deemed confidential and shall not
be used by it as the basis for any market transactions in the securities of the
Company or its Affiliates unless and until such information is made generally
available to the public. The Investor further agrees that it will, upon learning
that disclosure of such Records is sought in a court of competent jurisdiction,
give notice to the Company and allow the Company, at its expense, to undertake
appropriate action to prevent disclosure of the Records deemed confidential.
(l) The Company shall deliver, in accordance with the notice provisions
of Section 4.8, to the Investor a signed counterpart, addressed to the Investor,
of (1) an opinion or opinions of counsel to the Company, and (2) to the extent
required by law or reasonably necessary to effect a sale of Registrable
Securities in accordance with prevailing business practices at the time of any
sale of Registrable Securities pursuant to a Registration Statement, a comfort
letter or comfort letters from the Company's independent public accountants,
each in customary form and covering such matters of the type customarily covered
by opinions or comfort letters, as the case may be, as the Investor reasonably
requests.
(m) The Company shall otherwise comply with all applicable rules and
regulations of the SEC, including, without limitation, compliance with
applicable reporting requirements under the Exchange Act.
(n) The Company shall appoint a transfer agent and registrar for all
such Registrable Securities covered by such Registration Statement not later
than the effective date of such Registration Statement.
(o) The Company may require the Investor to promptly furnish in writing
to the Company such information as may be legally required in connection with
such registration including, without limitation, all such information as may be
requested by the SEC or the National Association of Securities Dealers. The
Investor agrees to provide such information requested in connection with such
registration within ten (10) business days after receiving such written request,
and the Company shall not be responsible for any delays in obtaining or
maintaining the effectiveness of the Registration Statement caused by the
Investor's failure to timely provide such information.
Section 2.2. REGISTRATION EXPENSES. In connection with each Registration
Statement, the Company shall pay all registration expenses incurred in
connection with the registration thereunder (the "Registration Expenses"),
including, without limitation: (i) all registration, filing, securities exchange
listing and fees required by the National Association of Securities Dealers,
(ii) all registration, filing, qualification and other fees and expenses of
compliance with securities or blue sky laws (including reasonable fees and
disbursements of counsel in connection with blue sky qualifications of the
Registrable Securities), (iii) all word processing, duplicating, printing,
messenger and delivery expenses, (iv) the Company's internal expenses
(including, without limitation, all salaries and expenses of its officers and
employees performing legal or accounting duties), (v) the fees and expenses
incurred in connection with the listing of the Registrable Securities, (vi) fees
and disbursements of counsel for the Company and customary fees and expenses for
independent certified public accountants retained by the Company (including the
Page 7
<PAGE>
expenses of any special audits or comfort letters or costs associated with the
delivery by independent certified public accountants of such special audit(s) or
comfort letter(s) requested pursuant to Section 2.1(l) hereof), (vii) the fees
and expenses of any special experts retained by the Company in connection with
such registration, (viii) premiums and other costs of policies of insurance
against liabilities arising out of any public offering of the Registrable
Securities being registered, and (ix) any fees and disbursements of underwriters
customarily paid by issuers or sellers of securities, but excluding underwriting
fees, discounts, transfer taxes or commissions, if any, attributable to the sale
of Registrable Securities, which shall be payable by each holder of Registrable
Securities pro rata on the basis of the number of Registrable Securities of each
such holder that are included in a registration under this Agreement.
ARTICLE III
INDEMNIFICATION AND CONTRIBUTION
Section 3.1. INDEMNIFICATION BY THE COMPANY. The Company agrees to indemnify and
hold harmless the Investor, its partners, Affiliates, officers, directors,
employees and duly authorized agents, and each Person or entity, if any, who
controls the Investor within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act, together with the partners, Affiliates,
officers, directors, employees and duly authorized agents of such controlling
Person or entity (collectively, the "Controlling Persons"), from and against any
loss, claim, damage, liability, costs and expenses (including, without
limitation, reasonable attorneys' fees and disbursements and costs and expenses
of investigating and defending any such claim) (collectively, "Damages"), joint
or several, and any action or proceeding in respect thereof to which the
Investor, its partners, Affiliates, officers, directors, employees and duly
authorized agents, and any such Controlling Person may become subject under the
Securities Act or otherwise as incurred and, insofar as such Damages (or actions
or proceedings in respect thereof) arise out of, or are based upon, any untrue
statement or alleged untrue statement of a material fact contained in any
Registration Statement or prospectus relating to the Registrable Securities or
any preliminary prospectus, or arises out of, or are based upon, any omission or
alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein not misleading, except insofar as
the same are based upon information furnished in writing to the Company by the
Investor expressly for use therein. The Company shall reimburse the Investor,
its partners, Affiliates, officers, directors, employees and duly authorized
agents, and each such Controlling Person for any legal and other expenses
reasonably incurred by the Investor, its partners, Affiliates, officers,
directors, employees and duly authorized agents, or any such Controlling Person,
as incurred, in investigating or defending or preparing to defend against any
such Damages or actions or proceedings. Notwithstanding the foregoing, the
Company shall not be liable to the Investor to the extent that any such Damages
arise out of or are based upon an untrue statement or omission made in any
preliminary prospectus if (i) the Investor failed to send or deliver a copy of
the final prospectus delivered by the Company to the Investor with or prior to
the delivery of written confirmation of the sale by the Investor to the Person
asserting the claim from which such Damages arise, and (ii) the final prospectus
would have corrected such untrue statement or alleged untrue statement or such
omission or alleged omission.
Page 8
<PAGE>
Section 3.2. CONDUCT OF INDEMNIFICATION PROCEEDINGS. Promptly after receipt by
any person or entity in respect of which indemnity may be sought pursuant to
Section 3.1 (an "Indemnified Party") of notice of any claim or the commencement
of any action, the Indemnified Party shall, if a claim in respect thereof is to
be made against the person or entity against whom such indemnity may be sought
(the "Indemnifying Party"), notify the Indemnifying Party in writing of the
claim or the commencement of such action; in the event an Indemnified Party
shall fail to give such notice as provided in this Section 3.2 and the
Indemnifying Party to whom notice was not given was unaware of the proceeding to
which such notice would have related and was materially prejudiced by the
failure to give such notice, the indemnification provided for in Section 3.1
shall be reduced to the extent of any actual prejudice resulting from such
failure to so notify the Indemnifying Party; provided, that the failure to
notify the Indemnifying Party shall not relieve it from any liability that it
may have to an Indemnified Party otherwise than under Section 3.1. If any such
claim or action shall be brought against an Indemnified Party, and it shall
notify the Indemnifying Party thereof, the Indemnifying Party shall be entitled
to participate therein, and, to the extent that it wishes, jointly with any
other similarly notified Indemnifying Party, to assume the defense thereof with
counsel reasonably satisfactory to the Indemnified Party. After notice from the
Indemnifying Party to the Indemnified Party of its election to assume the
defense of such claim or action, the Indemnifying Party shall not be liable to
the Indemnified Party for any legal or other expenses subsequently incurred by
the Indemnified Party in connection with the defense thereof other than
reasonable costs of investigation; provided that the Indemnified Party shall
have the right to employ separate counsel to represent the Indemnified Party and
its controlling persons who may be subject to liability arising out of any claim
in respect of which indemnity may be sought by the Indemnified Party against the
Indemnifying Party, but the fees and expenses of such counsel shall be for the
account of such Indemnified Party unless (i) the Indemnifying Party and the
Indemnified Party shall have mutually agreed to the retention of such counsel or
(ii) in the reasonable judgment of the Company and such Indemnified Party,
representation of both parties by the same counsel would be inappropriate due to
actual or potential conflicts of interest between them, it being understood,
however, that the Indemnifying Party shall not, in connection with any one such
claim or action or separate but substantially similar or related claims or
actions in the same jurisdiction arising out of the same general allegations or
circumstances, be liable for the fees and expenses of more than one separate
firm of attorneys (together with appropriate local counsel) at any time for all
Indemnified Parties, or for fees and expenses that are not reasonable. No
Indemnifying Party shall, without the prior written consent of the Indemnified
Party, effect any settlement of any claim or pending or threatened proceeding in
respect of which the Indemnified Party is or could have been a party and
indemnity could have been sought hereunder by such Indemnified Party, unless
such settlement includes an unconditional release of such Indemnified Party from
all liability arising out of such claim or proceeding. Whether or not the
defense of any claim or action is assumed by the Indemnifying Party, such
Indemnifying Party will not be subject to any liability for any settlement made
without its consent, which consent will not be unreasonably withheld.
Section 3.3. OTHER INDEMNIFICATION. Indemnification similar to that specified in
the preceding paragraphs of this Article III (with appropriate modifications)
shall be given by the Company and each seller of Registrable Securities with
respect to any required registration or other qualification of securities under
any federal or state law or regulation of any governmental authority other than
the
Page 9
<PAGE>
Securities Act. The provisions of this Article III shall be in addition to any
other rights to indemnification, contribution or other remedies which an
Indemnified Party may have pursuant to law, equity, contract or otherwise.
Section 3.4 CONTRIBUTION. If the indemnification provided for in this Article
III is unavailable to the Indemnified Parties in respect of any Damages referred
to herein, then the Indemnifying Party, in lieu of indemnifying such Indemnified
Party, shall contribute to the amount paid or payable by such Indemnified Party
as a result of such Damages as between the Company on the one hand and the
Investor on the other, in such proportion as is appropriate to reflect the
relative fault of the Company and of the Investor in connection with such
statements or omissions, as well as other equitable considerations. The relative
fault of the Company on the one hand and of the Investor on the other shall be
determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by such party, and the parties'
relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission.
The Company and the Investor agree that it would not be just and equitable if
contribution pursuant to this Section 3.4 were determined by pro rata allocation
or by any other method of allocation that does not take account of the equitable
considerations referred to in the immediately preceding paragraph. The amount
paid or payable by an Indemnified Party as a result of the Damages referred to
in the immediately preceding paragraph shall be deemed to include, subject to
the limitations set forth above, any legal or other expenses reasonably incurred
by such Indemnified Party in connection with investigating or defending any such
action or claim. Notwithstanding the provisions of this Section 3.4, the
Investor shall in no event be required to contribute any amount in excess of the
amount by which the total price at which the Registrable Securities of the
Investor were sold to the public (less underwriting discounts and commissions)
exceeds the amount of any damages which the Investor has otherwise been required
to pay by reason of such untrue or alleged untrue statement or omission or
alleged omission. No Person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any Person who was not guilty of such fraudulent
misrepresentation.
ARTICLE IV
MISCELLANEOUS
Section 4.1. NO OUTSTANDING REGISTRATION RIGHTS. Except as disclosed in the SEC
Documents, the Company represents and warrants to the Investor that there is not
in effect on the date hereof any agreement by the Company pursuant to which any
holders of securities of the Company have a right to cause the Company to
register or qualify such securities under the Securities Act or any securities
or blue sky laws of any jurisdiction that would conflict or be inconsistent with
any provision of this Agreement or the Investment Agreement.
Section 4.2. TERM. The registration rights provided to the holders of
Registrable Securities hereunder shall terminate at such time as the Registrable
Securities (i) have been disposed of
Page 10
<PAGE>
pursuant to the Registration Statement, (ii) have been sold under circumstances
under which all of the applicable conditions of Rule 144 (or any similar
provision then in force) under the Securities Act ("Rule 144") are met, (iii)
have been otherwise transferred to holders who may trade such shares without
restriction under the Securities Act, and the Company has delivered a new
certificate or other evidence of ownership for such securities not bearing a
restrictive legend, or (iv) may be sold without any time, volume or manner
limitations pursuant to Rule 144(k) (or any similar provision then in effect)
under the Securities Act in the opinion of counsel to the Company, which counsel
shall be reasonably acceptable to the Investor; provided, however, that such
registration rights shall not terminate sooner than two years following the
Subscription Date. Notwithstanding the foregoing, paragraphs (c) and (d) of
Section 1.1, Article III, Section 4.8, and Section 4.9 shall survive the
termination of this Agreement.
Section 4.3. RULE 144. The Company covenants that it will file all reports
required to be filed by it under the Securities Act and the Exchange Act and
that it will take such further action as holders of Registrable Securities may
reasonably request, all to the extent required from time to time to enable the
Investor to sell Registrable Securities without registration under the
Securities Act within the limitation of the exemptions provided by (a) Rule 144,
as such Rule may be amended from time to time, or (b) any similar rule or
regulation hereafter adopted by the SEC. If at any time the Company is not
required to file such reports, it will, upon the request of any holder of
Registrable Securities, make publicly available other information so long as
necessary to permit sales pursuant to Rule 144. Upon the request of the
Investor, the Company will deliver to the Investor a written statement as to
whether it has complied with such requirements.
Section 4.4 CERTIFICATE. The Company will, at its expense, forthwith upon the
request of any holder of Registrable Securities, deliver to such holder a
certificate, signed by the Company's principal financial officer, stating (a)
the Company's name, address and telephone number (including area code), (b) the
Company's Internal Revenue Service identification number, (c) the Company's
Commission file number, (d) the number of shares of each class of Stock
outstanding as shown by the most recent report or statement published by the
Company, and (e) whether the Company has filed the reports required to be filed
under the Exchange Act for a period of at least ninety (90) days prior to the
date of such certificate and in addition has filed the most recent annual report
required to be filed thereunder.
Section 4.5. AMENDMENT AND MODIFICATION. Any provision of this Agreement may be
waived, provided that such waiver is set forth in a writing executed by both
parties to this Agreement. The provisions of this Agreement, including the
provisions of this sentence, may not be amended, modified or supplemented, and
waivers or consents to departures from the provisions hereof may not be given,
unless the Company has obtained the written consent of the holders of a majority
of the then outstanding Registrable Securities. Notwithstanding the foregoing,
the waiver of any provision hereof with respect to a matter that relates
exclusively to the rights of holders of Registrable Securities whose securities
are being sold pursuant to a Registration Statement and does not directly or
indirectly affect the rights of other holders of Registrable Securities may be
given by holders of at least a majority of the Registrable Securities being sold
by such holders; provided that the provisions of this sentence may not be
amended, modified or supplemented except in accordance with the provisions of
the immediately preceding sentence. No course of dealing between or among any
Person having any interest in this
Page 11
<PAGE>
Agreement will be deemed effective to modify, amend or discharge any part of
this Agreement or any rights or obligations of any person under or by reason of
this Agreement.
Section 4.6. SUCCESSORS AND ASSIGNS; ENTIRE AGREEMENT. This Agreement and all of
the provisions hereof shall be binding upon and inure to the benefit of the
parties hereto and their respective successors and assigns. The Investor may
assign its rights under this Agreement to any subsequent holder the Registrable
Securities, provided that the Company shall have the right to require any holder
of Registrable Securities to execute a counterpart of this Agreement as a
condition to such holder's claim to any rights hereunder. This Agreement,
together with the Investment Agreement, the Warrant, and the Supplemental
Warrant sets forth the entire agreement and understanding between the parties as
to the subject matter hereof and merges and supersedes all prior discussions,
agreements and understandings of any and every nature among them.
Section 4.7. SEPARABILITY. In the event that any provision of this Agreement or
the application of any provision hereof is declared to be illegal, invalid or
otherwise unenforceable by a court of competent jurisdiction, the remainder of
this Agreement shall not be affected except to the extent necessary to delete
such illegal, invalid or unenforceable provision unless that provision held
invalid shall substantially impair the benefits of the remaining portions of
this Agreement.
Section 4.8. NOTICES. All notices, demands, requests, consents, approvals, and
other communications required or permitted hereunder shall be in writing and
shall be (i) personally served, (ii) deposited in the mail, registered or
certified, return receipt requested, postage prepaid, (iii) delivered by
reputable air courier service with charges prepaid, or (iv) transmitted by hand
delivery, telegram, or facsimile, addressed as set forth below or to such other
address as such party shall have specified most recently by written notice. Any
notice or other communication required or permitted to be given hereunder shall
be deemed effective (a) upon hand delivery or delivery by facsimile, with
accurate confirmation generated by the transmitting facsimile machine at the
address or number designated below (if delivered on a business day during normal
business hours where such notice is to be received), or the first business day
following such delivery (if delivered other than on a business day during normal
business hours where such notice is to be received) or (b) on the second
business day following the date of mailing by express courier service, fully
prepaid, addressed to such address, or upon actual receipt of such mailing,
whichever shall first occur. The addresses for such communications shall be:
If to NUWAVE Technologies, Inc.: Jeremiah O'Brien
Chief Financial Officer
One Passaic Avenue
Fairfield, New Jersey 07004
Telephone (973) 882-8810 ext. 212
Facsimile (973) 882-8812
with a copy to: Fredric Klink, Esq.
(shall not constitute notice) Dechert, Price & Rhoads
30 Rockefeller Plaza, 23rd Floor
New York, New York 10112
Telephone (212) 698-3537
Facsimile (212) 698-3599
Page 12
<PAGE>
If to the Investor: Gary D. Halbert
President
ProFutures Special Equities Fund, L.P.
1310 Highway 620 South, Suite 200
Austin, TX 78734
Telephone (512) 263-3800
Facsimile (512) 263-3459
with a copy to: John Gray, Esq.
(shall not constitute notice) Fishman, Jones, Walsh & Marsh, P.C.
1310 Highway 620 South, Suite 200
Austin, TX 78734
Telephone (512) 263-8057
Facsimile (512) 263-8058
Either party hereto may from time to time change its address or facsimile number
for notices under this Section 4.8 by giving at least ten (10) days' prior
written notice of such changed address or facsimile number to the other party
hereto.
Section 4.9. GOVERNING LAW. This Agreement shall be governed by and construed in
accordance with the laws of the State of New Jersey without giving effect to the
provisions governing conflict of laws.
Section 4.10. HEADINGS. The headings in this Agreement are for convenience of
reference only and shall not constitute a part of this Agreement, nor shall they
affect their meaning, construction or effect.
Section 4.11. COUNTERPARTS. This Agreement may be executed in multiple
counterparts, each of which shall be deemed to be an original instrument and all
of which together shall constitute one and the same instrument.
Section 4.12. FURTHER ASSURANCES. Each party shall cooperate and take such
action as may be reasonably requested by another party in order to carry out the
provisions and purposes of this Agreement and the transactions contemplated
hereby.
Section 4.13. REMEDIES. In the event of a breach or a threatened breach by any
party to this Agreement of its obligations under this Agreement, any party
injured or to be injured by such breach will be entitled to specific performance
of its rights under this Agreement or to injunctive relief, in addition to being
entitled to exercise all rights provided in this Agreement and granted by law.
The parties agree that the provisions of this Agreement shall be specifically
enforceable, it being agreed by the parties that the remedy at law, including
monetary damages, for breach of any such provision will be inadequate
compensation for any loss and that any defense or objection in
Page 13
<PAGE>
any action for specific performance or injunctive relief that a remedy at law
would be adequate is waived.
Section 4.14 DEFINITIONS. Capitalized terms not otherwise defined herein shall
have the same meanings herein as are ascribed to them in the Investment
Agreement, the Warrant, and the Supplemental Warrant.
Page 14
<PAGE>
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed by the undersigned, thereunto duly authorized, as of the date first set
forth above.
NUWAVE TECHNOLOGIES, INC.
By:
-------------------------------------
Gerald Zarin
Chairman and Chief Executive Officer
PROFUTURES SPECIAL EQUITIES FUND, L.P.
By: ProFutures Fund Management, Inc., the
co-General Partner
By:
-------------------------------------
Gary D. Halbert
President
Page 15
PRIVATE SECURITIES SUBSCRIPTION AGREEMENT
Between
PROFUTURES SPECIAL EQUITIES FUND, L.P.
And
NUWAVE TECHNOLOGIES, INC.
Dated as of February 6, 1998
PRIVATE SECURITIES SUBSCRIPTION AGREEMENT dated as of February 6, 1998,
(the "Agreement"), between ProFutures Special Equities Fund, L.P. (the
"Investor"), a corporation organized and existing under the laws of Texas, and
NUWAVE Technologies, Inc., a corporation organized and existing under the laws
of the State of Delaware (the "Company").
WHEREAS, the parties desire that, upon the terms and subject to the
conditions contained herein and in reliance upon the representations and
warranties contained herein, the Company shall issue and sell to the Investor
and the Investor shall purchase shares of the Common Stock (as defined below)
for an aggregate purchase price of $1,000,000 (the "Initial Investment Amount")
payable in United States Dollars;
WHEREAS, the parties desire that, upon the terms and subject to the
conditions contained herein, the Company shall issue and sell to the Investor,
from time to time as provided herein, and the Investor shall purchase, up to an
additional $5,000,000 of the Common Stock (as defined below); and
WHEREAS, such investments will be made in reliance upon the provisions
of Section 4(2) ("Section 4(2)") and Regulation D ("Regulation D") of the United
States Securities Act of 1933, as amended, and the regulations promulgated
thereunder (the "Securities Act"), and/or upon such other exemption from the
registration requirements of the Securities Act as may be available with respect
to any or all of the investments in Common Stock to be made hereunder.
NOW, THEREFORE, the parties hereto agree as follows:
ARTICLE I
Certain Definitions
Section 1.1. "Bid Price" shall mean the closing bid price (as reported by
Bloomberg L.P.) of the Common Stock on the Principal Market.
Section 1.2. "Capital Shares" shall mean the Common Stock and any shares of any
other class of common stock whether now or hereafter authorized, having the
right to participate in the distribution of earnings and assets of the Company.
Section 1.3. "Capital Shares Equivalents" shall mean any securities, rights, or
obligations that are convertible into or exchangeable for or giving any right to
subscribe for any
<PAGE>
Capital Stock of the Company or any warrants, options or other rights to
subscribe for or purchase Common Stock or any such convertible or exchangeable
securities.
Section 1.4. "Closing" shall mean one of the closings of a purchase and sale of
the Common Stock through a Put pursuant to Section 2.1(b).
Section 1.5. "Closing Date" shall mean, with respect to a Closing, the fifth
Trading Day following the Put Date related to such Closing, provided all
conditions to such Closing have been satisfied on or before such Trading Day.
Section 1.6. "Commitment Amount" shall mean the $5,000,000 up to which the
Investor has agreed to provide to the Company in order to purchase Put Shares
pursuant to the terms and conditions of this Agreement.
Section 1.7. "Commitment Period" shall mean the period commencing on the earlier
to occur of (i) the Effective Date or (ii) such earlier date as the Company and
the Investor may mutually agree in writing, and expiring on the earliest to
occur of (x) the date on which the Investor shall have purchased Put Shares
pursuant to this Agreement for an aggregate Purchase Price of $5,000,000, (y)
the date this Agreement is terminated pursuant to Section 2.4, or (z) the date
occurring two years from the date of commencement of the Commitment Period.
Section 1.8. "Common Stock" shall mean the Company's common stock, par value
$0.01 per share.
Section 1.9. "Condition Satisfaction Date" shall have the meaning set forth in
Section 7.2.
Section 1.10. "Damages" shall mean any loss, claim, damage, liability, costs and
expenses (including, without limitation, reasonable attorney's fees and
disbursements and costs and expenses of expert witnesses and investigation).
Section 1.11. "Effective Date" shall mean the date on which the SEC first
declares effective a Registration Statement registering the resale of the
Registrable Securities as set forth in Section 7.2(a).
Section 1.12. "Exchange Act" shall mean the Securities Exchange Act of 1934, as
amended, and the regulations promulgated thereunder.
Section 1.13. "Floor Price" shall mean $2.50 per share of Common Stock.
Section 1.14. "Initial Investment Amount" shall mean $1,000,000 U.S.
Section 1.15. "Initial Shares" shall mean all shares of Common Stock issued
pursuant to the tender of the Initial Investment Amount by the Investor to the
Company on the Subscription Date in accordance with the terms of Section 2.1
hereof.
Page 2
<PAGE>
Section 1.16. "Investment Amount" shall mean the dollar amount to be invested by
the Investor to purchase Put Shares with respect to any Put Date as notified by
the Company to the Investor, all in accordance with the terms of Section 2.2
hereof.
Section 1.17. "Legend" shall have the meaning set forth in Section 9.1.
Section 1.18. "Market Price" on any given date shall mean the average of the Bid
Price on each Trading Day during the Valuation Period.
Section 1.19. "Material Adverse Effect" shall mean any effect on the business,
operations, properties, prospects, or financial condition of the Company that is
material and adverse to the Company or to the Company and such other entities
controlling or controlled by the Company, taken as a whole, and/or any
condition, circumstance, or situation that would materially interfere with the
ability of the Company to enter into and perform any of its obligations under
this Agreement, the Registration Rights Agreement, the Warrant, or the
Supplemental Warrant.
Section 1.20. "NASD" shall mean the National Association of Securities Dealers,
Inc.
Section 1.21. "Outstanding" when used with reference to shares of Common Stock
or Capital Shares (collectively the "Shares"), shall mean, at any date as of
which the number of such Shares is to be determined, all issued and outstanding
Shares, and shall include all such Shares issuable in respect of outstanding
scrip or any certificates representing fractional interests in such Shares;
provided, however, that "Outstanding" shall not mean any such Shares then
directly or indirectly owned or held by or for the account of the Company.
Section 1.22. "Person" shall mean an individual, a corporation, a partnership,
an association, a trust or other entity or organization, including a government
or political subdivision or an agency or instrumentality thereof.
Section 1.23. "Principal Market" shall mean the Nasdaq National Market, the
Nasdaq Small-Cap Market, the American Stock Exchange or the New York Stock
Exchange, whichever is at the time the principal trading exchange or market for
the Common Stock.
Section 1.24. "Purchase Price" shall mean (A) with respect to the Put Shares,
eighty-eight percent (88%) of the Market Price upon a Put Date (or such other
date on which the Purchase Price is calculated in accordance with the terms and
conditions of this Agreement) and (B) with respect to the Initial Shares, eighty
percent (80%) of the Market Price upon the Subscription Date.
Section 1.25. "Put" shall mean each occasion the Company elects to exercise its
right to tender a Put Notice requiring the Investor to purchase Common Stock,
pursuant to the terms and conditions of this Agreement.
Section 1.26. "Put Date" shall mean the Trading Day during the Commitment Period
that a Put Notice to sell Common Stock to the Investor is deemed delivered
pursuant to Section 2.2(b) hereof.
Page 3
<PAGE>
Section 1.27. "Put Notice" shall mean the written notice to the Investor of a
Put setting forth the Investment Amount that the Company intends to sell to the
Investor.
Section 1.28. 1. "Put Shares" shall mean all shares of Common Stock or other
securities issued or issuable pursuant to a Put that has occurred or may occur
in accordance with the terms and conditions of this Agreement.
Section 1.29. "Registrable Securities" shall mean the Initial Shares, the Put
Shares, the Warrant Shares, and the Supplemental Warrant Shares until (i) the
Registration Statement has been declared effective by the SEC, and all Initial
Shares, Put Shares, Warrant Shares, and Supplemental Warrant Shares have been
disposed of pursuant to the Registration Statement, (ii) all Initial Shares, Put
Shares, Warrant Shares, and Supplemental Warrant Shares have been sold under
circumstances under which all of the applicable conditions of Rule 144 (or any
similar provision then in force) under the Securities Act ("Rule 144") are met,
(iii) all Initial Shares, Put Shares, Warrant Shares, and Supplemental Warrant
Shares have been otherwise transferred to holders who may trade such shares
without restriction under the Securities Act, and the Company has delivered a
new certificate or other evidence of ownership for such securities not bearing a
restrictive legend or (iv) such time as, in the opinion of counsel to the
Company, which counsel shall be reasonably acceptable to the Investor, all
Initial Shares, Put Shares, Warrant Shares, and Supplemental Warrant Shares may
be sold without any time, volume or manner limitations pursuant to Rule 144(k)
(or any similar provision then in effect) under the Securities Act.
Section 1.30. "Registration Rights Agreement" shall mean the agreement regarding
the filing of the Registration Statement for the resale of the Registrable
Securities, entered into between the Company and the Investor on the
Subscription Date.
Section 1.31. "Registration Statement" shall mean a registration statement on
Form S-3 (if use of such form is then available to the Company pursuant to the
rules of the SEC and, if not, on such other form promulgated by the SEC for
which the Company then qualifies and which counsel for the Company shall deem
appropriate, and which form shall be available for the resale of the Registrable
Securities to be registered thereunder in accordance with the provisions of this
Agreement, the Registration Rights Agreement, the Warrant, and the Supplemental
Warrant and in accordance with the intended method of distribution of the
Registrable Securities), for the registration of the resale by the Investor of
the Registrable Securities under the Securities Act.
Section 1.32. "Regulation D" shall have the meaning set forth in the recitals of
this Agreement.
Section 1.33. "SEC" shall mean the Securities and Exchange Commission.
Section 1.34. "Section 4(2)" shall have the meaning set forth in the recitals of
this Agreement.
Section 1.35. "Securities Act" shall have the meaning set forth in the recitals
of this Agreement.
Page 4
<PAGE>
Section 1.36. "SEC Documents" shall mean the Company's latest Form 10-K as of
the time in question, all Forms 10-Q and 8-K filed thereafter, and the Proxy
Statement for its latest fiscal year as of the time in question until such time
the Company no longer has an obligation to maintain the effectiveness of a
Registration Statement as set forth in the Registration Rights Agreement.
Section 1.37. "Subscription Date" shall mean the date on which this Agreement is
executed and delivered by the parties hereto.
Section 1.38. "Supplemental Warrant" shall have the meaning set forth in Section
2.6.
Section 1.39. "Supplemental Warrant Shares" shall mean all shares of Common
Stock or other securities issued or issuable pursuant to exercise of the
Supplemental Warrant.
Section 1.40. "Trading Cushion" shall mean the mandatory twenty (20) Trading
Days between Put Dates.
Section 1.41. "Trading Day" shall mean any day during which the New York Stock
Exchange shall be open for business.
Section 1.42. "Valuation Event" shall mean an event in which the Company at any
time during a Valuation Period takes any of the following actions:
a) subdivides or combines its Common Stock;
b) pays a dividend in its Capital Stock or makes any other distribution of
its Capital Shares;
c) issues any additional Capital Shares ("Additional Capital Shares"),
otherwise than as provided in the foregoing Subsections (a) and (b) above, at a
price per share less, or for other consideration lower, than the Bid Price in
effect immediately prior to such issuance, or without consideration;
d) issues any warrants, options or other rights to subscribe for or
purchase any Additional Capital Shares and the price per share for which
Additional Capital Shares may at any time thereafter be issuable pursuant to
such warrants, options or other rights shall be less than the Bid Price in
effect immediately prior to such issuance;
e) issues any securities convertible into or exchangeable for Capital
Shares and the consideration per share for which Additional Capital Shares may
at any time thereafter be issuable pursuant to the terms of such convertible or
exchangeable securities shall be less than the Bid Price in effect immediately
prior to such issuance;
f) makes a distribution of its assets or evidences of indebtedness to the
holders of its Capital Shares as a dividend in liquidation or by way of return
of capital or other than as a dividend payable out of earnings or surplus
legally available for dividends under applicable law or any distribution to such
holders made in respect of the sale of all or
Page 5
<PAGE>
substantially all of the Company's assets (other than under the circumstances
provided for in the foregoing subsections (a) through (e); or
g) takes any action affecting the number of Outstanding Capital Shares,
other than an action described in any of the foregoing Subsections (a) through
(f) hereof, inclusive, which in the opinion of the Company's Board of Directors,
determined in good faith, would have a Material Adverse Effect upon the rights
of the Investor at the time of a Put or exercise of the Warrant or the
Supplemental Warrant.
Section 1.43. "Valuation Period" shall mean the period of five (5) Trading Days
during which the Purchase Price of the Common Stock is valued, which period
shall be (A) with respect to the Put Shares, the two (2) Trading Days
immediately preceding and the two (2) Trading Days following the applicable Put
Date, as well as the Put Date and (B) with respect to the Initial Shares the two
(2) Trading Days immediately preceding and the two (2) Trading Days following
the Subscription Date (or following Trading Day if the Subscription Date is not
a Trading Day) as well as the Subscription Date; provided, however, that if a
Valuation Event occurs during a Valuation Period, a new Valuation Period shall
begin on the Trading Day immediately after such Valuation Event.
Section 1.44. "Warrant" shall have the meaning set forth in Section 2.5.
Section 1.45. "Warrant Shares" shall mean all shares of Common Stock or other
securities issued or issuable pursuant to exercise of the Warrant.
ARTICLE II
Purchase and Sale of Common Stock
Section 2.1 Investments.
(a) Initial Shares. Upon the execution of this Agreement, the Company
agrees to sell and Investor agrees to purchase a number of shares of Common
Stock (the "Initial Shares") determined by dividing the Initial Investment
Amount by the Purchase Price on the Subscription Date.
(b) Puts. Upon the terms and conditions set forth herein (including,
without limitation, the provisions of Article VII hereof), on any Put Date, the
Company may make a Put by the delivery of a Put Notice. The number of Put Shares
that the Investor shall receive pursuant to such Put shall be determined by
dividing the Investment Amount specified in the Put Notice by the Purchase Price
on such Put Date.
(c) Minimum Aggregate Amount of Puts. The Company shall, in accordance with
Section 2.2(a), issue and sell Put Shares to the Investor totaling (in aggregate
Purchase Prices) at least $1,000,000. If the Company for any reason fails to
issue and deliver such Put Shares during the Commitment Period, on the first
Trading Day after the expiration of the Commitment Period, the Company shall
deliver to Investor a sum in cash equal to ($1,000,000 minus the aggregate
Investment Amounts of the Put Shares delivered hereunder) X 0.2.
Page 6
<PAGE>
(d) Maximum Aggregate Issuance of Common Stock. The Company may not issue
or sell more than 1,069,000 shares of Common Stock (as such number shall be
adjusted for stock splits or combinations) pursuant to Puts.
Section 2.2 Mechanics.
(a) Put Notice. At any time during the Commitment Period, the Company may
deliver a Put Notice to the Investor, subject to the conditions set forth in
Section 7.2; provided, however, the Investment Amount for each Put as designated
by the Company in the applicable Put Notice shall be neither less than $250,000
nor more than $750,000.
(b) Date of Delivery of Put Notice. A Put Notice shall be deemed delivered
on (i) the Trading Day it is received by facsimile or otherwise by the Investor
if such notice is received prior to 12:00 noon Eastern Time, or (ii) the
immediately succeeding Trading Day if it is received by facsimile or otherwise
after 12:00 noon Eastern Time on a Trading Day or at any time on a day which is
not a Trading Day. No Put Notice may be deemed delivered, on a day that is not a
Trading Day.
Section 2.3 Closings.
(a) Put Closings. On each Closing Date, (i) the Company shall deliver to
the Investor one or more certificates, at the Investor's option, representing
the Put Shares to be purchased by the Investor pursuant to Section 2.1 herein,
registered in the name of the Investor or, at the Investor's option, deposit
such certificate(s) into such account or accounts previously designated by the
Investor, and (ii) the Investor shall deliver to escrow the Investment Amount
specified in the Put Notice by wire transfer of immediately available funds to
an account designated by the Company on or before the Closing Date. In addition,
on or prior to the Closing Date, each of the Company and the Investor shall
deliver all documents, instruments and writings required to be delivered or
reasonably requested by either of them pursuant to this Agreement in order to
implement and effect the transactions contemplated herein. Payment of funds to
the Company and delivery of the certificates to the Investor shall occur out of
escrow in accordance with the escrow agreement referred to in Section 7.2(p)
following (x) the Company's deposit into escrow of the certificates representing
the Put Shares and (y) the Investor's deposit into escrow of the Investment
Amount; provided, however, that to the extent the Company has not paid the fees,
expenses, and disbursements of the Investor's counsel in accordance with Section
13.7, the amount of such fees, expenses, and disbursements shall be paid in
immediately available funds, at the direction of the Investor, to Investor's
counsel with no reduction in the number of Put Shares issuable to the Investor
on such Closing Date. In the event the Company fails to deliver certificates
representing the Put Shares to escrow by the related Closing Date, the Company
shall pay to the Investor an amount equal to five percent (5%) of the aggregate
purchase price of the Put Shares represented by such certificates within five
Trading Days of such Closing Date.
(b) Initial Shares Closing. On the Subscription Date, (i) the Company shall
deliver to the Investor one or more certificates, at the Investor's option,
representing the Initial Shares to be purchased by the Investor pursuant to
Section 2.1 herein,
Page 7
<PAGE>
registered in the name of the Investor or, at the Investor's option, deposit
such certificate(s) into such account or accounts previously designated by the
Investor, and (ii) the Investor shall deliver to escrow the Initial Investment
Amount by wire transfer of immediately available funds to an account designated
by the Company on or before the Closing Date. In addition, on or prior to the
Closing Date, each of the Company and the Investor shall deliver all documents,
instruments and writings required to be delivered or reasonably requested by
either of them pursuant to this Agreement in order to implement and effect the
transactions contemplated herein. Payment of funds to the Company and delivery
of the certificates to the Investor shall occur following (x) the Company's
deposit into escrow of the certificates representing the Initial Shares and (y)
the Investor's deposit into escrow of the Initial Investment Amount. In the
event the Company fails to deliver certificates representing the Initial Shares
to escrow by the closing of the purchase of the Initial Shares, the Company
shall pay to the Investor an amount equal to five percent (5%) of the aggregate
purchase price of the Initial Shares represented by such certificates.
Section 2.4 Termination of Investment Obligation. This Agreement and the
obligation of the Investor to purchase shares of Common Stock shall terminate
permanently at the Investor's option (including with respect to a Closing Date
that has not yet occurred) in the event that (i) there shall occur any stop
orders or suspensions of the effectiveness of the Registration Statement for an
aggregate of over fifteen (15) Trading Days during any calendar year during the
Commitment Period, (ii) the Company shall at any time fail to comply with the
requirements of Section 6.3, 6.4 or 6.6, (iii) the Commitment Period shall
expire, or (iv) the Company issues the maximum number of shares of common stock
permitted by this Agreement pursuant to Section 2.1(d).
Section 2.5 The Warrant. On the Subscription Date, the Company will issue to the
Investor a warrant (the "Warrant"), substantially in the form of Exhibit A
hereto to purchase an aggregate of 50,000 shares of Common Stock at a price
equal to one hundred and thirty (130%) of the Market Price as of the
Subscription Date. The Warrant may be exercised at any time beginning six months
from the Subscription Date and ending three years thereafter. The Warrant shall
be delivered by the Company to the Investor upon execution of this Agreement by
the parties hereto. The Warrant Shares shall be registered for resale pursuant
to the Registration Rights Agreement.
Section 2.6 The Supplemental Warrant. In the event that the Market Price as of
the Effective Date is less than the Market Price as of the Subscription Date,
the Company will issue to the Investor a warrant (the "Supplemental Warrant"),
substantially in the form of Exhibit B hereto, to purchase 50,000 shares of
Common Stock at a strike price equal to the Market Price as of the Subscription
Date. If necessary, the Supplemental Warrant may be exercised at any time
beginning five (5) Trading Day after the Effective Date and ending five years
thereafter. The Supplemental Warrant shall be delivered by the Company to the
Investor within five (5) Trading Days of the Effective Date. The Supplemental
Warrant Shares shall be registered for resale pursuant to the Registration
Rights Agreement.
Section 2.7 Reserved.
Page 8
<PAGE>
Section 2.8 Liquidated Damages. The parties hereto acknowledge and agree that
the sums payable under Section 2.1(c), 2.3(a) and 2.3(b) shall constitute
liquidated damages and not penalties. The parties further acknowledge that (a)
the amount of loss or damages likely to be incurred is incapable or is difficult
to precisely estimate, (b) the amounts specified in such Sections bear a
reasonable proportion and are not plainly or grossly disproportionate to the
probable loss likely to be incurred by the Investor in connection with the
failure by the Company to make Puts with aggregate Purchase Prices totaling at
least $1,000,000 , and (c) the parties are sophisticated business parties and
have been represented by sophisticated and able legal and financial counsel and
negotiated this Agreement at arm's length. The rights and remedies in this
Section 2.8, including the payment of liquidated damages, shall be in addition
to the provisions of Section 13.8 hereof.
ARTICLE III
Representations and Warranties of Investor
The Investor represents and warrants to the Company that:
Section 3.1 Intent. The Investor is entering into this Agreement for its own
account and the Investor has no present arrangement (whether or not legally
binding) at any time to sell the Common Stock to or through any person or
entity; provided, however, that by making the representations herein, the
Investor does not agree to hold the Common Stock for any minimum or other
specific term and reserves the right to dispose of the Common Stock at any time
in accordance with federal and state securities laws applicable to such
disposition.
Section 3.2 Sophisticated Investor. The Investor is a sophisticated investor (as
described in Rule 506(b)(2)(ii) of Regulation D) and an accredited investor (as
defined in Rule 501 of Regulation D), and Investor has such experience in
business and financial matters that it is capable of evaluating the merits and
risks of an investment in Common Stock. The Investor acknowledges that an
investment in the Common Stock is speculative and involves a high degree of
risk.
Section 3.3 Authority. This Agreement has been duly authorized and validly
executed and delivered by the Investor and is a valid and binding agreement of
the Investor enforceable against it in accordance with its terms, subject to
applicable bankruptcy, insolvency, or similar laws relating to, or affecting
generally the enforcement of, creditors' rights and remedies or by other
equitable principles of general application.
Section 3.4 Not an Affiliate. The Investor is not an officer, director or
"affiliate" (as that term is defined in Rule 405 of the Securities Act) of the
Company.
Section 3.5 Organization and Standing. The Investor is a limited partnership
duly organized, validly existing, and in good standing under the laws of
Delaware.
Section 3.6 Absence of Conflicts. The execution and delivery of this Agreement
and any other document or instrument executed in connection herewith, and the
Page 9
<PAGE>
consummation of the transactions contemplated thereby, and compliance with the
requirements thereof, will not violate any law, rule, regulation, order, writ,
judgment, injunction, decree or award binding on Investor, or, to the Investor's
knowledge, (a) violate any provision of any indenture, instrument or agreement
to which Investor is a party or is subject, or by which Investor or any of its
assets is bound; (b) conflict with or constitute a material default thereunder;
(c) result in the creation or imposition of any lien pursuant to the terms of
any such indenture, instrument or agreement, or constitute a breach of any
fiduciary duty owed by Investor to any third party; or (d) require the approval
of any third-party (which has not been obtained) pursuant to any material
contract, agreement, instrument, relationship or legal obligation to which
Investor is subject or to which any of its assets, operations or management may
be subject.
Section 3.7 Disclosure; Access to Information. Investor has received all
documents, records, books and other information pertaining to Investor's
investment in the Company that have been requested by Investor. The Company is
subject to the periodic reporting requirements of the Exchange Act, and Investor
has reviewed or received copies of any such reports that have been requested by
it.
Section 3.8 Manner of Sale. At no time was Investor presented with or solicited
by or through any leaflet, public promotional meeting, television advertisement
or any other form of general solicitation or advertising.
ARTICLE IV
Representations and Warranties of the Company
The Company represents and warrants to the Investor that, except as set forth in
the Schedule of Exceptions attached hereto:
Section 4.1 Organization of the Company. The Company is a corporation duly
incorporated and existing in good standing under the laws of the State of
Delaware and has all requisite corporate authority to own its properties and to
carry on its business as now being conducted. Except as set forth in the SEC
Documents, the Company does not have any subsidiaries. Except as set forth in
the SEC Documents , the Company does not own more than fifty percent (50%) of or
control any other business entity. The Company is duly qualified as a foreign
corporation to do business and is in good standing in every jurisdiction in
which the nature of the business conducted or property owned by it makes such
qualification necessary, other than those in which the failure so to qualify
would not have a Material Adverse Effect.
Section 4.2 Authority. (i) The Company has the requisite corporate power and
authority to enter into and perform its obligations under this Agreement, the
Registration Rights Agreement, and the Warrant and to issue the Put Shares, the
Warrant and the Warrant Shares, (ii) the execution, issuance and delivery of
this Agreement, the Registration Rights Agreement, and the Warrant by the
Company and the consummation by it of the transactions contemplated hereby have
been duly authorized by all necessary corporate action and no further consent or
authorization of the Company or its Board of Directors or stockholders is
required, and (iii) this Agreement, the Registration Rights
Page 10
<PAGE>
Agreement, and the Warrant have been duly executed and delivered by the Company
and constitute valid and binding obligations of the Company enforceable against
the Company in accordance with their terms, except as such enforceability may be
limited by applicable bankruptcy, insolvency, or similar laws relating to, or
affecting generally the enforcement of, creditors' rights and remedies or by
other equitable principles of general application.
Section 4.3 Capitalization. The authorized capital stock of the Company consists
of 20,000,000 shares of Common Stock, par value $0.01, of which 5,348,334 shares
were issued and outstanding as of September 30, 1997, and 1,000,000 shares of
Preferred Stock, par value $0.01, none of which were issued and outstanding as
of September 30, 1997. Schedule 4.3 lists all outstanding options, warrants,
convertible securities or other rights to purchase common stock. Except stated
above and except as set forth in the SEC Documents, there are no outstanding
Capital Shares Equivalents. All of the outstanding shares of Common Stock of the
Company have been duly and validly authorized and issued and are fully paid and
nonassessable.
Section 4.4 Common Stock. The Company has registered its Common Stock pursuant
to Section 12(b) or 12(g) of the Exchange Act and is in full compliance with all
reporting requirements of the Exchange Act, and the Company has maintained all
requirements for the continued listing or quotation of its Common Stock, and
such Common Stock is currently listed or quoted on the Principal Market. As of
the date hereof, the Principal Market is the Nasdaq Small Cap Market.
Section 4.5. SEC Documents. The Company has delivered or made available to the
Investor true and complete copies of the SEC Documents (including, without
limitation, proxy information and solicitation materials). The Company has not
provided to the Investor any information that, according to applicable law, rule
or regulation, should have been disclosed publicly prior to the date hereof by
the Company, but which has not been so disclosed. As of their respective dates,
the SEC Documents complied in all material respects with the requirements of the
Securities Act or the Exchange Act, as the case may be, and rules and
regulations of the SEC promulgated thereunder and other federal, state and local
laws, rules and regulations applicable to such SEC Documents, and none of the
SEC Documents contained any untrue statement of a material fact or omitted to
state a material fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances under which they were
made, not misleading. The financial statements of the Company included in the
SEC Documents comply as to form in all material respects with applicable
accounting requirements and the published rules and regulations of the SEC or
other applicable rules and regulations with respect thereto. Such financial
statements have been prepared in accordance with generally accepted accounting
principles applied on a consistent basis during the periods involved (except (i)
as may be otherwise indicated in such financial statements or the notes thereto
or (ii) in the case of unaudited interim statements, to the extent they may not
include footnotes or may be condensed or summary statements) and fairly present
in all material respects the financial position of the Company as of the dates
thereof and the results of operations and cash flows for the periods then ended
(subject, in the case of unaudited statements, to normal year-end audit
adjustments).
Page 11
<PAGE>
Section 4.6 Exemption from Registration; Valid Issuances. The sale of the
Initial Shares, the Put Shares, the Warrant, and the Supplemental Warrant may
and will be properly conducted pursuant to Rule 4(2), Regulation D, any
applicable federal securities law, and/or any applicable state law. When issued,
the Registrable Securities will be duly and validly issued, fully paid, and
nonassessable. Neither the sales of the Registrable Securities pursuant to, nor
the Company's performance of its obligations under, this Agreement, the
Registration Rights Agreement, the Warrant, or the Supplemental Warrant will (i)
result in the creation or imposition of any liens, charges, claims or other
encumbrances upon the Registrable Securities or any of the assets of the
Company, or (ii) entitle the holders of Outstanding Capital Shares to preemptive
or other rights to subscribe to or acquire the Capital Shares or other
securities of the Company. The Registrable Securities shall not subject the
Investor to personal liability by reason of the possession thereof.
Section 4.7 No General Solicitation or Advertising in Regard to this
Transaction. Neither the Company nor any of its affiliates nor any distributor
or any person acting on its or their behalf (i) has conducted or will conduct
any general solicitation (as that term is used in Rule 502(c) of Regulation D)
or general advertising with respect to any of the Put Shares, the Warrant, or
the Warrant Shares, or (ii) made any offers or sales of any security or
solicited any offers to buy any security under any circumstances that would
require registration of the Common Stock under the Securities Act.
Section 4.8 Corporate Documents. The Company has furnished or made available to
the Investor true and correct copies of the Company's Articles of Incorporation,
as amended and in effect on the date hereof (the "Articles"), and the Company's
By-Laws, as amended and in effect on the date hereof (the "By-Laws").
Section 4.9 No Conflicts. The execution, delivery and performance of this
Agreement by the Company and the consummation by the Company of the transactions
contemplated hereby, including without limitation the issuance of Common Stock,
the Warrant and the Supplemental Warrant do not and will not (i) result in a
violation of the Company's Articles or By-Laws or (ii) conflict with, or
constitute a default (or an event that with notice or lapse of time or both
would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any material agreement, indenture,
instrument or any "lock-up" or similar provision of any underwriting or similar
agreement to which the Company is a party, or (iii) result in a violation of any
federal, state, local or foreign law, rule, regulation, order, judgment or
decree (including federal and state securities laws and regulations) applicable
to the Company or by which any property or asset of the Company is bound or
affected (except for such conflicts, defaults, terminations, amendments,
accelerations, cancellations and violations as would not, individually or in the
aggregate, have a Material Adverse Effect) nor is the Company otherwise in
violation of, conflict with or in default under any of the foregoing; provided
that, for purposes of the Company's representations and warranties as to
violations of foreign law, rule or regulation referenced in clause (iii), such
representations and warranties are made only to the best of the Company's
knowledge insofar as the execution, delivery and performance of this Agreement
by the Company and the consummation by the Company of the transactions
contemplated hereby are or may be
Page 12
<PAGE>
affected by the status of the Investor under or pursuant to any such foreign
law, rule or regulation. The business of the Company is not being conducted in
violation of any law, ordinance or regulation of any governmental entity, except
for possible violations that either singly or in the aggregate do not and will
not have a Material Adverse Effect. The Company is not required under federal,
state or local law, rule or regulation to obtain any consent, authorization or
order of, or make any filing or registration with, any court or governmental
agency in order for it to execute, deliver or perform any of its obligations
under this Agreement or issue and sell the Common Stock or the Warrant in
accordance with the terms hereof (other than any SEC, NASD or state securities
filings that may be required to be made by the Company subsequent to any
Closing, any registration statement that may be filed pursuant hereto, and any
shareholder approval required by the rules applicable to companies whose common
stock trades on the Nasdaq Small Cap Market referenced in Section 4.4); provided
that, for purposes of the representation made in this sentence, the Company is
assuming and relying upon the accuracy of the relevant representations and
agreements of the Investor herein.
Section 4.10 No Material Adverse Change. Since September 30, 1997, no Material
Adverse Effect has occurred or exists with respect to the Company, except as
disclosed in the SEC Documents.
Section 4.11 No Undisclosed Liabilities. The Company has no liabilities or
obligations which are material, individually or in the aggregate, and are not
disclosed in the SEC Documents or otherwise publicly announced, other than those
incurred in the ordinary course of the Company's businesses since September 30,
1997, and which, individually or in the aggregate, do not or would not have a
Material Adverse Effect on the Company.
Section 4.12 No Undisclosed Events or Circumstances. Since September 30, 1997,
no event or circumstance has occurred or exists with respect to the or its
businesses, properties, prospects, operations or financial condition, that,
under applicable law, rule or regulation, requires public disclosure or
announcement prior to the date hereof by the Company but which has not been so
publicly announced or disclosed in the SEC Documents.
Section 4.13 No Integrated Offering. Neither the Company, nor any of its
affiliates, nor any person acting on its or their behalf has, directly or
indirectly, made any offers or sales of any security or solicited any offers to
buy any security, other than pursuant to this Agreement, under circumstances
that would require registration of the Common Stock under the Securities Act.
Section 4.14 Litigation and Other Proceedings. Except as may be set forth in the
SEC Documents, there are no lawsuits or proceedings pending or, to the best
knowledge of the Company, threatened against the Company, nor has the Company
received any written or oral notice of any such action, suit, proceeding or
investigation, which might have a Material Adverse Effect. Except as set forth
in the SEC Documents, no judgment, order, writ, injunction or decree or award
has been issued by or, so far as is known by the Company, requested of any
court, arbitrator or governmental agency which might result in a Material
Adverse Effect.
Page 13
<PAGE>
Section 4.15 No Misleading or Untrue Communication. The Company, any person
representing the Company, and, to the best knowledge of the Company, any other
person selling or offering to sell the Put Shares, the Warrant or the Warrant
Shares in connection with the transaction contemplated by this Agreement, have
not made, at any time, any oral communication in connection with the offer or
sale of the same which contained any untrue statement of a material fact or
omitted to state any material fact necessary in order to make the statements, in
the light of the circumstances under which they were made, not misleading.
Section 4.16 Material Non-Public Information. The Company neither possesses nor
has disclosed to the Investor any material non-public information that (i) if
disclosed, would, or could reasonably be expected to have, an effect on the
price of the Common Stock or (ii) according to applicable law, rule or
regulation, should have been disclosed publicly by the Company prior to the date
hereof but which has not been so disclosed.
ARTICLE V
Covenants of the Investor
Reserved
ARTICLE VI
Covenants of the Company
Section 6.1 Registration Rights. The Company shall use its best efforts to cause
the Registration Rights Agreement to remain in full force and effect and the
Company shall comply in all respects with the terms thereof.
Section 6.2 Reservation of Common Stock. As of the date hereof, the Company has
reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, shares of Common Stock for the purpose of
enabling the Company to satisfy any obligation to issue the Put Shares and the
Warrant Shares; such amount of shares of Common Stock to be reserved shall be
calculated based upon the minimum Purchase Price therefor under the terms of
this Agreement and the Warrant respectively. The number of shares so reserved
from time to time, as theretofore increased or reduced as hereinafter provided,
may be reduced by the number of shares actually delivered hereunder and the
number of shares so reserved shall be increased or decreased to reflect
potential increases or decreases in the Common Stock that the Company may
thereafter be so obligated to issue by reason of adjustments to Warrant.
Section 6.3 Listing of Common Stock. The Company hereby agrees to maintain the
listing of the Common Stock on a Principal Market, and as soon as practicable
(but in any event prior to the commencement of the Commitment Period) to list
the Put Shares and the Warrant Shares. The Company further agrees, if the
Company applies to have the Common Stock traded on any other Principal Market,
it will include in such application the Put Shares and the Warrant Shares, and
will take such other action as is necessary or desirable in the opinion of the
Investor to cause the Common Stock to be listed on such
Page 14
<PAGE>
other Principal Market as promptly as possible. The Company will take all action
to continue the listing and trading of its Common Stock on the Principal Market
(including, without limitation, maintaining sufficient net tangible assets) and
will comply in all respects with the Company's reporting, filing and other
obligations under the bylaws or rules of the NASD and the Principal Market,
including, without limitation, the corporate governance requirements of the
Principal Market.
Section 6.4 Exchange Act Registration. The Company will cause its Common Stock
to continue to be registered under Section 12(g) or 12(b) of the Exchange Act,
will comply in all respects with its reporting and filing obligations under said
Act, and will not take any action or file any document (whether or not permitted
by said Act or the rules thereunder) to terminate or suspend such registration
or to terminate or suspend its reporting and filing obligations under said Act.
The Company will take all action to continue the listing and trading of its
Common Stock on the Principal Market and will comply in all respects with the
Company's reporting, filing and other obligations under the bylaws of the NASD
and the Principal Market.
Section 6.5 Legends. The certificates evidencing the Common Stock to be sold by
the Investor shall be free of legends, except as set forth in Article IX.
Section 6.6 Corporate Existence. The Company will take all steps necessary to
preserve and continue the corporate existence of the Company.
Section 6.7 Additional SEC Documents. The Company will deliver to the Investor,
as and when the originals thereof are submitted to the SEC for filing, copies of
all SEC Documents so furnished or submitted to the SEC.
Section 6.8 Notice of Certain Events Affecting Registration; Suspension of Right
to Make a Put. The Company will immediately notify the Investor upon the
occurrence of any of the following events in respect of a registration statement
or related prospectus in respect of an offering of Registrable Securities; (i)
receipt of any request for additional information by the SEC or any other
federal or state governmental authority during the period of effectiveness of
the registration statement for amendments or supplements to the registration
statement or related prospectus; (ii) the issuance by the SEC or any other
federal or state governmental authority of any stop order suspending the
effectiveness of the Registration Statement or the initiation of any proceedings
for that purpose; (iii) receipt of any notification with respect to the
suspension of the qualification or exemption from qualification of any of the
Registrable Securities for sale in any jurisdiction or the initiation or
threatening of any proceeding for such purpose; (iv) the happening of any event
that makes any statement made in such registration statement or related
prospectus or any document incorporated or deemed to be incorporated therein by
reference untrue in any material respect or that requires the making of any
changes in the registration statement, related prospectus or documents so that,
in the case of the registration statement, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be
stated therein or necessary to make the statements therein not misleading, and
that in the case of the related prospectus, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be
stated therein
Page 15
<PAGE>
or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading; and (v) the Company's reasonable
determination that a post-effective amendment to the registration statement
would be appropriate; and the Company will promptly make available to the
Investor any such supplement or amendment to the related prospectus. The Company
shall not deliver to the Investor any Put Notice during the continuation of any
of the foregoing events.
Section 6.9 Expectations Regarding Put Notices. Within ten (10) days after the
commencement of each calendar quarter occurring subsequent to the commencement
of the Commitment Period, the Company undertakes to notify the Investor as to
its reasonable expectations as to the dollar amount it intends to raise during
such calendar quarter, if any, through the issuance of Put Notices. Such
notification shall constitute only the Company's good faith estimate and shall
in no way obligate the Company to raise such amount, or any amount, or otherwise
limit its ability to deliver Put Notices. The failure by the Company to comply
with this provision can be cured by the Company's notifying the Investor at any
time as to its reasonable expectations with respect to the current calendar
quarter.
Section 6.10 Consolidation; Merger. The Company shall not, at any time after the
date hereof, effect any merger or consolidation of the Company with or into, or
a transfer of all or substantially all of the assets of the Company to, another
entity (a "Consolidation Event") unless the resulting successor or acquiring
entity (if not the Company) assumes by written instrument the obligation to
deliver to the Investor such shares of stock and/or securities as the Investor
is entitled to receive pursuant to this Agreement.
Section 6.11 Issuance of Put Shares, Warrant Shares and Supplemental Warrant
Shares. The sale of the Put Shares and the issuance of the Warrant Shares and
the Supplemental Warrant Shares pursuant to the exercise of the Warrant and the
Supplemental Warrant shall be made in accordance with the provisions and
requirements of Regulation D and any applicable state law. Issuance of the
Warrant Shares and the Supplemental Warrant Shares pursuant to exercise of the
Warrant and the Supplemental Warrant through a cashless exercise shall be made
in accordance with the provisions and requirements of Section 3(a)(9) under the
Securities Act and any applicable state law.
Section 6.12 Legal Opinion on Subscription Date. The Company's independent
counsel shall deliver to the Investor upon execution of this Agreement an
opinion in form and substance satisfactory to the Investor addressing, among
other things, corporate matters and the exemption from registration under the
Securities Act of the issuance to the Investor of the Registrable Securities,
the Warrant, and the Supplemental Warrant under this Agreement.
Section 6.13 Company Standoff. Except pursuant to a corporate reorganization,
business combination, stock or asset purchase, merger or consolidation, an
existing employee stock incentive or purchase plan, or this Agreement, the
Company shall not effect any public sale or other public distribution of any
securities similar to the Registrable Securities or any Capital Shares
Equivalents during the period beginning three (3) calendar days prior to the
Subscription Date and ending sixty (60) calendar days after
Page 16
<PAGE>
the Effective Date; provided, however, that the Company may effect such public
sale or distribution during such period if such sale or distribution of
securities is at a price equal to or greater than 135% of the Bid Price as of
the Subscription Date.
ARTICLE VII
Conditions to Delivery of Puts
and Conditions to Closing.
Section 7.1 Conditions Precedent to the Obligation of the Company to Issue and
Sell Common Stock. The obligation hereunder of the Company to issue and sell the
Put Shares to the Investor incident to each Closing is subject to the
satisfaction, at or before each such Closing, of each of the conditions set
forth below.
(a) Accuracy of the Investor's Representation and Warranties. The
representations and warranties of the Investor shall be true and correct in all
material respects as of the date of this Agreement and as of the date of each
such Closing as though made at each such time.
(b) Performance by the Investor. The Investor shall have performed,
satisfied and complied in all respects with all covenants, agreements and
conditions required by this Agreement to be performed, satisfied or complied
with by the Investor at or prior to such Closing.
Section 7.2 Conditions Precedent to the Right of the Company to Deliver a Put
Notice and the Obligation of the Investor to Purchase Put Shares. Except as set
forth in section 7.3, the right of the Company to deliver a Put Notice and the
obligation of the Investor hereunder to acquire and pay for the Put Shares
incident to a Closing is subject to the satisfaction, on (i) the applicable Put
Date and (ii) the applicable Closing Date (each a "Condition Satisfaction
Date"), of each of the following conditions.
(a) Registration of the Common Stock with the SEC. As set forth in the
Registration Rights Agreement, the Company shall have filed with the SEC a
Registration Statement with respect to the resale of the Registrable Securities
that shall have been declared effective by the SEC prior to the first Put Date.
(b) Effective Registration Statement. As set forth in the Registration
Rights Agreement, the Registration Statement shall have previously become
effective and shall remain effective on each Condition Satisfaction Date and (i)
neither the Company nor the Investor shall have received notice that the SEC has
issued or intends to issue a stop order with respect to the Registration
Statement or that the SEC otherwise has suspended or withdrawn the effectiveness
of the Registration Statement, either temporarily or permanently, or intends or
has threatened to do so (unless the SEC's concerns have been addressed and the
Investor is reasonably satisfied that the SEC no longer is considering or
intends to take such action), and (ii) no other suspension of the use or
withdrawal of the effectiveness of the Registration Statement or related
prospectus shall exist.
Page 17
<PAGE>
(c) Accuracy of the Company's Representations and Warranties. The
representations and warranties of the Company shall be true and correct as of
each Condition Satisfaction Date as though made at each such time (except for
representations and warranties specifically made as of a particular date) with
respect to all periods, and as to all events and circumstances occurring or
existing to and including each Condition Satisfaction Date, except for any
conditions which have temporarily caused any representations or warranties
herein to be incorrect and which have been corrected with no continuing
impairment to the Company or the Investor.
(d) Performance by the Company. The Company shall have performed, satisfied
and complied in all respects with all covenants, agreements and conditions
required by this Agreement, the Registration Rights Agreement and the Warrant to
be performed, satisfied or complied with by the Company at or prior to each
Condition Satisfaction Date.
(e) No Injunction. No statute, rule, regulation, executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction that prohibits
or directly and adversely affects any of the transactions contemplated by this
Agreement, and no proceeding shall have been commenced that may have the effect
of prohibiting or adversely affecting any of the transactions contemplated by
this Agreement.
(f) Adverse Changes. Since the date of filing of the Company's most recent
SEC Document, no event that had or is reasonably likely to have a Material
Adverse Effect has occurred.
(g) No Suspension of Trading In or Delisting of Common Stock. The trading
of the Common Stock (including, without limitation, the Put Shares) is not
suspended by the SEC, the Principal Market or the NASD, and the Common Stock
(including, without limitation, the Put Shares) shall have been approved for
listing or quotation on and shall be listed on the Principal Market. The
issuance of shares of Common Stock with respect to the applicable Closing, if
any, shall not violate the shareholder approval requirements of the Principal
Market.
(h) Legal Opinions. The Company shall have caused to be delivered to the
Investor, within five (5) Trading Days of the effective date of the Registration
Statement, an opinion of the Company's independent counsel in the form of
Exhibit C hereto, addressed to the Investor.
(i) Due Diligence. No dispute between the Company and the Investor shall
exist pursuant to Section 8.1 as to the accuracy or adequacy of the disclosures
contained in the Registration Statement. If the Investor disputes the accuracy
or adequacy of the disclosure contained in the Registration Statement, the
Investor shall notify the Company within five (5) calendar days of discovery of
such purported inaccuracy or inadequacy. Failure to do so, however, shall not
prevent the Investor from pursuing the indemnification and remedies set forth
herein.
Page 18
<PAGE>
(j) Ten Percent Limitation. Unless the Investor agrees otherwise, on each
Closing Date, the number of Put Shares then to be purchased by the Investor,
when aggregated with all other shares of Common Stock then owned by the Investor
beneficially or deemed beneficially owned by the Investor, would result in the
Investor owning no more than 9.9% of all of such Common Stock as would be
outstanding on such Closing Date, as determined in accordance with Section 16 of
the Exchange Act and the regulations promulgated thereunder. For purposes of
this Section 7.2(j), in the event that the amount of Common Stock outstanding as
determined in accordance with Section 16 of the Exchange Act and the regulations
promulgated thereunder is greater on a Closing Date than on the date upon which
the Put Notice associated with such Closing Date is given, the amount of Common
Stock outstanding on such Closing Date shall govern for purposes of determining
whether the Investor, when aggregating all purchases of Common Stock made
pursuant to this Agreement and, if any, Warrant Shares, would own more than 9.9%
of the Common Stock following such Closing.
(k) Minimum Bid Price. The Bid Price equals or exceeds the Floor Price from
the Trading Day immediately preceding the date on which such Notice is deemed
delivered until the Trading Day immediately preceding the Closing Date (as
adjusted for stock splits, stock dividends, reverse stock splits, and similar
events).
(l) Minimum Average Trading Volume. The average trading volume for the
Common Stock over the previous thirty (30) Trading Days equals or exceeds 20,000
shares per Trading Day.
(m) No Knowledge. The Company has no knowledge of any event more likely
than not to have the effect of causing such Registration Statement to be
suspended or otherwise ineffective.
(n) Trading Cushion. The Trading Cushion shall have elapsed since the next
preceding Put Date.
(o) Shareholder Vote. The issuance of shares of Common Stock with respect
to the applicable Closing, if any, shall not violate the shareholder approval
requirements of the Principal Market.
(p) Escrow Agreement. The parties hereto shall have entered into a mutually
acceptable escrow agreement for the Purchase Prices due hereunder, providing for
reasonable interest on any funds deposited into the escrow account established
under such agreement.
(q) Other. On each Condition Satisfaction Date, the Investor shall have
received and been reasonably satisfied with such other certificates and
documents as shall have been reasonably requested by the Investor in order for
the Investor to confirm the Company's satisfaction of the conditions set forth
in this Section 7.2, except as otherwise provided in Section 7.3, including,
without limitation, a certificate in substantially the form and substance of
Exhibit D hereto, executed in either case by an executive officer of the Company
and to the effect that all the conditions to such Closing shall have been
satisfied as at the date of each such certificate.
Page 19
<PAGE>
Section 7.3 Exception to Conditions Precedent to the Right of the Company to
Deliver a Put Notice and the Obligation of the Investor to Purchase Put Shares.
Nothing herein to the contrary withstanding, Sections 7.2 (j), 7.2(k) and 7.2(l)
shall not apply to the first Put made pursuant to this Agreement.
ARTICLE VIII
Due Diligence Review; Non-Disclosure of Non-Public Information.
Section 8.1 Due Diligence Review. The Company shall make available for
inspection and review by the Investor, advisors to and representatives of the
Investor (who may or may not be affiliated with the Investor and who are
reasonably acceptable to the Company), any underwriter participating in any
disposition of the Registrable Securities on behalf of the Investor pursuant to
the Registration Statement, any such registration statement or amendment or
supplement thereto or any blue sky, NASD or other filing, all financial and
other records, all SEC Documents and other filings with the SEC, and all other
corporate documents and properties of the Company as may be reasonably necessary
for the purpose of such review, and cause the Company's officers, directors and
employees to supply all such information reasonably requested by the Investor or
any such representative, advisor or underwriter in connection with such
Registration Statement (including, without limitation, in response to all
questions and other inquiries reasonably made or submitted by any of them),
prior to and from time to time after the filing and effectiveness of the
Registration Statement for the sole purpose of enabling the Investor and such
representatives, advisors and underwriters and their respective accountants and
attorneys to conduct initial and ongoing due diligence with respect to the
Company and the accuracy of the Registration Statement. If the Investor disputes
the accuracy or adequacy of the disclosures contained in the Registration
Statement, the Investor shall notify the Company within five (5) calendar days
of discovery of such purported inaccuracy or inadequacy. Failure to do so,
however, shall not prevent the Investor from pursuing the indemnification and
remedies set forth herein.
Section 8.2 Non-Disclosure of Non-Public Information
(a) The Company shall in no event disclose non-public information to the
Investor, advisors to or representatives of the Investor unless prior to
disclosure of such information the Company marks such information as "Non-Public
Information Confidential" and provides the Investor, such advisors and
representatives with the opportunity to accept or refuse to accept such
non-public information for review. The Company may, as a condition to disclosing
any non-public information hereunder, require the Investor's advisors and
representatives to enter into a confidentiality agreement in form reasonably
satisfactory to the Company and the Investor.
(b) Nothing herein shall require the Company to disclose non-public
information to the Investor or its advisors or representatives, and the Company
represents that it does not disseminate non-public information to any investors
who purchase stock in the Company in a public offering, to money managers or to
securities analysts, provided, however, that notwithstanding anything herein to
the contrary, the Company will, as hereinabove provided, immediately notify the
advisors and representatives of the Investor
Page 20
<PAGE>
and, if any, underwriters, of any event or the existence of any circumstance
(without any obligation to disclose the specific event or circumstance) of which
it becomes aware, constituting non-public information (whether or not requested
of the Company specifically or generally during the course of due diligence by
such persons or entities), which, if not disclosed in the prospectus included in
the Registration Statement would cause such prospectus to include a material
misstatement or to omit a material fact required to be stated therein in order
to make the statements, therein, in light of the circumstances in which they
were made, not misleading. Nothing herein shall be construed to mean that such
persons or entities other than the Investor (without the written consent of the
Investor prior to disclosure of such information) may not obtain non-public
information in the course of conducting due diligence in accordance with the
terms of this Agreement and nothing herein shall prevent any such persons or
entities from notifying the Company of their opinion that based on such due
diligence by such persons or entities, that the Registration Statement contains
an untrue statement of a material fact or omits a material fact required to be
stated in the Registration Statement or necessary to make the statements
contained therein, in light of the circumstances in which they were made, not
misleading.
ARTICLE IX
Legends
Section 9.1 Legends. Unless otherwise provided below, each certificate
representing Registrable Securities will bear the following legend (the
"Legend"):
THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY OTHER
APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION
FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER
SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN
MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, HYPOTHECATED
OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO A TRANSACTION THAT IS EXEMPT FROM, OR
NOT SUBJECT TO, SUCH REGISTRATION. THE HOLDER OF THIS CERTIFICATE IS THE
BENEFICIARY OF CERTAIN OBLIGATIONS OF THE COMPANY SET FORTH IN A PRIVATE
SECURITIES SUBSCRIPTION AGREEMENT BETWEEN NUWAVE TECHNOLOGIES, INC. AND
PROFUTURES SPECIAL EQUITIES FUND, L.P. DATED FEBRUARY 6, 1998. A COPY OF THE
PORTION OF THE AFORESAID AGREEMENT EVIDENCING SUCH OBLIGATIONS MAY BE OBTAINED
FROM THE COMPANY'S EXECUTIVE OFFICES.
Upon the execution and delivery hereof, the Company is issuing to the transfer
agent for its Common Stock (and to any substitute or replacement transfer agent
for its Common Stock upon the Company's appointment of any such substitute or
replacement transfer
Page 21
<PAGE>
agent) instructions in substantially the form of Exhibit E hereto. Such
instructions shall be irrevocable by the Company from and after the date hereof
or from and after the issuance thereof to any such substitute or replacement
transfer agent, as the case may be, except as otherwise expressly provided in
the Registration Rights Agreement. It is the intent and purpose of such
instructions, as provided therein, to require the transfer agent for the Common
Stock from time to time upon transfer of Registrable Securities by the Investor
to issue certificates evidencing such Registrable Securities free of the Legend
during the following periods and under the following circumstances and without
consultation by the transfer agent with the Company or its counsel and without
the need for any further advice or instruction or documentation to the transfer
agent by or from the Company or its counsel or the Investor:
(a) at any time after the Effective Date, upon surrender of one or more
certificates evidencing Common Stock that bear the Legend, to the extent
accompanied by a notice requesting the issuance of new certificates free of the
Legend to replace those surrendered; provided that (i) the Registration
Statement shall then be effective; (ii) the Investor confirms to the transfer
agent that it has sold, pledged or otherwise transferred or agreed to sell,
pledge or otherwise transfer such Common Stock in a bona fide transaction to a
third party that is not an affiliate of the Company; and (iii) the Investor
confirms to the transfer agent that the Investor has complied with the
prospectus delivery requirement.
(b) at any time upon any surrender of one or more certificates evidencing
Registrable Securities that bear the Legend, to the extent accompanied by a
notice requesting the issuance of new certificates free of the Legend to replace
those surrendered and containing representations that (i) the Investor is
permitted to dispose of such Registrable Securities without limitation as to
amount or manner of sale pursuant to Rule 144(k) under the Securities Act or
(ii) the Investor has sold, pledged or otherwise transferred or agreed to sell,
pledge or otherwise transfer such Registrable Securities in a manner other than
pursuant to an effective registration statement, to a transferee who will upon
such transfer be entitled to freely tradeable securities.
Any of the notices referred to above in this Section 9.1 may be sent by
facsimile to the Company's transfer agent.
Notwithstanding any provision herein to the contrary, the Investor may pledge
any securities of the Company Investor may hold as collateral for a revolving
credit note pursuant to a loan and security agreement with a lending
institution.
Section 9.2 No Other Legend or Stock Transfer Restrictions. No legend other than
the one specified in Section 9.1 has been or shall be placed on the share
certificates representing the Common Stock and no instructions or "stop transfer
orders," so called, "stock transfer restrictions," or other restrictions have
been or shall be given to the Company's transfer agent with respect thereto
other than as expressly set forth in this Article IX.
Section 9.3 Investor's Compliance. Nothing in this Article IX shall affect in
any way the Investor' s obligations under any agreement to comply with all
applicable securities laws upon resale of the Common Stock.
Page 22
<PAGE>
ARTICLE X
Choice of Law
Section 10.1 Choice of Law; Venue; Jurisdiction. This Agreement shall be
governed by and construed in accordance with the laws of the State of New Jersey
without giving effect to provisions regarding conflict of laws or choice of law.
ARTICLE XI
Assignment; Entire Agreement, Amendment; Termination
Section 11.1 Assignment. Neither this Agreement nor any rights of the Investor
or the Company hereunder may be assigned by either party to any other person.
Notwithstanding the foregoing, (a) the provisions of this Agreement shall inure
to the benefit of, and be enforceable by, any transferee of any of the Common
Stock purchased or acquired by the Investor hereunder with respect to the Common
Stock held by such person, and (b) the Investor's interest in this Agreement may
be assigned at any time, in whole or in part, to any other person or entity
(including any affiliate of the Investor) upon the prior written consent of the
Company, which consent shall not be unreasonably withheld.
Section 11.2 Termination. This Agreement shall terminate two years after the
commencement of the Commitment Period; provided, however, that the provisions of
Articles VI, VII, VIII, IX, X, XI, and XII shall survive the termination of this
Agreement.
Section 11.3 Entire Agreement, Amendment. This Agreement, the Registration
Rights Agreement, the Warrant, and the Supplemental Warrant constitute the full
and entire understanding and agreement between the parties with regard to the
subjects hereof and thereof, and no party shall be liable or bound to any other
party in any manner by any warranties, representations or covenants except as
specifically set forth in this Agreement or therein. Except as expressly
provided in this Agreement, neither this Agreement nor any term hereof may be
amended, waived, discharged or terminated other than by a written instrument
signed by both parties hereto.
ARTICLE XII
Notices; Indemnification
Section 12.1 Notices. All notices, demands, requests, consents, approvals, and
other communications required or permitted hereunder shall be in writing and,
unless otherwise specified herein, shall be (i) personally served, (ii)
deposited in the mail, registered or certified, return receipt requested,
postage prepaid, (iii) delivered by reputable air courier service with charges
prepaid, or (iv) transmitted by hand delivery, telegram, or facsimile, addressed
as set forth below or to such other address as such party shall have specified
most recently by written notice. Any notice or other communication required or
permitted to be given hereunder shall be deemed effective (a) upon hand delivery
or delivery by facsimile, with accurate confirmation generated by the
transmitting facsimile machine, at the address or number designated below (if
delivered on a business day during normal business hours where such notice is to
be received), or the first business day following
Page 23
<PAGE>
such delivery (if delivered other than on a business day during normal business
hours where such notice is to be received) or (b) on the second business day
following the date of mailing by express courier service, fully prepaid,
addressed to such address, or upon actual receipt of such mailing, whichever
shall first occur. The addresses for such communications shall be:
If to NUWAVE Technologies, Inc.: Jeremiah O'Brien
Chief Financial Officer
One Passaic Avenue
Fairfield, New Jersey 07004
Telephone (973) 882-8810 ext. 212
Facsimile (973) 882-8812
with a copy to: Fredric Klink, Esq.
(shall not constitute notice) Dechert, Price & Rhoads
30 Rockefeller Plaza, 23rd Floor
New York, New York 10112
Telephone (212) 698-3537
Facsimile (212) 698-3599
if to the Investor: Gary D. Halbert
President
ProFutures Special Equities Fund, L.P.
1310 Highway 620 South, Suite 200
Austin, Texas 78734
Telephone (512) 263-3800
Facsimile (512) 263-3459
with a copy to: John Gray, Esq.
(shall not constitute notice) Fishman, Jones, Walsh & Marsh, P.C.
1310 Highway 620 South, Suite 200
Austin, Texas 78734
Telephone (512) 263-8057
Facsimile (512) 263-8058
Either party hereto may from time to time change its address or facsimile number
for notices under this Section 12.1 by giving at least ten (10) days' prior
written notice of such changed address or facsimile number to the other party
hereto.
Section 12.2 Indemnification.
(a) The Company agrees to indemnify and hold harmless the Investor, its
partners, Affiliates, officers, directors, employees, and duly authorized
agents, and each Person or entity, if any, who controls the Investor within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act,
together with the Controlling Persons (as defined in the Registration Rights
Agreement) from and against any Damages (as defined in the Registration Rights
Agreement), joint or several, and any action in respect thereof to which the
Investor, its partners, Affiliates, officers, directors, employees, and
Page 24
<PAGE>
duly authorized agents, and any such Controlling Person becomes subject to,
resulting from, arising out of or relating to any material misrepresentation,
breach of warranty or nonfulfillment of or failure to perform any covenant or
agreement on the part of Company contained in this Agreement, as such Damages
are incurred, unless such Damages result primarily from the Investor's gross
negligence, recklessness or bad faith in performing its obligations under this
Agreement.
(b) The Investor agrees to indemnify and hold harmless the Company, its
partners, Affiliates, officers, directors, employees, and duly authorized
agents, and each Person or entity, if any, who controls the Investor within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act,
together with the Controlling Persons (as defined in the Registration Rights
Agreement) from and against any Damages, joint or several, and any action in
respect thereof to which the Company, its partners, Affiliates, officers,
directors, employees, and duly authorized agents, and any such Controlling
Person becomes subject to, resulting from, arising out of, or relating to any
material misrepresentation, breach of warranty or nonfulfillment of or failure
to perform any covenant or agreement on the part of Investor contained in this
Agreement.
Section 12.3 Method of Asserting Indemnification Claims. All claims for
indemnification by any Indemnified Party (as defined below) under Section 12.2
will be asserted and resolved as follows:
(a) In the event any claim or demand in respect of which any person
claiming indemnification under any provision of Section 12.2 (an "Indemnified
Party") might seek indemnity under Section 12.2 is asserted against or sought to
be collected from such Indemnified Party by a person other than the Company, the
Investor or any Affiliate of the Company or the Investor (a "Third Party
Claim"), the Indemnified Party shall deliver a written notification, enclosing a
copy of all papers served, if any, and specifying the nature of and basis for
such Third Party Claim and for the Indemnified Party's claim for indemnification
that is being asserted under any provision of Section 12.2 against any person
(the "Indemnifying Party"), together with the amount or, if not then reasonably
ascertainable, the estimated amount, determined in good faith, of such Third
Party Claim (a "Claim Notice") with reasonable promptness to the Indemnifying
Party. If the Indemnified Party fails to provide the Claim Notice with
reasonable promptness after the Indemnified Party receives notice of such Third
Party Claim, the Indemnifying Party will not be obligated to indemnify the
Indemnified Party with respect to such Third Party Claim to the extent that the
Indemnifying Party's ability to defend has been irreparably prejudiced by such
failure of the Indemnified Party. The Indemnifying Party will notify the
Indemnified Party as soon as practicable within the period ending thirty (30)
calendar days following receipt by the Indemnifying Party of either a Claim
Notice or an Indemnity Notice (as defined below) (the "Dispute Period") whether
the Indemnifying Party disputes its liability or the amount of its liability to
the Indemnified Party under Section 12.2 and whether the Indemnifying Party
desires, at its sole cost and expense, to defend the Indemnified Party against
such Third Party Claim.
1. If the Indemnifying Party notifies the Indemnified Party within the
Dispute Period that the Indemnifying Party desires to defend the Indemnified
Party with
Page 25
<PAGE>
respect to the Third Party Claim pursuant to this Section 12.3(a), then the
Indemnifying Party will have the right to defend, with counsel reasonably
satisfactory to the Indemnified Party, at the sole cost and expense of the
Indemnifying Party, such Third Party Claim by all appropriate proceedings, which
proceedings will be vigorously and diligently prosecuted by the Indemnifying
Party to a final conclusion or will be settled at the discretion of the
Indemnifying Party (but only with the consent of the Indemnified Party in the
case of any settlement that provides for any relief other than the payment of
monetary damages or that provides for the payment of monetary damages as to
which the Indemnified Party will not be indemnified in full pursuant to Section
12.2). The Indemnifying Party will have full control of such defense and
proceedings, including any compromise or settlement thereof; provided, however,
that the Indemnified Party may, at the sole cost and expense of the Indemnified
Party, at any time prior to the Indemnifying Party's delivery of the notice
referred to in the first sentence of this clause (1), file any motion, answer or
other pleadings or take any other action that the Indemnified Party reasonably
believes to be necessary or appropriate to protect its interests; and provided
further, that if requested by the Indemnifying Party, the Indemnified Party
will, at the sole cost and expense of the Indemnifying Party, provide reasonable
cooperation to the Indemnifying Party in contesting any Third Party Claim that
the Indemnifying Party elects to contest. The Indemnified Party may participate
in, but not control, any defense or settlement of any Third Party Claim
controlled by the Indemnifying Party pursuant to this clause (1), and except as
provided in the preceding sentence, the Indemnified Party will bear its own
costs and expenses with respect to such participation. Notwithstanding the
foregoing, the Indemnified Party may take over the control of the defense or
settlement of a Third Party Claim at any time if it irrevocably waives its right
to indemnity under Section 12.2 with respect to such Third Party Claim.
2. If the Indemnifying Party fails to notify the Indemnified Party
within the Dispute Period that the Indemnifying Party desires to defend the
Third Party Claim pursuant to Section 12.3(a), or if the Indemnifying Party
gives such notice but fails to prosecute vigorously and diligently or settle the
Third Party Claim, or if the Indemnifying Party fails to give any notice
whatsoever within the Dispute Period, then the Indemnified Party will have the
right to defend, at the sole cost and expense of the Indemnifying Party, the
Third Party Claim by all appropriate proceedings, which proceedings will be
prosecuted by the Indemnified Party in a reasonable manner and in good faith or
will be settled at the discretion of the Indemnified Party (with the consent of
the Indemnifying Party, which consent will not be unreasonably withheld). The
Indemnified Party will have full control of such defense and proceedings,
including any compromise or settlement thereof; provided, however, that if
requested by the Indemnified Party, the Indemnifying Party will, at the sole
cost and expense of the Indemnifying Party, provide reasonable cooperation to
the Indemnified Party and its counsel in contesting any Third Party Claim which
the Indemnified Party is contesting. Notwithstanding the foregoing provisions of
this clause (2), if the Indemnifying Party has notified the Indemnified Party
within the Dispute Period that the Indemnifying Party disputes its liability or
the amount of its liability hereunder to the Indemnified Party with respect to
such Third Party Claim and if such dispute is resolved in favor of the
Indemnifying Party in the manner provided in clause (3) below, the Indemnifying
Party will not be required to bear the costs and expenses of the Indemnified
Party's defense pursuant to this clause (2) or of the
Page 26
<PAGE>
Indemnifying Party's participation therein at the Indemnified Party's request,
and the Indemnified Party will reimburse the Indemnifying Party in full for all
reasonable costs and expenses incurred by the Indemnifying Party in connection
with such litigation. The Indemnifying Party may participate in, but not
control, any defense or settlement controlled by the Indemnified Party pursuant
to this clause (2), and the Indemnifying Party will bear its own costs and
expenses with respect to such participation.
3. If the Indemnifying Party notifies the Indemnified Party that it
does not dispute its liability or the amount of its liability to the Indemnified
Party with respect to the Third Party Claim under Section 12.2 or fails to
notify the Indemnified Party within the Dispute Period whether the Indemnifying
Party disputes its liability or the amount of its liability to the Indemnified
Party with respect to such Third Party Claim, the Loss in the amount specified
in the Claim Notice will be conclusively deemed a liability of the Indemnifying
Party under Section 12.2 and the Indemnifying Party shall pay the amount of such
Loss to the Indemnified Party on demand. If the Indemnifying Party has timely
disputed its liability or the amount of its liability with respect to such
claim, the Indemnifying Party and the Indemnified Party will proceed in good
faith to negotiate a resolution of such dispute, and if not resolved through
negotiations within the Resolution Period, such dispute shall be resolved by
arbitration in accordance with paragraph (c) of this Section 12.3.
(b) In the event any Indemnified Party should have a claim under Section
12.2 against the Indemnifying Party that does not involve a Third Party Claim,
the Indemnified Party shall deliver a written notification of a claim for
indemnity under Section 12.2 specifying the nature of and basis for such claim,
together with the amount or, if not then reasonably ascertainable, the estimated
amount, determined in good faith, of such claim (an "Indemnity Notice") with
reasonable promptness to the Indemnifying Party. The failure by any Indemnified
Party to give the Indemnity Notice shall not impair such party's rights
hereunder except to the extent that the Indemnifying Party demonstrates that it
has been irreparably prejudiced thereby. If the Indemnifying Party notifies the
Indemnified Party that it does not dispute the claim or the amount of the claim
described in such Indemnity Notice or fails to notify the Indemnified Party
within the Dispute Period whether the Indemnifying Party disputes the claim or
the amount of the claim described in such Indemnity Notice, the Loss in the
amount specified in the Indemnity Notice will be conclusively deemed a liability
of the Indemnifying Party under Section 12.2 and the Indemnifying Party shall
pay the amount of such Loss to the Indemnified Party on demand. If the
Indemnifying Party has timely disputed its liability or the amount of its
liability with respect to such claim, the Indemnifying Party and the Indemnified
Party will proceed in good faith to negotiate a resolution of such dispute, and
if not resolved through negotiations within sixty (60) days of notification of
dispute with respect to the Indemnifying Party's liability (the "Resolution
Period"), such dispute shall be resolved by arbitration in accordance with
paragraph (c) of this Section 12.3.
(c) Any dispute under this Agreement (including, without limitation, in
connection with this Section 12.3) or the Registration Rights Agreement shall be
submitted to arbitration and shall be finally and conclusively determined by the
decision of a board of arbitration consisting of three (3) members (the "Board
of Arbitration")
Page 27
<PAGE>
selected as hereinafter provided. Each of the Indemnified Party and the
Indemnifying Party shall select one (1) member and the third member shall be
selected by mutual agreement of the other members, or if the other members fail
to reach agreement on a third member within twenty (20) days after their
selection, such third member shall thereafter be selected by the American
Arbitration Association upon application made to it for such purpose by the
Indemnified Party. The Board of Arbitration shall meet on consecutive business
days in New York City or such other place as a majority of the members of the
Board of Arbitration determines more appropriate, and shall reach and render a
decision in writing (concurred in by a majority of the members of the Board of
Arbitration) with respect to the amount, if any, which the Indemnifying Party is
required to pay to the Indemnified Party in respect of a claim filed by the
Indemnified Party. In connection with rendering its decisions, the Board of
Arbitration shall adopt and follow such rules and procedures as a majority of
the members of the Board of Arbitration deems necessary or appropriate. To the
extent practical, decisions of the Board of Arbitration shall be rendered no
more than thirty (30) calendar days following commencement of proceedings with
respect thereto. The Board of Arbitration shall cause its written decision to be
delivered to the Indemnified Party and the Indemnifying Party. Any decision made
by the Board of Arbitration (either prior to or after the expiration of such
thirty (30) calendar day period) shall be final, binding and conclusive on the
Indemnified Party and the Indemnifying Party and entitled to be enforced to the
fullest extent permitted by law and entered in any court of competent
jurisdiction. Each party to any arbitration shall bear its own expense in
relation thereto, including but not limited to such party's attorneys' fees, if
any, and the expenses and fees of the Board of Arbitration shall be divided
between the Indemnifying Party and the Indemnified Party in the same proportion
as the portion of the related claim determined by the Board of Arbitration to be
payable to the Indemnified Party bears to the portion of such claim determined
not to be so payable.
ARTICLE XIII
Miscellaneous
Section 13.1 Counterparts. This Agreement may be executed in multiple
counterparts, each of which may be executed by less than all of the parties and
shall be deemed to be an original instrument which shall be enforceable against
the parties actually executing such counterparts and all of which together shall
constitute one and the same instrument.
Section 13.2 Entire Agreement. This Agreement, the Exhibits hereto, the Warrant,
the Supplemental Warrant, and the Registration Rights Agreement set forth the
entire agreement and understanding of the parties relating to the subject matter
hereof and supersedes all prior and contemporaneous agreements, negotiations and
understandings between the parties, both oral and written relating to the
subject matter hereof. The terms and conditions of all Exhibits to this
Agreement are incorporated herein by this reference and shall constitute part of
this Agreement as if fully set forth herein.
Section 13.3 Survival; Severability. The representations, warranties, covenants
and agreements of the parties hereto shall survive each Closing hereunder. In
the event that any provision of this Agreement becomes or is declared by a court
of competent
Page 28
<PAGE>
jurisdiction to be illegal, unenforceable or void, this Agreement shall continue
in full force and effect without said provision; provided that such severability
shall be ineffective if it materially changes the economic benefit of this
Agreement to any party.
Section 13.4 Title and Subtitles. The titles and subtitles used in this
Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.
Section 13.5 Reporting Entity for the Common Stock. The reporting entity relied
upon for the determination of the trading price or trading volume of the Common
Stock on any given Trading Day for the purposes of this Agreement shall be
Bloomberg, L.P. or any successor thereto. The written mutual consent of the
Investor and the Company shall be required to employ any other reporting entity.
Section 13.6 Replacement of Certificates. Upon (i) receipt of evidence
reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of a certificate representing any of the Registrable Securities, the
Warrant, or the Supplemental Warrant and (ii) in the case of any such loss,
theft or destruction of such certificate, upon delivery of an indemnity
agreement or security reasonably satisfactory in form and amount to the Company
or (iii) in the case of any such mutilation, on surrender and cancellation of
such certificate, the Company at its expense will execute and deliver, in lieu
thereof, a new certificate of like tenor.
Section 13.7 Fees and Expenses. Each of the Company and the Investor agrees to
pay its own expenses incident to the evaluation and/or the performance of its
obligations hereunder, except that the Company shall reimburse the Investor up
to $10,000 for fees and expenses of its counsel in connection with the
preparation, negotiation and coordination of this Agreement, the Warrant, the
Supplemental Warrant, the Registration Rights Agreement, and other agreements
and documents executed in connection herewith.
Section 13.8 Remedies. In the event of a breach or a threatened breach by any
party to this Agreement of its obligations under this Agreement, any party
injured or to be injured by such breach will be entitled to specific performance
of its rights under this Agreement or to injunctive relief, in addition to being
entitled to exercise all rights provided in this Agreement and granted by law.
The parties agree that the provisions of this Agreement shall be specifically
enforceable, it being agreed by the parties that the remedy at law, including
monetary damages, for breach of any such provision will be inadequate
compensation for any loss and that any defense or objection in any action for
specific performance or injunctive relief that a remedy at law would be adequate
is waived.
Page 29
<PAGE>
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed by the undersigned, thereunto duly authorized, as of the date first set
forth above.
NUWAVE TECHNOLOGIES, INC.
By:
-----------------------------------------
Gerald Zarin
Chairman and Chief Executive Officer
PROFUTURES SPECIAL EQUITIES FUND, L.P.
By: ProFutures Fund Management, Inc.,
the co-General Partner
By:
-----------------------------------------
Gary D. Halbert
President
Page 30
<PAGE>
EXHIBIT A
THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY OTHER
APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION
FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER
SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN
MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, HYPOTHECATED
OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO A TRANSACTION WHICH IS EXEMPT FROM, OR
NOT SUBJECT TO, SUCH REGISTRATION. THE HOLDER OF THIS CERTIFICATE IS THE
BENEFICIARY OF CERTAIN OBLIGATIONS OF THE COMPANY SET FORTH IN A PRIVATE
SECURITIES SUBSCRIPTION AGREEMENT BETWEEN NUWAVE TECHNOLOGIES, INC. AND
PROFUTURES SPECIAL EQUITIES FUND, L.P. DATED FEBRUARY 6, 1998. A COPY OF THE
PORTION OF THE AFORESAID AGREEMENT EVIDENCING SUCH OBLIGATIONS MAY BE OBTAINED
FROM THE COMPANY'S EXECUTIVE OFFICES.
February 6, 1998
Warrant to Purchase up to 50,000 Shares of Common Stock of NUWAVE Technologies,
Inc.
NUWAVE Technologies, Inc., a Delaware corporation (the "Company"), hereby
acknowledges that ProFutures Special Equities Fund, L.P. (the "Investor") or any
other Warrant Holder is entitled, on the terms and conditions set forth below,
to purchase from the Company at any time during the Exercise Period up to 50,000
fully paid and nonassessable shares of Common Stock, par value $0.01 per share,
of the Company (the "Common Stock"), as the same may be adjusted pursuant to
Section 6 herein, at the Exercise Price (hereinafter defined), as the same may
be adjusted pursuant to Section 6 herein.
Section 1. Definitions.
"Agreement" shall mean the Private Securities Subscription Agreement, dated
as of February 6, 1998, between the Company and the Investor.
"Capital Shares" shall mean the Common Stock and any shares of any other
class of common stock whether now or hereafter authorized, having the right to
participate in the distribution of earnings and assets of the Company except for
any common stock issued pursuant to warrants, stock options, and convertible
securities outstanding and described in the SEC Documents on file with the
Commission as of the date of this Agreement.
<PAGE>
"Date of Exercise" shall mean the date that the advance copy of the
Exercise Form is deemed delivered by facsimile to the Company in accordance with
Section 13 hereof, provided that the original Warrant and Exercise Form are
received by the Company within five (5) Trading Days thereafter. If the Warrant
Holder has not sent advance notice by facsimile, the Date of Exercise shall be
the date the original Exercise Form is actually received by the Company.
"Exercise Period" shall mean that period beginning August 6, 1998, and
ending on August 6, 2001; provided that such period shall be extended one
Trading Day for each Trading Day that a Registration Statement is not effective
during the period such Registration Statement is required to be effective
pursuant to the Registration Rights Agreement.
"Exercise Price" shall mean $6.41.
"Per Share Warrant Value" shall mean the difference resulting from
subtracting the Exercise Price from the Bid Price of one share of Common Stock
on the Trading Day next preceding the Date of Exercise.
"Registration Rights Agreement" shall mean the registration rights
agreement dated as of February 6, 1998, between the Company and the Investor.
"Warrant Holder" shall mean the Investor or any assignee or transferee of
all or any portion of this Warrant; and
other capitalized terms used herein that are defined in the Agreement shall
have the same meanings herein as therein.
Section 2. Exercise.
(a) Cash Exercise. This Warrant may be exercised by the Warrant Holder, in
whole or in part, at any time and from time to time during the Exercise Period
by surrender to the Company at its principal executive offices at the address
set forth in Section 13 of (i) this Warrant; (ii) the form of exercise attached
hereto as Exhibit A (the "Cash Exercise Form") duly executed by Warrant Holder,
and (iii) the full Exercise Price for each share of Common Stock as to which
this Warrant is exercised. In the event that the Warrant is not exercised in
full, the number of Warrant Shares shall be reduced by the number of such
Warrant Shares for which this Warrant is exercised, and the Company, at its
expense, shall forthwith issue and deliver to or upon the order of the Warrant
Holder a new Warrant of like tenor in the name of the Warrant Holder or as the
Warrant Holder may request, reflecting such adjusted number of Warrant Shares
within three (3) Trading Days.
(b) Net Exercise. This Warrant may be exercised at any time during the
Exercise Period, by presentation and surrender to the Company at its principal
executive offices at the address set forth in Section 13 of (i) this Warrant and
(ii) the form of exercise attached hereto as Exhibit B (the "Net Exercise Form")
duly executed by
Page 2
<PAGE>
Warrant Holder, including a calculation of the number of shares of Common Stock
to be issued upon such exercise in accordance with the terms hereof (a "Cashless
Exercise"). In the event of a Cashless Exercise, the holder shall surrender this
Warrant for that number of shares of Common Stock determined by (i) multiplying
the number of Warrant Shares for which this Warrant is being exercised by the
Per Share Warrant Value and (ii) dividing the product by the Bid Price of one
share of the Common Stock on the Trading Day next preceding the Date of
Exercise. In the event that the Warrant is not exercised in full, the number of
Warrant Shares shall be reduced by the number of such Warrant Shares for which
this Warrant is exercised, and the Company, at its expense, shall forthwith
issue and deliver to or upon the order of the Warrant Holder a new Warrant of
like tenor in the name of the Warrant Holder or as the Warrant Holder may
request, reflecting such adjusted number of Warrant Shares within three (3)
Trading Days.
Section 3. Ten Percent Limitation. Notwithstanding anything herein to the
contrary, unless the Investor agrees otherwise, the Warrant Holder may not
exercise the Warrant if the aggregate number of shares of common stock
beneficially owned by the holder and its affiliates following such conversion
exceeds 9.9% of the outstanding shares of the common stock following such
exercise. For purposes of the foregoing provision, the aggregate number of
shares of common stock beneficially owned by the holder and its affiliates shall
include the number as shares of common stock issuable upon exercise of the
Warrant with respect to which the determination of such proviso is being made,
but shall exclude the number of shares of common stock which would be issuable
upon (i) exercise of the remaining, Warrant beneficially owned by the holder and
its affiliates and (ii) exercise or conversion of the unexercised or unconverted
portion of any other securities of the Company (including, without limitation,
any warrants) subject to a limitation on conversion or exercise analogous to the
limitation contained herein beneficially owned by the holder and its affiliates.
Except as set forth in the preceding sentence, for purposes of this paragraph,
beneficial ownership shall be calculated in accordance with Section 16 of the
Securities Exchange Act of 1934, as amended. The holder may waive the foregoing
limitations by written notice to the Company upon not less than 61 days prior
notice (with such waiver taking effect only upon the expiration of such 61 day
notice period).
Section 4. Delivery of Stock Certificates.
(a) Subject to the terms and conditions of this Warrant, as soon as
practicable after the Date of Exercise of this Warrant in full or in part, and
in any event within three (3) Trading Days thereafter, the Company at its
expense (including, without limitation, the payment by it of any applicable
issue taxes) will cause to be issued in the name of and delivered to the Warrant
Holder, or as the Warrant Holder may lawfully direct, a certificate or
certificates for the number of validly issued, fully paid and non-assessable
Warrant Shares to which the Warrant Holder shall be entitled on such exercise,
together with any other stock or other securities or property (including cash,
where applicable) to which the Warrant Holder is entitled upon such exercise in
accordance with the provisions hereof.
Page 3
<PAGE>
(b) This Warrant may not be exercised as to fractional shares of Common
Stock. In the event that the exercise of this Warrant, in full or in part, would
result in the issuance of any fractional share of Common Stock, then in such
event the Warrant Holder shall receive in cash an amount equal to the Bid Price
of such fractional share within five (5) Trading Days.
Section 5. Covenants of the Company.
(a) The Company shall use its best efforts to insure that a Registration
Statement under the Securities Act covering the resale or other disposition
thereof of the Warrant Shares by the Warrant Holder is effective to the extent
required by the Registration Rights Agreement.
(b) The Company shall take all necessary action and proceedings as may be
required and permitted by applicable law, rule and regulation, including,
without limitation, the notification of the Principal Market, for the legal and
valid issuance of this Warrant and the Warrant Shares to the Warrant Holder.
(c) From the date hereof through the last date on which this Warrant is
exercisable, the Company shall take all steps reasonably necessary and within
its control to insure that the Common Stock remains listed or quoted on the
Principal Market.
(d) The Warrant Shares, when issued in accordance with the terms hereof,
will be duly authorized and, when paid for or issued in accordance with the
terms hereof, shall be validly issued, fully paid and non-assessable.
(e) The Company has authorized and reserved for issuance to the Warrant
Holder the requisite number of shares of Common Stock to be issued pursuant to
this Warrant. The Company shall at all times reserve and keep available, solely
for issuance and delivery as Warrant Shares hereunder, such shares of Common
Stock as shall from time to time be issuable as Warrant Shares.
(f) With a view to making available to the Warrant Holder the benefits of
Rule 144 promulgated under the Securities Act ("Rule 144") and any other rule or
regulation of the Securities and Exchange Commission (the "SEC"), that may at
any time permit the Warrant Holder to sell securities of the Company to the
public without registration, the Company agrees to use its reasonable best
efforts to (i) make and keep public information available, as those terms are
understood and defined in Rule 144, at all times; and (ii) file with the SEC in
a timely manner all reports and other documents required of the Company under
the Securities Act and the Exchange Act.
Section 6.1 Adjustment of the Exercise Price. The Exercise Price and,
accordingly, the number of Warrant Shares issuable upon exercise of the Warrant,
shall be subject to adjustment from time to time upon the happening of certain
events as follows:
(a) Reclassification, Consolidation, Merger or Mandatory Share Exchange. If
the Company, at any time while this Warrant is unexpired and not exercised in
full (i) reclassifies or
Page 4
<PAGE>
changes its Outstanding Capital Shares (other than a change in par value, or
from par value to no par value per share, or from no par value per share to par
value or as a result of a subdivision or combination of outstanding securities
issuable upon exercise of the Warrant) or (ii) consolidates, merges or effects a
mandatory share exchange with or into another corporation (other than a merger
or mandatory share exchange with another corporation in which the Company is a
continuing corporation and that does not result in any reclassification or
change, other than a change in par value, or from par value to no par value per
share, or from no par value per share to par value, or as a result of a
subdivision or combination of Outstanding Capital Shares issuable upon exercise
of the Warrant) at any time while this Warrant is unexpired and not exercised in
full, then in any such event the Company, or such successor or purchasing
corporation, as the case may be, shall, without payment of any additional
consideration therefore, amend this Warrant or enter into a new Warrant
providing that the Warrant Holder shall have rights not less favorable to the
holder than those then applicable to this Warrant and to receive upon exercise
under such amendment of this Warrant or new Warrant, in lieu of each share of
Common Stock theretofore issuable upon exercise of the Warrant hereunder, the
kind and amount of shares of stock, other securities, money or property
receivable upon such reclassification, change, consolidation, merger, mandatory
share exchange, sale or transfer by the holder of one share of Common Stock
issuable upon exercise of the Warrant had the Warrant been exercised immediately
prior to such reclassification, change, consolidation, merger, mandatory share
exchange or sale or transfer. Such amended Warrant shall provide for adjustments
which shall be as nearly equivalent as may be practicable to the adjustments
provided for in this Section 6.1. The provisions of this subsection (a) shall
similarly apply to successive reclassifications, changes, consolidations,
mergers, mandatory share exchanges and sales and transfers.
(b) Subdivision or Combination of Shares. If the Company, at any time while
this Warrant is unexpired and not exercised in full, shall subdivide its Common
Stock, the Exercise Price shall be proportionately reduced as of the effective
date of such subdivision, or, if the Company shall take a record of holders of
its Common Stock for the purpose of so subdividing, as of such record date,
whichever is earlier. If the Company, at any time while this Warrant is
unexpired and not exercised in full, shall combine its Common Stock, the
Exercise Price shall be proportionately increased as of the effective date of
such combination, or, if the Company shall take a record of holders of its
Common Stock for the purpose of so combining, as of such record date, whichever
is earlier.
(c) Stock Dividends. If the Company, at any time while this Warrant is
unexpired and not exercised in full, shall pay a dividend in its Capital Shares,
or make any other distribution of its Capital Shares, then the Exercise Price
shall be adjusted, as of the date the Company shall take a record of the holders
of its Capital Shares for the purpose of receiving such dividend or other
distribution (or if no such record is taken, as at the date of such payment or
other distribution), to that price determined by multiplying the Exercise Price
in effect immediately prior to such payment or other distribution by a fraction:
1. the numerator of which shall be the total number of Outstanding
Capital Shares immediately prior to such dividend or distribution, and
Page 5
<PAGE>
2. the denominator of which shall be the total number of Outstanding
Capital Shares immediately after such dividend or distribution.
The provisions of this subsection (c) shall not apply under any of the
circumstances for which an adjustment is provided in subsections (a) or (b).
(d) Issuance of Additional Capital Shares. If the Company, at any time
while this Warrant is unexpired and not exercised in full, shall issue any
additional Capital Shares ("Additional Capital Shares"), otherwise than as
provided in the foregoing subsections (a) through (c) above, at a price per
share less, or for other consideration lower, than the Bid Price in effect
immediately prior to such issuance, or without consideration, then upon such
issuance the Exercise Price shall be reduced to that price determined by
multiplying the Exercise Price in effect immediately prior to such event by a
fraction:
1. the numerator of which shall be the number of Outstanding Capital
Shares immediately prior to the issuance of the Additional Capital Shares plus
the number of Capital Shares that the aggregate consideration for the total
number of such Additional Capital Shares so issued would purchase at the then
effective Bid Price, and
2. the denominator of which shall be the number of Outstanding Capital
Shares immediately after the issuance of the Additional Capital Shares.
The provisions of this subsection (d) shall not apply under any of the
circumstances for which an adjustment is provided in subsections (a), (b) or
(c). The provisions of this subsection (d) shall not apply to the issuance of
any Additional Capital Shares that are issued pursuant to the exercise of any
warrants, options or other subscription or purchase rights or pursuant to the
exercise of any conversion or exchange rights in any convertible or exchangeable
securities.
(e) Issuance of Warrants, Options or Other Rights. If the Company, at any
time while this Warrant is unexpired and not exercised in full, shall issue any
warrants, options or other rights to subscribe for or purchase any Additional
Capital Shares and the price per share for which Additional Capital Shares may
at any time thereafter be issuable pursuant to such warrants, options or other
rights shall be less than the Bid Price in effect immediately prior to such
issuance, then upon the issuance of such options, warrants or other rights, the
Exercise Price shall be adjusted as provided in subsection (d) hereof on the
basis that:
1. the maximum number of Additional Capital Shares issuable on the
date of determination (subject to adjustment on the date(s) of exercise)
pursuant to all such warrants, options or other rights shall be deemed to have
been issued as of the date of actual issuance of such warrants, options or other
rights, and
2. the aggregate consideration for such maximum number of Additional
Capital Shares issuable pursuant to such warrants, options or other rights,
shall be deemed to be the consideration received by the Company for the issuance
of such warrants, options, or other rights plus the minimum consideration to be
received by the Company for the issuance of Additional Capital Shares pursuant
to such warrants, options, or other rights.
Page 6
<PAGE>
(f) Issuance of Convertible or Exchangeable Securities. If the Company, at
any time while this Warrant is unexpired and not exercised in full, shall issue
any securities convertible into or exchangeable for Capital Shares and the
consideration per share for which Additional Capital Shares may at any time
thereafter be issuable pursuant to the terms of such convertible or exchangeable
securities shall be less than the Bid Price in effect immediately prior to such
issuance, then upon the issuance of such convertible or exchangeable securities,
the Exercise Price shall be adjusted as provided in subsection (d) hereof on the
basis that:
1. the maximum number of Additional Capital Shares necessary on the
date of determination (subject to adjustment on the date(s) of conversion or
exchange) to effect the conversion or exchange of all such convertible or
exchangeable securities shall be deemed to have been issued as of the date of
issuance of such convertible or exchangeable securities, and
2. the aggregate consideration for such maximum number of Additional
Capital Shares shall be deemed to be the consideration received by the Company
for the issuance of such convertible or exchangeable securities plus the minimum
consideration received by the Company for the issuance of such Additional
Capital Shares pursuant to the terms of such convertible or exchangeable
securities.
No adjustment of the Exercise Price shall be made under this subsection (f) upon
the issuance of any convertible or exchangeable securities that are issued
pursuant to the exercise of any warrants, options or other subscription or
purchase rights therefor, if the issuance of such warrants, options or other
rights was subject to subsection (e) hereof.
(g) Adjustment of Number of Shares. Upon each adjustment of the Exercise
Price pursuant to any provisions of this Section 6.1, the number of Warrant
Shares issuable hereunder at the option of the Warrant Holder shall be
calculated, to the nearest one hundredth of a whole share, multiplying the
number of Warrant Shares issuable prior to an adjustment by a fraction
1. the numerator of which shall be the Exercise Price before any
adjustment pursuant to this Section 6.1; and
2. the denominator of which shall be the Exercise Price after such
adjustment.
(h) Liquidating Dividends, Etc. If the Company, at any time while this
Warrant is unexpired and not exercised in full, makes a distribution of its
assets or evidences of indebtedness to the holders of its Capital Shares as a
dividend in liquidation or by way of return of capital or other than as a
dividend payable out of earnings or surplus legally available for dividends
under applicable law or any distribution to such holders made in respect of the
sale of all or substantially all of the Company's assets (other than under the
circumstances provided for in the foregoing subsections (a) through (g)) while
an exercise is pending, then the Warrant Holder shall be entitled to receive
upon such exercise of the Warrant in addition to the Warrant Shares receivable
in connection therewith, and without payment of any consideration other
Page 7
<PAGE>
than the Exercise Price, an amount in cash equal to the value of such
distribution per Capital Share multiplied by the number of Warrant Shares that,
on the record date for such distribution, are issuable upon such exercise of the
Warrant (with no further adjustment being made following any event which causes
a subsequent adjustment in the number of Warrant Shares issuable), and an
appropriate provision therefor shall be made a part of any such distribution.
The value of a distribution that is paid in other than cash shall be determined
in good faith by the Board of Directors of the Company.
(i) Other Provisions Applicable to Adjustments Under this Section. The
following provisions will be applicable to the making of adjustments in a
Exercise Price hereinabove provided in this Section 6.1:
1. Computation of Consideration. To the extent that any Additional
Capital Shares or any convertible or exchangeable securities or any warrants,
options or other rights to subscribe for or purchase any Additional Capital
Shares or any convertible or exchangeable securities shall be issued for a cash
consideration, the consideration received by the Company therefor shall be
deemed to be the amount of the cash received by the Company therefor, or, if
such Additional Capital Shares or convertible or exchangeable securities are
offered by the Company for subscription, the subscription price, or, if such
Additional Capital Shares or convertible or exchangeable securities are sold to
or through underwriters or dealers for public offering without a subscription
offering, the initial public offering price, in any such case excluding any
amounts paid or incurred by the Company for and in the underwriting of, or
otherwise in connection with the issue thereof. To the extent that such issuance
shall be for a consideration other than cash, then, the amount of such
consideration shall be deemed to be the fair market value of such consideration
at the time of such issuance as determined in good faith by the Company's Board
of Directors. The consideration for any Additional Capital Shares issuable
pursuant to any warrants, options or other rights to subscribe for or purchase
the same shall be the consideration received by the Company for issuing such
warrants, options or other rights, plus the additional consideration payable to
the Company upon the exercise of such warrants, options or other rights. The
consideration for any Additional Capital Shares issuable pursuant to the terms
of any convertible or exchangeable securities shall be the consideration paid or
payable to the Company in respect of the subscription for or purchase of such
convertible or exchangeable securities, plus the additional consideration, if
any, payable to the Company upon the exercise of the right of conversion or
exchange in such convertible or exchangeable securities. In case of the issuance
at any time of any Additional Capital Shares or convertible or exchangeable
securities in payment or satisfaction of any dividend upon any class of stock
preferred as to dividends in a fixed amount, the Company shall be deemed to have
received for such Additional Capital Shares or convertible or exchangeable
securities a consideration equal to the amount of such dividend so paid or
satisfied.
2. Readjustment of Exercise Price. Upon the expiration of the right to
convert or exchange any convertible or exchangeable securities, or upon the
expiration of any rights, options or warrants, the issuance of which convertible
or exchangeable securities, rights, options or warrants effected an adjustment
in Exercise Price, if any such convertible or exchangeable securities shall not
have been converted or exchanged, or if any such rights, options or warrants
shall not have been exercised, the number of Capital Shares deemed to be
Page 8
<PAGE>
issued and Outstanding by reason of the fact that they were issuable upon
conversion or exchange of any such convertible or exchangeable securities or
upon exercise of any such rights, options, or warrants shall no longer be
computed as set forth above, and such Exercise Price shall forthwith be
readjusted and thereafter be the price that it would have been (but reflecting
any other adjustments in the Exercise Price made pursuant to the provisions of
this Section 6.1 after the issuance of such convertible or exchangeable
securities, rights, options or warrants) had the adjustment of the Exercise
Price made upon the issuance or sale of such convertible or exchangeable
securities or issuance of rights, options or warrants been made on the basis of
the issuance only of the number of Additional Capital Shares actually issued
upon conversion or exchange of such convertible or exchangeable securities, or
upon the exercise of such rights, options or warrants, and thereupon only the
number of Additional Capital Shares actually so issued, if any, shall be deemed
to have been issued and only the consideration actually received by the Company
(computed as set forth in sub-subsection (i) hereof) shall be deemed to have
been received by the Company. If the purchase price provided for in any rights,
options or warrants, or the additional consideration (if any) payable upon the
conversion or exchange of any convertible or exchangeable securities, or the
rate at which any convertible or exchangeable securities are convertible into or
exchangeable for Capital Shares changes at any time (other than under or by
reason of provisions designed to protect against dilution), the Exercise Price
in effect at the time of the change shall be adjusted to the Exercise Price that
would have been in effect at such time had such rights, options, warrants or
convertible or exchangeable securities still outstanding provided for such
changed purchase price, additional consideration or conversion rate, as the case
may be, at the time initially granted, issued or sold.
3. Other Action Affecting Capital Shares. In case after the date
hereof the Company shall take any action affecting the number of Outstanding
Capital Shares, other than an action described in any of the foregoing
subsections (a) through (h) hereof, inclusive, which in the opinion of the
Company's Board of Directors would have a materially adverse effect upon the
rights of the Warrant Holder at the time of exercise of the Warrant, the
Exercise Price shall be adjusted in such manner and at such time as the Board or
Directors on the advice of the Company's independent public accountants may in
good faith determine to be equitable in the circumstances.
(j) No Adjustments. No adjustments to the Exercise Price shall be made
whatsoever as a result of (i) warrants and stock options granted or reserved for
issuance to employees and directors as described in the SEC Documents on file
with the Commission as of the date of this Agreement, (ii) pursuant to an
Employee Stock Purchase Plan qualified under Section 423 of the Internal Revenue
Code as of the date of this Agreement (iii) the purchase and sale of the Put
Shares hereunder, (iv) the Warrant, (v) the Supplemental Warrant, or (vi) any
Common Stock issuable upon conversion or exercise of any of the foregoing.
(k) In the event the Company shall, at a time while the Warrant is
unexpired and outstanding, take any action which pursuant to subsections (a)
through (g) of this Section 6.1 may result in an adjustment of the Exercise
Price, the Company shall give to the Warrant Holder at its last address known to
the Company written notice of such action ten (10) days in
Page 9
<PAGE>
advance of its effective date in order to afford to the Warrant Holder an
opportunity to exercise the Warrant prior to such action becoming effective.
Section 6.2 Notice of Adjustments. Whenever the Exercise Price or number of
Warrant Shares shall be adjusted pursuant to Section 6.1 hereof, the Company
shall promptly make a certificate signed by its President or a Vice President
and by its Treasurer or Assistant Treasurer or its Secretary or Assistant
Secretary, setting forth in reasonable detail the event requiring the
adjustment, the amount of the adjustment, the method by which such adjustment
was calculated (including a description of the basis on which the Company's
Board of Directors made any determination hereunder), and the Exercise Price and
number of Warrant Shares purchasable at that Exercise Price after giving effect
to such adjustment, and shall promptly cause copies of such certificate to be
mailed (by first class and postage prepaid) to the Holder of the Warrant.
In the event the Company shall, at any time while the Warrant is unexpired and
not exercised in full, take any action that pursuant to subsections (a) through
(g) of Section 6.1 may result in an adjustment of the Exercise Price, the
Company shall give to the Holder of the Warrant at its last address known to the
Company written notice of such action ten (10) days in advance of its effective
date in order to afford to the Holder of the Warrant an opportunity to exercise
the Warrant prior to such action becoming effective.
Section 7. No Impairment. The Company will not, by amendment of its Articles of
Incorporation or By-Laws or through any reorganization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of
the terms of this Warrant, but will at all times in good faith assist in the
carrying out of all such terms and in the taking of all such action as may be
necessary or appropriate in order to protect the rights of the Warrant Holder
against impairment. Without limiting the generality of the foregoing, the
Company (a) will not increase the par value of any Warrant Shares above the
amount payable therefor on such exercise, and (b) will take all such action as
may be reasonably necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable Warrant Shares on the exercise of
this Warrant.
Section 8 Rights As Stockholder. Prior to exercise of this Warrant, the Warrant
Holder shall not be entitled to any rights as a stockholder of the Company with
respect to the Warrant Shares, including (without limitation) the right to vote
such shares, receive dividends or other distributions thereon or be notified of
stockholder meetings. However, in the event of any taking by the Company of a
record of the holders of any class of securities for the purpose of determining
the holders thereof who are entitled to receive any dividend (other than a cash
dividend) or other distribution, any right to subscribe for, purchase or
otherwise acquire any shares of stock of any class or any other securities or
property, or to receive any other right, the Company shall mail to each Warrant
Holder, at least 10 days prior to the date specified therein, a notice
specifying the date on which any such record is to be taken for the purpose of
such dividend, distribution or right, and the amount and character of such
dividend, distribution or right.
Page 10
<PAGE>
Section 9. Replacement of Warrant. Upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of the
Warrant and, in the case of any such loss, theft or destruction of the Warrant,
upon delivery of an indemnity agreement or security reasonably satisfactory in
form and amount to the Company or, in the case of any such mutilation, on
surrender and cancellation of such Warrant, the Company at its expense will
execute and deliver, in lieu thereof, a new Warrant of like tenor.
Section 10. Choice of Law. This Agreement shall be construed under the laws of
the State of New Jersey, without giving effect to provisions regarding conflicts
of law or choice of law.
Section 11. Entire Agreement; Amendments. This Warrant, the Registration Rights
Agreement, and the Agreement contain the entire understanding of the parties
with respect to the matters covered hereby and thereby. No provision of this
Warrant may be waived or amended other than by a written instrument signed by
the party against whom enforcement of any such amendment or waiver is sought.
Section 12. Restricted Securities.
(a) Registration or Exemption Required. This Warrant has been issued in a
transaction exempt from the registration requirements of the Securities Act in
reliance upon the provisions of Section 4(2) promulgated by the SEC under the
Securities Act. This Warrant and the Warrant Shares issuable upon exercise of
this Warrant may not be resold except pursuant to an effective registration
statement or an exemption to the registration requirements of the Securities Act
and applicable state laws.
(b) Legend. The Warrant and any Warrant Shares issued upon exercise
thereof, shall bear the following legend:
"THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
U.S. SECURITIES ACT OF 1933, AS AMENDED (THE"ACT" OR THE "SECURITIES ACT"), OR
ANY OTHER APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN
EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH
OTHER SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION
HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED,
HYPOTHECATED OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO A TRANSACTION
WHICH IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION. THE HOLDER OF THIS
CERTIFICATE IS THE BENEFICIARY OF CERTAIN OBLIGATIONS OF THE COMPANY SET FORTH
IN A PRIVATE SECURITIES SUBSCRIPTION AGREEMENT BETWEEN NUWAVE TECHNOLOGIES, INC.
AND PROFUTURES SPECIAL EQUITIES FUND, L.P. DATED AS OF FEBRUARY 6, 1998. A COPY
OF THE PORTION OF THE
Page 11
<PAGE>
AFORESAID AGREEMENT EVIDENCING SUCH OBLIGATIONS MAY BE OBTAINED FROM THE
COMPANY'S EXECUTIVE OFFICES."
(a) No Other Legend or Stock Transfer Restrictions. No legend other than
the one specified in Section 12(b) has been or shall be placed on the share
certificates representing the Common Stock and no instructions or "stop transfer
orders," so called, "stock transfer restrictions," or other restrictions have
been or shall be given to the Company's transfer agent with respect thereto
other than as expressly set forth in this Section 12.
(b) Assignment. Assuming the conditions of Section 12(a) above regarding
registration or exemption have been satisfied, the Warrant Holder may sell,
transfer, assign, pledge or otherwise dispose of this Warrant, in whole or in
part. The Warrant Holder shall deliver a written notice to Company,
substantially in the form of the Assignment attached hereto as Exhibit C,
indicating the person or persons to whom the Warrant shall be assigned and the
respective number of warrants to be assigned to each assignee. The Company shall
effect the assignment within ten (10) days, and shall deliver to the assignee(s)
designated by the Warrant Holder a Warrant or Warrants of like tenor and terms
for the appropriate number of shares.
(c) Investor's Compliance. Nothing in this Section 12 shall affect in any
way the Investor's obligations under any agreement to comply with all applicable
securities laws upon resale of the Common Stock.
(d) Collateral. Notwithstanding any provision herein to the contrary, the
Investor may pledge such Registrable Securities as Investor may hold as
collateral for a revolving credit note pursuant to a loan and security agreement
with a lending institution.
Section 13. Notices. All notices, demands, requests, consents, approvals, and
other communications required or permitted hereunder shall be in writing and
shall be (i) personally served, (ii) deposited in the mail, registered or
certified, return receipt requested, postage prepaid, (iii) delivered by
reputable air courier service with charges prepaid, or (iv) transmitted by hand
delivery, telegram, telex or facsimile, addressed as set forth below or to such
other address as such party shall have specified most recently by written
notice. Any notice or other communication required or permitted to be given
hereunder shall be deemed effective (a) upon hand delivery or delivery by
facsimile (with accurate confirmation generated by the transmitting facsimile
machine) at the address or number designated below (if delivered on a business
day during normal business hours where such notice is to be received), or the
first business day following such delivery (if delivered other than on a
business day during normal business hours where such notice is to be received)
or (b) on the second business day following the date of mailing by express
courier service, fully prepaid, addressed to such address, or upon actual
receipt of such mailing, whichever shall first occur. The addresses for such
communications shall be:
Page 12
<PAGE>
If to NUWAVE Technologies, Inc.: Jeremiah O'Brien
Chief Financial Officer
One Passaic Avenue
Fairfield, New Jersey 07004
Telephone (973) 882-8810 ext. 212
Facsimile (973) 882-8812
with a copy to: Fredric Klink, Esq.
(shall not constitute notice) Dechert, Price & Rhoads
30 Rockefeller Plaza, 23rd Floor
New York, New York 10112
Telephone (212) 698-3537
Facsimile (212) 698-3599
If to the Investor: Gary D. Halbert
President
ProFutures Special Equities Fund, L.P.
1310 Highway 620 South, Suite 200
Austin, TX 78734
Telephone (512) 263-3800
Facsimile (512) 263-3459
with a copy to: John Gray, Esq.
(shall not constitute notice) Fishman, Jones, Walsh & Marsh, P.C.
1310 Highway 620 South, Suite 200
Austin, TX 78734
Telephone (512) 263-8057
Facsimile (512) 263-8058
Either party hereto may from time to time change its address or facsimile number
for notices under this Section 13 by giving at least ten (10) days' prior
written notice of such changed address or facsimile number to the other party
hereto.
Section 14. Miscellaneous. This Warrant and any term hereof may be changed,
waived, discharged or terminated only by an instrument in writing signed by the
party against which enforcement of such change, waiver, discharge or termination
is sought. This Warrant shall be construed and enforced in accordance with and
governed by the laws of the State of New Jersey. The headings in this Warrant
are for purposes of reference only, and shall not limit or otherwise affect any
of the terms hereof. The invalidity or unenforceability of any provision hereof
shall in no way affect the validity or enforceability of any other provision.
Page 13
<PAGE>
IN WITNESS WHEREOF, this Warrant was duly executed on the date first
written above.
NUWAVE TECHNOLOGIES, INC.
By:
------------------------------------------
Gerald Zarin
Chairman and Chief Executive Officer
Attested
By:
------------------------------------------
Jeremiah F. O'Brien
Secretary and Chief Financial Officer
Page 14
<PAGE>
EXHIBIT A TO THE WARRANT
NUWAVE TECHNOLOGIES, INC.
CASH EXERCISE
The undersigned hereby irrevocably exercises the right to purchase
__________________ shares of Common Stock of NUWAVE Technologies, Inc., a
Delaware corporation, evidenced by the attached Warrant, and herewith makes
payment of the Exercise Price with respect to such shares in full in the form of
[wire transfer, cash or check in the amount of $___], [_____ Warrant Shares
which represent the amount of Warrant Shares as provided in the attached Warrant
to be canceled in connection with such exercise], all in accordance with the
conditions and provisions of said Warrant.
The undersigned requests that stock certificates for such Warrant
Shares be issued, and a Warrant representing any unexercised portion hereof be
issued, pursuant to this Warrant in the name of the registered Holder and
delivered to the undersigned at the address set forth below.
Dated:
--------------------------------------
- ---------------------------------------------
Signature of Registered Holder
- ---------------------------------------------
Name of Registered Holder (Print)
- ---------------------------------------------
- ---------------------------------------------
Address of Registered Holder (Print)
NOTICE
The signature to the foregoing Exercise Form must correspond to the name as
written upon the face of the attached Warrant in every particular, without
alteration or enlargement or any change whatsoever.
<PAGE>
EXHIBIT B TO THE WARRANT
NUWAVE TECHNOLOGIES, INC.
NET EXERCISE
The undersigned hereby irrevocably exercises the right to exchange the
attached Warrant for a number of shares of Common Stock of NUWAVE Technologies,
Inc., a Delaware corporation, as determined by multiplying the number of shares
as to which the Warrant is being exercised by the Per Share Warrant Value and
dividing the product by the Bid Price as the Trading Day immediately preceding
the Date of Exercise as set forth below:
No. of Shares for which this Warrant is exercised:
--------------------
Per Share Warrant Value $
--------------------
Bid Price (as of preceding Trading Day) $
--------------------
No. of Shares to be sent to Warrant Holder
--------------------
The undersigned requests that stock certificates for such Warrant
Shares be issued, and a Warrant representing any unexercised portion hereof be
issued, pursuant to this Warrant in the name of the registered Holder and
delivered to the undersigned at the address set forth below.
Dated:
------------------------------------
- -------------------------------------------
Signature of Registered Holder
- -------------------------------------------
Name of Registered Holder (Print)
- -------------------------------------------
- -------------------------------------------
Address of Registered Holder (Print)
NOTICE
The signature to the foregoing Exercise Form must correspond to the name as
written upon the face of the attached Warrant in every particular, without
alteration or enlargement or any change whatsoever.
<PAGE>
EXHIBIT C TO THE WARRANT
NUWAVE TECHNOLOGIES, INC.
ASSIGNMENT
(To be executed by the registered Warrant Holder desiring to transfer the
Warrant) FOR VALUED RECEIVED, the undersigned Warrant Holder of the attached
Warrant hereby sells, assigns and transfers unto the persons below named the
right to purchase ______________ shares of the Common Stock of NUWAVE
TECHNOLOGIES, INC. evidenced by the attached Warrant and does hereby irrevocably
constitute and appoint ______________________ attorney to transfer the said
Warrant on the books of the Company, with full power of substitution in the
premises.
Dated:
--------------------------------------
- ---------------------------------------------
Signature of Registered Holder
- ---------------------------------------------
Name of Registered Holder (Print)
- ---------------------------------------------
- ---------------------------------------------
Address of Registered Holder (Print)
NOTICE
The signature to the foregoing Exercise Form must correspond to the name as
written upon the face of the attached Warrant in every particular, without
alteration or enlargement or any change whatsoever.
<PAGE>
EXHIBIT B
THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY OTHER
APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION
FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER
SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN
MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, HYPOTHECATED
OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO A TRANSACTION WHICH IS EXEMPT FROM, OR
NOT SUBJECT TO, SUCH REGISTRATION. THE HOLDER OF THIS CERTIFICATE IS THE
BENEFICIARY OF CERTAIN OBLIGATIONS OF THE COMPANY SET FORTH IN A PRIVATE
SECURITIES SUBSCRIPTION AGREEMENT BETWEEN NUWAVE TECHNOLOGIES, INC. AND
PROFUTURES SPECIAL EQUITIES FUND, L.P. DATED FEBRUARY 6, 1998. A COPY OF THE
PORTION OF THE AFORESAID AGREEMENT EVIDENCING SUCH OBLIGATIONS MAY BE OBTAINED
FROM THE COMPANY'S EXECUTIVE OFFICES.
February 6, 1998
Warrant to Purchase up to 50,000 Shares of Common Stock of NUWAVE Technologies,
Inc.
NUWAVE Technologies, Inc., a Delaware corporation (the "Company"), hereby
acknowledges that ProFutures Special Equities Fund, L.P. (the "Investor") or any
other Warrant Holder is entitled, on the terms and conditions set forth below,
to purchase from the Company at any time during the Exercise Period up to 50,000
fully paid and nonassessable shares of Common Stock, par value $0.01 per share,
of the Company (the "Common Stock"), as the same may be adjusted pursuant to
Section 6 herein, at the Exercise Price (hereinafter defined), as the same may
be adjusted pursuant to Section 6 herein.
Section 1. Definitions.
"Agreement" shall mean the Private Securities Subscription Agreement, dated
as of February 6, 1998, between the Company and the Investor.
"Capital Shares" shall mean the Common Stock and any shares of any other
class of common stock whether now or hereafter authorized, having the right to
participate in the distribution of earnings and assets of the Company except for
any common stock issued pursuant to warrants, stock options, and convertible
securities outstanding and described in the SEC Documents on file with the
Commission as of the date of this Agreement.
<PAGE>
"Date of Exercise" shall mean the date that the advance copy of the
Exercise Form is deemed delivered by facsimile to the Company in accordance with
Section 13 hereof, provided that the original Warrant and Exercise Form are
received by the Company within five (5) Trading Days thereafter. If the Warrant
Holder has not sent advance notice by facsimile, the Date of Exercise shall be
the date the original Exercise Form is actually received by the Company.
"Exercise Period" shall mean that period beginning August 6, 1998, and
ending on August 6, 2003; provided that such period shall be extended one
Trading Day for each Trading Day that a Registration Statement is not effective
during the period such Registration Statement is required to be effective
pursuant to the Registration Rights Agreement.
"Exercise Price" shall mean $___ .
"Per Share Warrant Value" shall mean the difference resulting from
subtracting the Exercise Price from the Bid Price of one share of Common Stock
on the Trading Day next preceding the Date of Exercise.
"Registration Rights Agreement" shall mean the registration rights
agreement dated as of February 6, 1998, between the Company and the Investor.
"Warrant Holder" shall mean the Investor or any assignee or transferee of
all or any portion of this Warrant; and
other capitalized terms used herein that are defined in the Agreement shall
have the same meanings herein as therein.
Section 2. Exercise.
(a) Cash Exercise. This Warrant may be exercised by the Warrant Holder, in
whole or in part, at any time and from time to time during the Exercise Period
by surrender to the Company at its principal executive offices at the address
set forth in Section 13 of (i) this Warrant; (ii) the form of exercise attached
hereto as Exhibit A (the "Cash Exercise Form") duly executed by Warrant Holder,
and (iii) the full Exercise Price for each share of Common Stock as to which
this Warrant is exercised. In the event that the Warrant is not exercised in
full, the number of Warrant Shares shall be reduced by the number of such
Warrant Shares for which this Warrant is exercised, and the Company, at its
expense, shall forthwith issue and deliver to or upon the order of the Warrant
Holder a new Warrant of like tenor in the name of the Warrant Holder or as the
Warrant Holder may request, reflecting such adjusted number of Warrant Shares
within three (3) Trading Days.
(b) Net Exercise. This Warrant may be exercised at any time during the
Exercise Period, by presentation and surrender to the Company at its principal
executive offices at the address set forth in Section 13 of (i) this Warrant and
(ii) the form of exercise attached hereto as Exhibit B (the "Net Exercise Form")
duly executed by
Page 2
<PAGE>
Warrant Holder, including a calculation of the number of shares of Common Stock
to be issued upon such exercise in accordance with the terms hereof (a "Cashless
Exercise"). In the event of a Cashless Exercise, the holder shall surrender this
Warrant for that number of shares of Common Stock determined by (i) multiplying
the number of Warrant Shares for which this Warrant is being exercised by the
Per Share Warrant Value and (ii) dividing the product by the Bid Price of one
share of the Common Stock on the Trading Day next preceding the Date of
Exercise. In the event that the Warrant is not exercised in full, the number of
Warrant Shares shall be reduced by the number of such Warrant Shares for which
this Warrant is exercised, and the Company, at its expense, shall forthwith
issue and deliver to or upon the order of the Warrant Holder a new Warrant of
like tenor in the name of the Warrant Holder or as the Warrant Holder may
request, reflecting such adjusted number of Warrant Shares within three (3)
Trading Days.
Section 3. Ten Percent Limitation. Notwithstanding anything herein to the
contrary,unless the Investor agrees otherwise, the Warrant Holder may not
exercise the Warrant if the aggregate number of shares of common stock
beneficially owned by the holder and its affiliates following such conversion
exceeds 9.9% of the outstanding shares of the common stock following such
exercise. For purposes of the foregoing provision, the aggregate number of
shares of common stock beneficially owned by the holder and its affiliates shall
include the number as shares of common stock issuable upon exercise of the
Warrant with respect to which the determination of such proviso is being made,
but shall exclude the number of shares of common stock which would be issuable
upon (i) exercise of the remaining, Warrant beneficially owned by the holder and
its affiliates and (ii) exercise or conversion of the unexercised or unconverted
portion of any other securities of the Company (including, without limitation,
any warrants) subject to a limitation on conversion or exercise analogous to the
limitation contained herein beneficially owned by the holder and its affiliates.
Except as set forth in the preceding sentence, for purposes of this paragraph,
beneficial ownership shall be calculated in accordance with Section 16 of the
Securities Exchange Act of 1934, as amended. The holder may waive the foregoing
limitations by written notice to the Company upon not less than 61 days prior
notice (with such waiver taking effect only upon the expiration of such 61 day
notice period).
Section 4. Delivery of Stock Certificates.
(a) Subject to the terms and conditions of this Warrant, as soon as
practicable after the Date of Exercise of this Warrant in full or in part, and
in any event within three (3) Trading Days thereafter, the Company at its
expense (including, without limitation, the payment by it of any applicable
issue taxes) will cause to be issued in the name of and delivered to the Warrant
Holder, or as the Warrant Holder may lawfully direct, a certificate or
certificates for the number of validly issued, fully paid and non-assessable
Warrant Shares to which the Warrant Holder shall be entitled on such exercise,
together with any other stock or other securities or property (including cash,
where applicable) to which the Warrant Holder is entitled upon such exercise in
accordance with the provisions hereof.
Page 3
<PAGE>
(b) This Warrant may not be exercised as to fractional shares of Common
Stock. In the event that the exercise of this Warrant, in full or in part, would
result in the issuance of any fractional share of Common Stock, then in such
event the Warrant Holder shall receive in cash an amount equal to the Bid Price
of such fractional share within five (5) Trading Days.
Section 5. Covenants of the Company.
(a) The Company shall use its best efforts to insure that a Registration
Statement under the Securities Act covering the resale or other disposition
thereof of the Warrant Shares by the Warrant Holder is effective to the extent
required by the Registration Rights Agreement.
(b) The Company shall take all necessary action and proceedings as may be
required and permitted by applicable law, rule and regulation, including,
without limitation, the notification of the Principal Market, for the legal and
valid issuance of this Warrant and the Warrant Shares to the Warrant Holder.
(c) From the date hereof through the last date on which this Warrant is
exercisable, the Company shall take all steps reasonably necessary and within
its control to insure that the Common Stock remains listed or quoted on the
Principal Market.
(d) The Warrant Shares, when issued in accordance with the terms hereof,
will be duly authorized and, when paid for or issued in accordance with the
terms hereof, shall be validly issued, fully paid and non-assessable.
(e) The Company has authorized and reserved for issuance to the Warrant
Holder the requisite number of shares of Common Stock to be issued pursuant to
this Warrant. The Company shall at all times reserve and keep available, solely
for issuance and delivery as Warrant Shares hereunder, such shares of Common
Stock as shall from time to time be issuable as Warrant Shares.
(f) With a view to making available to the Warrant Holder the benefits of
Rule 144 promulgated under the Securities Act ("Rule 144") and any other rule or
regulation of the Securities and Exchange Commission (the "SEC"), that may at
any time permit the Warrant Holder to sell securities of the Company to the
public without registration, the Company agrees to use its reasonable best
efforts to (i) make and keep public information available, as those terms are
understood and defined in Rule 144, at all times; and (ii) file with the SEC in
a timely manner all reports and other documents required of the Company under
the Securities Act and the Exchange Act.
Section 6.1 Adjustment of the Exercise Price. The Exercise Price and,
accordingly, the number of Warrant Shares issuable upon exercise of the Warrant,
shall be subject to adjustment from time to time upon the happening of certain
events as follows:
(a) Reclassification, Consolidation, Merger or Mandatory Share Exchange. If
the Company, at any time while this Warrant is unexpired and not exercised in
full (i) reclassifies or
Page 4
<PAGE>
changes its Outstanding Capital Shares (other than a change in par value, or
from par value to no par value per share, or from no par value per share to par
value or as a result of a subdivision or combination of outstanding securities
issuable upon exercise of the Warrant) or (ii) consolidates, merges or effects a
mandatory share exchange with or into another corporation (other than a merger
or mandatory share exchange with another corporation in which the Company is a
continuing corporation and that does not result in any reclassification or
change, other than a change in par value, or from par value to no par value per
share, or from no par value per share to par value, or as a result of a
subdivision or combination of Outstanding Capital Shares issuable upon exercise
of the Warrant) at any time while this Warrant is unexpired and not exercised in
full, then in any such event the Company, or such successor or purchasing
corporation, as the case may be, shall, without payment of any additional
consideration therefore, amend this Warrant or enter into a new Warrant
providing that the Warrant Holder shall have rights not less favorable to the
holder than those then applicable to this Warrant and to receive upon exercise
under such amendment of this Warrant or new Warrant, in lieu of each share of
Common Stock theretofore issuable upon exercise of the Warrant hereunder, the
kind and amount of shares of stock, other securities, money or property
receivable upon such reclassification, change, consolidation, merger, mandatory
share exchange, sale or transfer by the holder of one share of Common Stock
issuable upon exercise of the Warrant had the Warrant been exercised immediately
prior to such reclassification, change, consolidation, merger, mandatory share
exchange or sale or transfer. Such amended Warrant shall provide for adjustments
which shall be as nearly equivalent as may be practicable to the adjustments
provided for in this Section 6.1. The provisions of this subsection (a) shall
similarly apply to successive reclassifications, changes, consolidations,
mergers, mandatory share exchanges and sales and transfers.
(b) Subdivision or Combination of Shares. If the Company, at any time while
this Warrant is unexpired and not exercised in full, shall subdivide its Common
Stock, the Exercise Price shall be proportionately reduced as of the effective
date of such subdivision, or, if the Company shall take a record of holders of
its Common Stock for the purpose of so subdividing, as of such record date,
whichever is earlier. If the Company, at any time while this Warrant is
unexpired and not exercised in full, shall combine its Common Stock, the
Exercise Price shall be proportionately increased as of the effective date of
such combination, or, if the Company shall take a record of holders of its
Common Stock for the purpose of so combining, as of such record date, whichever
is earlier.
(c) Stock Dividends. If the Company, at any time while this Warrant is
unexpired and not exercised in full, shall pay a dividend in its Capital Shares,
or make any other distribution of its Capital Shares, then the Exercise Price
shall be adjusted, as of the date the Company shall take a record of the holders
of its Capital Shares for the purpose of receiving such dividend or other
distribution (or if no such record is taken, as at the date of such payment or
other distribution), to that price determined by multiplying the Exercise Price
in effect immediately prior to such payment or other distribution by a fraction:
1. the numerator of which shall be the total number of Outstanding
Capital Shares immediately prior to such dividend or distribution, and
Page 5
<PAGE>
2. the denominator of which shall be the total number of Outstanding
Capital Shares immediately after such dividend or distribution.
The provisions of this subsection (c) shall not apply under any of the
circumstances for which an adjustment is provided in subsections (a) or (b).
(d) Issuance of Additional Capital Shares. If the Company, at any time
while this Warrant is unexpired and not exercised in full, shall issue any
additional Capital Shares ("Additional Capital Shares"), otherwise than as
provided in the foregoing subsections (a) through (c) above, at a price per
share less, or for other consideration lower, than the Bid Price in effect
immediately prior to such issuance, or without consideration, then upon such
issuance the Exercise Price shall be reduced to that price determined by
multiplying the Exercise Price in effect immediately prior to such event by a
fraction:
1. the numerator of which shall be the number of Outstanding Capital
Shares immediately prior to the issuance of the Additional Capital Shares plus
the number of Capital Shares that the aggregate consideration for the total
number of such Additional Capital Shares so issued would purchase at the then
effective Bid Price, and
2. the denominator of which shall be the number of Outstanding Capital
Shares immediately after the issuance of the Additional Capital Shares.
The provisions of this subsection (d) shall not apply under any of the
circumstances for which an adjustment is provided in subsections (a), (b) or
(c). The provisions of this subsection (d) shall not apply to the issuance of
any Additional Capital Shares that are issued pursuant to the exercise of any
warrants, options or other subscription or purchase rights or pursuant to the
exercise of any conversion or exchange rights in any convertible or exchangeable
securities.
(e) Issuance of Warrants, Options or Other Rights. If the Company, at any
time while this Warrant is unexpired and not exercised in full, shall issue any
warrants, options or other rights to subscribe for or purchase any Additional
Capital Shares and the price per share for which Additional Capital Shares may
at any time thereafter be issuable pursuant to such warrants, options or other
rights shall be less than the Bid Price in effect immediately prior to such
issuance, then upon the issuance of such options, warrants or other rights, the
Exercise Price shall be adjusted as provided in subsection (d) hereof on the
basis that:
1. the maximum number of Additional Capital Shares issuable on the
date of determination (subject to adjustment on the date(s) of exercise)
pursuant to all such warrants, options or other rights shall be deemed to have
been issued as of the date of actual issuance of such warrants, options or other
rights, and
2. the aggregate consideration for such maximum number of Additional
Capital Shares issuable pursuant to such warrants, options or other rights,
shall be deemed to be the consideration received by the Company for the issuance
of such warrants, options, or other rights plus the minimum consideration to be
received by the Company for the issuance of Additional Capital Shares pursuant
to such warrants, options, or other rights.
Page 6
<PAGE>
(f) Issuance of Convertible or Exchangeable Securities. If the Company, at
any time while this Warrant is unexpired and not exercised in full, shall issue
any securities convertible into or exchangeable for Capital Shares and the
consideration per share for which Additional Capital Shares may at any time
thereafter be issuable pursuant to the terms of such convertible or exchangeable
securities shall be less than the Bid Price in effect immediately prior to such
issuance, then upon the issuance of such convertible or exchangeable securities,
the Exercise Price shall be adjusted as provided in subsection (d) hereof on the
basis that:
1. the maximum number of Additional Capital Shares necessary on the
date of determination (subject to adjustment on the date(s) of conversion or
exchange) to effect the conversion or exchange of all such convertible or
exchangeable securities shall be deemed to have been issued as of the date of
issuance of such convertible or exchangeable securities, and
2. the aggregate consideration for such maximum number of Additional
Capital Shares shall be deemed to be the consideration received by the Company
for the issuance of such convertible or exchangeable securities plus the minimum
consideration received by the Company for the issuance of such Additional
Capital Shares pursuant to the terms of such convertible or exchangeable
securities.
No adjustment of the Exercise Price shall be made under this subsection (f) upon
the issuance of any convertible or exchangeable securities that are issued
pursuant to the exercise of any warrants, options or other subscription or
purchase rights therefor, if the issuance of such warrants, options or other
rights was subject to subsection (e) hereof.
(g) Adjustment of Number of Shares. Upon each adjustment of the Exercise
Price pursuant to any provisions of this Section 6.1, the number of Warrant
Shares issuable hereunder at the option of the Warrant Holder shall be
calculated, to the nearest one hundredth of a whole share, multiplying the
number of Warrant Shares issuable prior to an adjustment by a fraction
1. the numerator of which shall be the Exercise Price before any
adjustment pursuant to this Section 6.1; and
2. the denominator of which shall be the Exercise Price after such
adjustment.
(h) Liquidating Dividends, Etc. If the Company, at any time while this
Warrant is unexpired and not exercised in full, makes a distribution of its
assets or evidences of indebtedness to the holders of its Capital Shares as a
dividend in liquidation or by way of return of capital or other than as a
dividend payable out of earnings or surplus legally available for dividends
under applicable law or any distribution to such holders made in respect of the
sale of all or substantially all of the Company's assets (other than under the
circumstances provided for in the foregoing subsections (a) through (g)) while
an exercise is pending, then the Warrant Holder shall be entitled to receive
upon such exercise of the Warrant in addition to the Warrant Shares receivable
in connection therewith, and without payment of any consideration other
Page 7
<PAGE>
than the Exercise Price, an amount in cash equal to the value of such
distribution per Capital Share multiplied by the number of Warrant Shares that,
on the record date for such distribution, are issuable upon such exercise of the
Warrant (with no further adjustment being made following any event which causes
a subsequent adjustment in the number of Warrant Shares issuable), and an
appropriate provision therefor shall be made a part of any such distribution.
The value of a distribution that is paid in other than cash shall be determined
in good faith by the Board of Directors of the Company.
(i) Other Provisions Applicable to Adjustments Under this Section. The
following provisions will be applicable to the making of adjustments in a
Exercise Price hereinabove provided in this Section 6.1:
1. Computation of Consideration. To the extent that any Additional
Capital Shares or any convertible or exchangeable securities or any warrants,
options or other rights to subscribe for or purchase any Additional Capital
Shares or any convertible or exchangeable securities shall be issued for a cash
consideration, the consideration received by the Company therefor shall be
deemed to be the amount of the cash received by the Company therefor, or, if
such Additional Capital Shares or convertible or exchangeable securities are
offered by the Company for subscription, the subscription price, or, if such
Additional Capital Shares or convertible or exchangeable securities are sold to
or through underwriters or dealers for public offering without a subscription
offering, the initial public offering price, in any such case excluding any
amounts paid or incurred by the Company for and in the underwriting of, or
otherwise in connection with the issue thereof. To the extent that such issuance
shall be for a consideration other than cash, then, the amount of such
consideration shall be deemed to be the fair market value of such consideration
at the time of such issuance as determined in good faith by the Company's Board
of Directors. The consideration for any Additional Capital Shares issuable
pursuant to any warrants, options or other rights to subscribe for or purchase
the same shall be the consideration received by the Company for issuing such
warrants, options or other rights, plus the additional consideration payable to
the Company upon the exercise of such warrants, options or other rights. The
consideration for any Additional Capital Shares issuable pursuant to the terms
of any convertible or exchangeable securities shall be the consideration paid or
payable to the Company in respect of the subscription for or purchase of such
convertible or exchangeable securities, plus the additional consideration, if
any, payable to the Company upon the exercise of the right of conversion or
exchange in such convertible or exchangeable securities. In case of the issuance
at any time of any Additional Capital Shares or convertible or exchangeable
securities in payment or satisfaction of any dividend upon any class of stock
preferred as to dividends in a fixed amount, the Company shall be deemed to have
received for such Additional Capital Shares or convertible or exchangeable
securities a consideration equal to the amount of such dividend so paid or
satisfied.
2. Readjustment of Exercise Price. Upon the expiration of the right to
convert or exchange any convertible or exchangeable securities, or upon the
expiration of any rights, options or warrants, the issuance of which convertible
or exchangeable securities, rights, options or warrants effected an adjustment
in Exercise Price, if any such convertible or exchangeable securities shall not
have been converted or exchanged, or if any such rights, options or warrants
shall not have been exercised, the number of Capital Shares deemed to be
Page 8
<PAGE>
issued and Outstanding by reason of the fact that they were issuable upon
conversion or exchange of any such convertible or exchangeable securities or
upon exercise of any such rights, options, or warrants shall no longer be
computed as set forth above, and such Exercise Price shall forthwith be
readjusted and thereafter be the price that it would have been (but reflecting
any other adjustments in the Exercise Price made pursuant to the provisions of
this Section 6.1 after the issuance of such convertible or exchangeable
securities, rights, options or warrants) had the adjustment of the Exercise
Price made upon the issuance or sale of such convertible or exchangeable
securities or issuance of rights, options or warrants been made on the basis of
the issuance only of the number of Additional Capital Shares actually issued
upon conversion or exchange of such convertible or exchangeable securities, or
upon the exercise of such rights, options or warrants, and thereupon only the
number of Additional Capital Shares actually so issued, if any, shall be deemed
to have been issued and only the consideration actually received by the Company
(computed as set forth in sub-subsection (i) hereof) shall be deemed to have
been received by the Company. If the purchase price provided for in any rights,
options or warrants, or the additional consideration (if any) payable upon the
conversion or exchange of any convertible or exchangeable securities, or the
rate at which any convertible or exchangeable securities are convertible into or
exchangeable for Capital Shares changes at any time (other than under or by
reason of provisions designed to protect against dilution), the Exercise Price
in effect at the time of the change shall be adjusted to the Exercise Price that
would have been in effect at such time had such rights, options, warrants or
convertible or exchangeable securities still outstanding provided for such
changed purchase price, additional consideration or conversion rate, as the case
may be, at the time initially granted, issued or sold.
3. Other Action Affecting Capital Shares. In case after the date
hereof the Company shall take any action affecting the number of Outstanding
Capital Shares, other than an action described in any of the foregoing
subsections (a) through (h) hereof, inclusive, which in the opinion of the
Company's Board of Directors would have a materially adverse effect upon the
rights of the Warrant Holder at the time of exercise of the Warrant, the
Exercise Price shall be adjusted in such manner and at such time as the Board or
Directors on the advice of the Company's independent public accountants may in
good faith determine to be equitable in the circumstances.
(j) No Adjustments. No adjustments to the Exercise Price shall be made
whatsoever as a result of (i) warrants and stock options granted or reserved for
issuance to employees and directors as described in the SEC Documents on file
with the Commission as of the date of this Agreement, (ii) pursuant to an
Employee Stock Purchase Plan qualified under Section 423 of the Internal Revenue
Code as of the date of this Agreement (iii) the purchase and sale of the Put
Shares hereunder, (iv) the Warrant, (v) the Supplemental Warrant, or (vi) any
Common Stock issuable upon conversion or exercise of any of the foregoing.
(k) In the event the Company shall, at a time while the Warrant is
unexpired and outstanding, take any action which pursuant to subsections (a)
through (g) of this Section 6.1 may result in an adjustment of the Exercise
Price, the Company shall give to the Warrant Holder at its last address known to
the Company written notice of such action ten (10) days in
Page 9
<PAGE>
advance of its effective date in order to afford to the Warrant Holder an
opportunity to exercise the Warrant prior to such action becoming effective.
Section 6.2 Notice of Adjustments. Whenever the Exercise Price or number of
Warrant Shares shall be adjusted pursuant to Section 6.1 hereof, the Company
shall promptly make a certificate signed by its President or a Vice President
and by its Treasurer or Assistant Treasurer or its Secretary or Assistant
Secretary, setting forth in reasonable detail the event requiring the
adjustment, the amount of the adjustment, the method by which such adjustment
was calculated (including a description of the basis on which the Company's
Board of Directors made any determination hereunder), and the Exercise Price and
number of Warrant Shares purchasable at that Exercise Price after giving effect
to such adjustment, and shall promptly cause copies of such certificate to be
mailed (by first class and postage prepaid) to the Holder of the Warrant.
In the event the Company shall, at any time while the Warrant is unexpired and
not exercised in full, take any action that pursuant to subsections (a) through
(g) of Section 6.1 may result in an adjustment of the Exercise Price, the
Company shall give to the Holder of the Warrant at its last address known to the
Company written notice of such action ten (10) days in advance of its effective
date in order to afford to the Holder of the Warrant an opportunity to exercise
the Warrant prior to such action becoming effective.
Section 7. No Impairment. The Company will not, by amendment of its Articles of
Incorporation or By-Laws or through any reorganization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of
the terms of this Warrant, but will at all times in good faith assist in the
carrying out of all such terms and in the taking of all such action as may be
necessary or appropriate in order to protect the rights of the Warrant Holder
against impairment. Without limiting the generality of the foregoing, the
Company (a) will not increase the par value of any Warrant Shares above the
amount payable therefor on such exercise, and (b) will take all such action as
may be reasonably necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable Warrant Shares on the exercise of
this Warrant.
Section 8 Rights As Stockholder. Prior to exercise of this Warrant, the Warrant
Holder shall not be entitled to any rights as a stockholder of the Company with
respect to the Warrant Shares, including (without limitation) the right to vote
such shares, receive dividends or other distributions thereon or be notified of
stockholder meetings. However, in the event of any taking by the Company of a
record of the holders of any class of securities for the purpose of determining
the holders thereof who are entitled to receive any dividend (other than a cash
dividend) or other distribution, any right to subscribe for, purchase or
otherwise acquire any shares of stock of any class or any other securities or
property, or to receive any other right, the Company shall mail to each Warrant
Holder, at least 10 days prior to the date specified therein, a notice
specifying the date on which any such record is to be taken for the purpose of
such dividend, distribution or right, and the amount and character of such
dividend, distribution or right.
Page 10
<PAGE>
Section 9. Replacement of Warrant. Upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of the
Warrant and, in the case of any such loss, theft or destruction of the Warrant,
upon delivery of an indemnity agreement or security reasonably satisfactory in
form and amount to the Company or, in the case of any such mutilation, on
surrender and cancellation of such Warrant, the Company at its expense will
execute and deliver, in lieu thereof, a new Warrant of like tenor.
Section 10. Choice of Law. This Agreement shall be construed under the laws of
the State of New Jersey, without giving effect to provisions regarding conflicts
of law or choice of law.
Section 11. Entire Agreement; Amendments. This Warrant, the Registration Rights
Agreement, and the Agreement contain the entire understanding of the parties
with respect to the matters covered hereby and thereby. No provision of this
Warrant may be waived or amended other than by a written instrument signed by
the party against whom enforcement of any such amendment or waiver is sought.
Section 12. Restricted Securities.
(a) Registration or Exemption Required. This Warrant has been issued in a
transaction exempt from the registration requirements of the Securities Act in
reliance upon the provisions of Section 4(2) promulgated by the SEC under the
Securities Act. This Warrant and the Warrant Shares issuable upon exercise of
this Warrant may not be resold except pursuant to an effective registration
statement or an exemption to the registration requirements of the Securities Act
and applicable state laws.
(b) Legend. The Warrant and any Warrant Shares issued upon exercise
thereof, shall bear the following legend:
"THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
U.S. SECURITIES ACT OF 1933, AS AMENDED (THE"ACT" OR THE "SECURITIES ACT"), OR
ANY OTHER APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN
EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH
OTHER SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION
HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED,
HYPOTHECATED OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO A TRANSACTION
WHICH IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION. THE HOLDER OF THIS
CERTIFICATE IS THE BENEFICIARY OF CERTAIN OBLIGATIONS OF THE COMPANY SET FORTH
IN A PRIVATE SECURITIES SUBSCRIPTION AGREEMENT BETWEEN NUWAVE TECHNOLOGIES, INC.
AND PROFUTURES SPECIAL EQUITIES FUND, L.P. DATED AS OF FEBRUARY 6, 1998. A COPY
OF THE PORTION OF THE
Page 11
<PAGE>
AFORESAID AGREEMENT EVIDENCING SUCH OBLIGATIONS MAY BE OBTAINED FROM THE
COMPANY'S EXECUTIVE OFFICES."
(a) No Other Legend or Stock Transfer Restrictions. No legend other than
the one specified in Section 12(b) has been or shall be placed on the share
certificates representing the Common Stock and no instructions or "stop transfer
orders," so called, "stock transfer restrictions," or other restrictions have
been or shall be given to the Company's transfer agent with respect thereto
other than as expressly set forth in this Section 12.
(b) Assignment. Assuming the conditions of Section 12(a) above regarding
registration or exemption have been satisfied, the Warrant Holder may sell,
transfer, assign, pledge or otherwise dispose of this Warrant, in whole or in
part. The Warrant Holder shall deliver a written notice to Company,
substantially in the form of the Assignment attached hereto as Exhibit C,
indicating the person or persons to whom the Warrant shall be assigned and the
respective number of warrants to be assigned to each assignee. The Company shall
effect the assignment within ten (10) days, and shall deliver to the assignee(s)
designated by the Warrant Holder a Warrant or Warrants of like tenor and terms
for the appropriate number of shares.
(c) Investor's Compliance. Nothing in this Section 12 shall affect in any
way the Investor's obligations under any agreement to comply with all applicable
securities laws upon resale of the Common Stock.
(d) Collateral. Notwithstanding any provision herein to the contrary, the
Investor may pledge such Registrable Securities as Investor may hold as
collateral for a revolving credit note pursuant to a loan and security agreement
with a lending institution.
Section 13. Notices. All notices, demands, requests, consents, approvals, and
other communications required or permitted hereunder shall be in writing and
shall be (i) personally served, (ii) deposited in the mail, registered or
certified, return receipt requested, postage prepaid, (iii) delivered by
reputable air courier service with charges prepaid, or (iv) transmitted by hand
delivery, telegram, telex or facsimile, addressed as set forth below or to such
other address as such party shall have specified most recently by written
notice. Any notice or other communication required or permitted to be given
hereunder shall be deemed effective (a) upon hand delivery or delivery by
facsimile (with accurate confirmation generated by the transmitting facsimile
machine) at the address or number designated below (if delivered on a business
day during normal business hours where such notice is to be received), or the
first business day following such delivery (if delivered other than on a
business day during normal business hours where such notice is to be received)
or (b) on the second business day following the date of mailing by express
courier service, fully prepaid, addressed to such address, or upon actual
receipt of such mailing, whichever shall first occur. The addresses for such
communications shall be:
Page 12
<PAGE>
If to NUWAVE Technologies, Inc.: Jeremiah O'Brien
Chief Financial Officer
One Passaic Avenue
Fairfield, New Jersey 07004
Telephone (973) 882-8810 ext. 212
Facsimile (973) 882-8812
with a copy to: Fredric Klink, Esq.
(shall not constitute notice) Dechert, Price & Rhoads
30 Rockefeller Plaza, 23rd Floor
New York, New York 10112
Telephone (212) 698-3537
Facsimile (212) 698-3599
If to the Investor: Gary D. Halbert
President
ProFutures Special Equities Fund, L.P.
1310 Highway 620 South, Suite 200
Austin, TX 78734
Telephone (512) 263-3800
Facsimile (512) 263-3459
with a copy to: John Gray, Esq.
(shall not constitute notice) Fishman, Jones, Walsh & Marsh, P.C.
1310 Highway 620 South, Suite 200
Austin, TX 78734
Telephone (512) 263-8057
Facsimile (512) 263-8058
Either party hereto may from time to time change its address or facsimile number
for notices under this Section 13 by giving at least ten (10) days' prior
written notice of such changed address or facsimile number to the other party
hereto.
Section 14. Miscellaneous. This Warrant and any term hereof may be changed,
waived, discharged or terminated only by an instrument in writing signed by the
party against which enforcement of such change, waiver, discharge or termination
is sought. This Warrant shall be construed and enforced in accordance with and
governed by the laws of the State of New Jersey. The headings in this Warrant
are for purposes of reference only, and shall not limit or otherwise affect any
of the terms hereof. The invalidity or unenforceability of any provision hereof
shall in no way affect the validity or enforceability of any other provision.
Page 13
<PAGE>
IN WITNESS WHEREOF, this Warrant was duly executed on the date first
written above.
NUWAVE TECHNOLOGIES, INC.
By:
------------------------------------------
Gerald Zarin
Chairman and Chief Executive Officer
Attested
By:
------------------------------------------
Jeremiah F. O'Brien
Secretary and Chief Financial Officer
Page 14
<PAGE>
EXHIBIT A TO THE SUPPLEMENTAL WARRANT
NUWAVE TECHNOLOGIES, INC.
CASH EXERCISE
The undersigned hereby irrevocably exercises the right to purchase
__________________ shares of Common Stock of NUWAVE Technologies, Inc., a
Delaware corporation, evidenced by the attached Warrant, and herewith makes
payment of the Exercise Price with respect to such shares in full in the form of
[wire transfer, cash or check in the amount of $___], [_____ Warrant Shares
which represent the amount of Warrant Shares as provided in the attached Warrant
to be canceled in connection with such exercise], all in accordance with the
conditions and provisions of said Warrant.
The undersigned requests that stock certificates for such Warrant Shares be
issued, and a Warrant representing any unexercised portion hereof be issued,
pursuant to this Warrant in the name of the registered Holder and delivered to
the undersigned at the address set forth below.
Dated:
--------------------------------------
- ---------------------------------------------
Signature of Registered Holder
- ---------------------------------------------
Name of Registered Holder (Print)
- ---------------------------------------------
- ---------------------------------------------
Address of Registered Holder (Print)
NOTICE
The signature to the foregoing Exercise Form must correspond to the name as
written upon the face of the attached Warrant in every particular, without
alteration or enlargement or any change whatsoever.
<PAGE>
EXHIBIT B TO THE SUPPLEMENTAL WARRANT
NUWAVE TECHNOLOGIES, INC.
NET EXERCISE
The undersigned hereby irrevocably exercises the right to exchange the
attached Warrant for a number of shares of Common Stock of NUWAVE Technologies,
Inc., a Delaware corporation, as determined by multiplying the number of shares
as to which the Warrant is being exercised by the Per Share Warrant Value and
dividing the product by the Bid Price as the Trading Day immediately preceding
the Date of Exercise as set forth below:
No. of Shares for which this Warrant is exercised:
--------------------
Per Share Warrant Value $
--------------------
Bid Price (as of preceding Trading Day) $
--------------------
No. of Shares to be sent to Warrant Holder
--------------------
The undersigned requests that stock certificates for such Warrant
Shares be issued, and a Warrant representing any unexercised portion hereof be
issued, pursuant to this Warrant in the name of the registered Holder and
delivered to the undersigned at the address set forth below.
Dated:
------------------------------------
- -------------------------------------------
Signature of Registered Holder
- -------------------------------------------
Name of Registered Holder (Print)
- -------------------------------------------
- -------------------------------------------
Address of Registered Holder (Print)
NOTICE
The signature to the foregoing Exercise Form must correspond to the name as
written upon the face of the attached Warrant in every particular, without
alteration or enlargement or any change whatsoever.
<PAGE>
EXHIBIT C TO THE SUPPLEMENTAL WARRANT
NUWAVE TECHNOLOGIES, INC.
ASSIGNMENT
(To be executed by the registered Warrant Holder desiring to transfer the
Warrant) FOR VALUED RECEIVED, the undersigned Warrant Holder of the attached
Warrant hereby sells, assigns and transfers unto the persons below named the
right to purchase ______________ shares of the Common Stock of NUWAVE
TECHNOLOGIES, INC. evidenced by the attached Warrant and does hereby irrevocably
constitute and appoint ______________________ attorney to transfer the said
Warrant on the books of the Company, with full power of substitution in the
premises.
Dated:
------------------------------------
- -------------------------------------------
Signature of Registered Holder
- -------------------------------------------
Name of Registered Holder (Print)
- -------------------------------------------
- -------------------------------------------
Address of Registered Holder (Print)
NOTICE
The signature to the foregoing Exercise Form must correspond to the name as
written upon the face of the attached Warrant in every particular, without
alteration or enlargement or any change whatsoever.
<PAGE>
EXHIBIT D
COMPLIANCE CERTIFICATE
NUWAVE TECHNOLOGIES, INC.
The undersigned, Gerald Zarin, hereby certifies, with respect to shares of
common stock of NUWAVE Technologi
s, Inc. (the "Company") issuable in connection
with the Put Notice dated _____________ (the "Notice"), delivered pursuant to
Article II of the Agreement, as follows:
1. The undersigned is the duly elected Chairman of the Company.
2. The representations and warranties of the Company set forth in Article IV of
the Private Securities Subscription Agreement dated as of February 6, 1998, are
true and correct in all material respects as though made on and as of the date
hereof.
3. The Company has performed in all material respects all covenants and
agreements to be performed by the Company on or prior to the Closing Date
related to the Put Notice and has complied in all material respects with all
obligations and conditions contained in Article VII of the Agreement.
The undersigned has executed this Certificate this ____ day of ________, 199_.
- ------------------------------------------------
Gerald Zarin
Chairman, President, and Chief Executive Officer
<PAGE>
Exhibit E
INSTRUCTIONS TO TRANSFER AGENT
NUWAVE TECHNOLOGIES, INC.
1998
- ------------------------------,
[Name and address of Transfer Agent]
Dear Sirs:
Reference is made to the Private Securities Subscription Agreement (the
"Agreement") dated as of ____________, 1998, between ProFutures Special Equities
Fund, L.P. (the "Investor") and NUWAVE Technologies, Inc. (the "Company").
Pursuant to the Agreement, subject to the terms and conditions set forth in the
Agreement (i) the Investor has agreed to purchase from the Company and the
Company has agreed to sell to the Investor from time to time during the term of
the Agreement shares of Common Stock of the Company, par value $0.01 per share
(the "Common Stock"), (ii) the Company has issued to the Investor a warrant to
purchase Common Stock (the "Warrant"), and (iii) the Company, under certain
circumstances, will issue to the Investor an additional Warrant (the
"Supplemental Warrant"). As a condition to the effectiveness of the Agreement,
the Company has agreed to issue to you, as the transfer agent for the Common
Stock (the "Transfer Agent"), these instructions relating to the Common Stock to
be issued to the Investor (or a permitted assignee) pursuant to the Agreement or
upon exercise of the Warrants. All terms used herein and not otherwise defined
shall have the meaning set forth in the Agreement.
1. ISSUANCE OF COMMON STOCK WITHOUT THE LEGEND
Pursuant to the Agreement, the Company is required to prepare and file with
the Commission, and maintain the effectiveness of, a registration statement or
registration statements registering the resale of the Common Stock to be
acquired by the Investor (i) under the Agreement and (ii) upon exercise of the
Warrant and/or the Supplemental Warrant. The Company will advise the Transfer
Agent in writing of the effectiveness of any such registration statement
promptly upon its being declared effective. The Transfer Agent shall be entitled
to rely on such advice and shall assume that the effectiveness of such
registration statement remains in effect unless the Transfer Agent is otherwise
advised in writing by the Company and shall not be required to independently
confirm the continued effectiveness of such registration statement. In the
circumstances set forth in the following two paragraphs, the Transfer Agent
shall deliver to the Investor certificates representing Common Stock not bearing
the Legend without requiring further advice or instruction or additional
documentation from the Company or its counsel or the Investor or its counsel or
any other party (other than as described in such paragraphs).
<PAGE>
At any time after the effective date of the applicable registration
statement (provided that the Company has not informed the Transfer Agent in
writing that such registration statement is not effective) upon any surrender of
one or more certificates evidencing Common Stock which bear the Legend, to the
extent accompanied by a notice requesting the issuance of new certificates free
of the Legend to replace those surrendered, the Transfer Agent shall deliver to
the Investor the certificates representing the Common Stock not bearing the
Legend, in such names and denominations as the Investor shall request, provided
that :
(a) in connection with any such event, the Investor (or its permitted
assignee) shall confirm in writing to the Transfer Agent that (i) the
Investor has sold, pledged or otherwise transferred or agreed to sell,
pledge or otherwise transfer such Common Stock in a bona fide
transactions to third parties that are not affiliates of the Company;
and (ii) the Investor confirms to the transfer agent that the Investor
has instructed its broker(s) to deliver the prospectus to such
parties;
(b) the Investor (or its permitted assignee) shall represent that it is
permitted to dispose of such Common Stock without limitation as to
amount or manner of sale pursuant to Rule 144(k) under the Securities
Act; or
(c) the Investor, or its permitted assignee, or either of their brokers
confirms to the transfer agent that (i) the Investor has held the
share of Common Stock for at least one year, (ii) counting the shares
surrendered as being sold upon the date the unlegended Certificates
would be delivered to the Investor (or the Trading Day immediately
following if such date is not a Trading Day), the Investor will not
have sold more than the greater of (a) one percent (1%) of the total
number of outstanding shares of Common Stock or (b) the average weekly
trading volume of the Common Stock for the preceding four weeks during
the three months ending upon such delivery date (or the Trading Day
immediately following if such date is not a Trading Day), and (iii)
the Investor has complied with the manner of sale and notice
requirements of Rule 144 under the Securities Act.
Any advice, notice, or instructions to the Transfer Agent required or permitted
to be given hereunder may be transmitted via facsimile to the Transfer Agent's
facsimile number of ( ) - .
2. MECHANICS OF DELIVERY OF CERTIFICATES REPRESENTING COMMON STOCK
In connection with any Closing pursuant to which the Investor acquires Common
Stock under the Agreement, the Transfer Agent shall deliver certificates
representing Common Stock (with or without the Legend, as appropriate) as
promptly as practicable, but in no event later than three business days, after
such Closing.
<PAGE>
3. FEES OF TRANSFER AGENT; INDEMNIFICATION
The Company agrees to pay the Transfer Agent for all fees incurred in connection
with these Irrevocable Instructions. The Company agrees to indemnify the
Transfer Agent and its officers, employees and agents, against any losses,
claims, damages or liabilities, joint or several, to which it or they become
subject based upon the performance by the Transfer Agent of its duties in
accordance with the Irrevocable Instructions.
4. THIRD PARTY BENEFICIARY
The Company and the Transfer Agent acknowledge and agree that the Investor
is an express third party beneficiary of these Irrevocable Instructions and
shall be entitled to rely upon, and enforce, the provisions thereof.
NUWAVE TECHNOLOGIES, INC.
By:
------------------------------------------
Gerald Zarin
Chairman and Chief Executive Officer
AGREED:
[NAME OF TRANSFER AGENT]
By:
-------------------------------
Name:
Title:
THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY OTHER
APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION
FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER
SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN
MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, HYPOTHECATED
OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO A TRANSACTION WHICH IS EXEMPT FROM, OR
NOT SUBJECT TO, SUCH REGISTRATION. THE HOLDER OF THIS CERTIFICATE IS THE
BENEFICIARY OF CERTAIN OBLIGATIONS OF THE COMPANY SET FORTH IN A PRIVATE
SECURITIES SUBSCRIPTION AGREEMENT BETWEEN NUWAVE TECHNOLOGIES, INC. AND
PROFUTURES SPECIAL EQUITIES FUND, L.P. DATED FEBRUARY 6, 1998. A COPY OF THE
PORTION OF THE AFORESAID AGREEMENT EVIDENCING SUCH OBLIGATIONS MAY BE OBTAINED
FROM THE COMPANY'S EXECUTIVE OFFICES.
February 6, 1998
Warrant to Purchase up to 50,000 Shares of Common Stock of NUWAVE Technologies,
Inc.
NUWAVE Technologies, Inc., a Delaware corporation (the "Company"), hereby
acknowledges that ProFutures Special Equities Fund, L.P. (the "Investor") or any
other Warrant Holder is entitled, on the terms and conditions set forth below,
to purchase from the Company at any time during the Exercise Period up to 50,000
fully paid and nonassessable shares of Common Stock, par value $0.01 per share,
of the Company (the "Common Stock"), as the same may be adjusted pursuant to
Section 6 herein, at the Exercise Price (hereinafter defined), as the same may
be adjusted pursuant to Section 6 herein.
Section 1. Definitions.
"Agreement" shall mean the Private Securities Subscription Agreement, dated
as of February 6, 1998, between the Company and the Investor.
"Capital Shares" shall mean the Common Stock and any shares of any other
class of common stock whether now or hereafter authorized, having the right to
participate in the distribution of earnings and assets of the Company except for
any common stock issued pursuant to warrants, stock options, and convertible
securities outstanding and described in the SEC Documents on file with the
Commission as of the date of this Agreement.
<PAGE>
"Date of Exercise" shall mean the date that the advance copy of the
Exercise Form is deemed delivered by facsimile to the Company in accordance with
Section 13 hereof, provided that the original Warrant and Exercise Form are
received by the Company within five (5) Trading Days thereafter. If the Warrant
Holder has not sent advance notice by facsimile, the Date of Exercise shall be
the date the original Exercise Form is actually received by the Company.
"Exercise Period" shall mean that period beginning August 6, 1998, and
ending on August 6, 2001; provided that such period shall be extended one
Trading Day for each Trading Day that a Registration Statement is not effective
during the period such Registration Statement is required to be effective
pursuant to the Registration Rights Agreement.
"Exercise Price" shall mean $6.41.
"Per Share Warrant Value" shall mean the difference resulting from
subtracting the Exercise Price from the Bid Price of one share of Common Stock
on the Trading Day next preceding the Date of Exercise.
"Registration Rights Agreement" shall mean the registration rights
agreement dated as of February 6, 1998, between the Company and the Investor.
"Warrant Holder" shall mean the Investor or any assignee or transferee of
all or any portion of this Warrant; and
other capitalized terms used herein that are defined in the Agreement shall
have the same meanings herein as therein.
Section 2. Exercise.
(a) Cash Exercise. This Warrant may be exercised by the Warrant Holder, in
whole or in part, at any time and from time to time during the Exercise Period
by surrender to the Company at its principal executive offices at the address
set forth in Section 13 of (i) this Warrant; (ii) the form of exercise attached
hereto as Exhibit A (the "Cash Exercise Form") duly executed by Warrant Holder,
and (iii) the full Exercise Price for each share of Common Stock as to which
this Warrant is exercised. In the event that the Warrant is not exercised in
full, the number of Warrant Shares shall be reduced by the number of such
Warrant Shares for which this Warrant is exercised, and the Company, at its
expense, shall forthwith issue and deliver to or upon the order of the Warrant
Holder a new Warrant of like tenor in the name of the Warrant Holder or as the
Warrant Holder may request, reflecting such adjusted number of Warrant Shares
within three (3) Trading Days.
(b) Net Exercise. This Warrant may be exercised at any time during the
Exercise Period, by presentation and surrender to the Company at its principal
executive offices at the address set forth in Section 13 of (i) this Warrant and
(ii) the form of exercise attached hereto as Exhibit B (the "Net Exercise Form")
duly executed by
Page 2
<PAGE>
Warrant Holder, including a calculation of the number of shares of Common Stock
to be issued upon such exercise in accordance with the terms hereof (a "Cashless
Exercise"). In the event of a Cashless Exercise, the holder shall surrender this
Warrant for that number of shares of Common Stock determined by (i) multiplying
the number of Warrant Shares for which this Warrant is being exercised by the
Per Share Warrant Value and (ii) dividing the product by the Bid Price of one
share of the Common Stock on the Trading Day next preceding the Date of
Exercise. In the event that the Warrant is not exercised in full, the number of
Warrant Shares shall be reduced by the number of such Warrant Shares for which
this Warrant is exercised, and the Company, at its expense, shall forthwith
issue and deliver to or upon the order of the Warrant Holder a new Warrant of
like tenor in the name of the Warrant Holder or as the Warrant Holder may
request, reflecting such adjusted number of Warrant Shares within three (3)
Trading Days.
Section 3. Ten Percent Limitation. Notwithstanding anything herein to the
contrary, unless the Investor agrees otherwise, the Warrant Holder may not
exercise the Warrant if the aggregate number of shares of common stock
beneficially owned by the holder and its affiliates following such conversion
exceeds 9.9% of the outstanding shares of the common stock following such
exercise. For purposes of the foregoing provision, the aggregate number of
shares of common stock beneficially owned by the holder and its affiliates shall
include the number as shares of common stock issuable upon exercise of the
Warrant with respect to which the determination of such proviso is being made,
but shall exclude the number of shares of common stock which would be issuable
upon (i) exercise of the remaining, Warrant beneficially owned by the holder and
its affiliates and (ii) exercise or conversion of the unexercised or unconverted
portion of any other securities of the Company (including, without limitation,
any warrants) subject to a limitation on conversion or exercise analogous to the
limitation contained herein beneficially owned by the holder and its affiliates.
Except as set forth in the preceding sentence, for purposes of this paragraph,
beneficial ownership shall be calculated in accordance with Section 16 of the
Securities Exchange Act of 1934, as amended. The holder may waive the foregoing
limitations by written notice to the Company upon not less than 61 days prior
notice (with such waiver taking effect only upon the expiration of such 61 day
notice period).
Section 4. Delivery of Stock Certificates.
(a) Subject to the terms and conditions of this Warrant, as soon as
practicable after the Date of Exercise of this Warrant in full or in part, and
in any event within three (3) Trading Days thereafter, the Company at its
expense (including, without limitation, the payment by it of any applicable
issue taxes) will cause to be issued in the name of and delivered to the Warrant
Holder, or as the Warrant Holder may lawfully direct, a certificate or
certificates for the number of validly issued, fully paid and non-assessable
Warrant Shares to which the Warrant Holder shall be entitled on such exercise,
together with any other stock or other securities or property (including cash,
where applicable) to which the Warrant Holder is entitled upon such exercise in
accordance with the provisions hereof.
Page 3
<PAGE>
(b) This Warrant may not be exercised as to fractional shares of Common
Stock. In the event that the exercise of this Warrant, in full or in part, would
result in the issuance of any fractional share of Common Stock, then in such
event the Warrant Holder shall receive in cash an amount equal to the Bid Price
of such fractional share within five (5) Trading Days.
Section 5. Covenants of the Company.
(a) The Company shall use its best efforts to insure that a Registration
Statement under the Securities Act covering the resale or other disposition
thereof of the Warrant Shares by the Warrant Holder is effective to the extent
required by the Registration Rights Agreement.
(b) The Company shall take all necessary action and proceedings as may be
required and permitted by applicable law, rule and regulation, including,
without limitation, the notification of the Principal Market, for the legal and
valid issuance of this Warrant and the Warrant Shares to the Warrant Holder.
(c) From the date hereof through the last date on which this Warrant is
exercisable, the Company shall take all steps reasonably necessary and within
its control to insure that the Common Stock remains listed or quoted on the
Principal Market.
(d) The Warrant Shares, when issued in accordance with the terms hereof,
will be duly authorized and, when paid for or issued in accordance with the
terms hereof, shall be validly issued, fully paid and non-assessable.
(e) The Company has authorized and reserved for issuance to the Warrant
Holder the requisite number of shares of Common Stock to be issued pursuant to
this Warrant. The Company shall at all times reserve and keep available, solely
for issuance and delivery as Warrant Shares hereunder, such shares of Common
Stock as shall from time to time be issuable as Warrant Shares.
(f) With a view to making available to the Warrant Holder the benefits of
Rule 144 promulgated under the Securities Act ("Rule 144") and any other rule or
regulation of the Securities and Exchange Commission (the "SEC"), that may at
any time permit the Warrant Holder to sell securities of the Company to the
public without registration, the Company agrees to use its reasonable best
efforts to (i) make and keep public information available, as those terms are
understood and defined in Rule 144, at all times; and (ii) file with the SEC in
a timely manner all reports and other documents required of the Company under
the Securities Act and the Exchange Act.
Section 6.1 Adjustment of the Exercise Price. The Exercise Price and,
accordingly, the number of Warrant Shares issuable upon exercise of the Warrant,
shall be subject to adjustment from time to time upon the happening of certain
events as follows:
(a) Reclassification, Consolidation, Merger or Mandatory Share Exchange. If
the Company, at any time while this Warrant is unexpired and not exercised in
full (i) reclassifies or
Page 4
<PAGE>
changes its Outstanding Capital Shares (other than a change in par value, or
from par value to no par value per share, or from no par value per share to par
value or as a result of a subdivision or combination of outstanding securities
issuable upon exercise of the Warrant) or (ii) consolidates, merges or effects a
mandatory share exchange with or into another corporation (other than a merger
or mandatory share exchange with another corporation in which the Company is a
continuing corporation and that does not result in any reclassification or
change, other than a change in par value, or from par value to no par value per
share, or from no par value per share to par value, or as a result of a
subdivision or combination of Outstanding Capital Shares issuable upon exercise
of the Warrant) at any time while this Warrant is unexpired and not exercised in
full, then in any such event the Company, or such successor or purchasing
corporation, as the case may be, shall, without payment of any additional
consideration therefore, amend this Warrant or enter into a new Warrant
providing that the Warrant Holder shall have rights not less favorable to the
holder than those then applicable to this Warrant and to receive upon exercise
under such amendment of this Warrant or new Warrant, in lieu of each share of
Common Stock theretofore issuable upon exercise of the Warrant hereunder, the
kind and amount of shares of stock, other securities, money or property
receivable upon such reclassification, change, consolidation, merger, mandatory
share exchange, sale or transfer by the holder of one share of Common Stock
issuable upon exercise of the Warrant had the Warrant been exercised immediately
prior to such reclassification, change, consolidation, merger, mandatory share
exchange or sale or transfer. Such amended Warrant shall provide for adjustments
which shall be as nearly equivalent as may be practicable to the adjustments
provided for in this Section 6.1. The provisions of this subsection (a) shall
similarly apply to successive reclassifications, changes, consolidations,
mergers, mandatory share exchanges and sales and transfers.
(b) Subdivision or Combination of Shares. If the Company, at any time while
this Warrant is unexpired and not exercised in full, shall subdivide its Common
Stock, the Exercise Price shall be proportionately reduced as of the effective
date of such subdivision, or, if the Company shall take a record of holders of
its Common Stock for the purpose of so subdividing, as of such record date,
whichever is earlier. If the Company, at any time while this Warrant is
unexpired and not exercised in full, shall combine its Common Stock, the
Exercise Price shall be proportionately increased as of the effective date of
such combination, or, if the Company shall take a record of holders of its
Common Stock for the purpose of so combining, as of such record date, whichever
is earlier.
(c) Stock Dividends. If the Company, at any time while this Warrant is
unexpired and not exercised in full, shall pay a dividend in its Capital Shares,
or make any other distribution of its Capital Shares, then the Exercise Price
shall be adjusted, as of the date the Company shall take a record of the holders
of its Capital Shares for the purpose of receiving such dividend or other
distribution (or if no such record is taken, as at the date of such payment or
other distribution), to that price determined by multiplying the Exercise Price
in effect immediately prior to such payment or other distribution by a fraction:
1. the numerator of which shall be the total number of Outstanding
Capital Shares immediately prior to such dividend or distribution, and
Page 5
<PAGE>
2. the denominator of which shall be the total number of Outstanding
Capital Shares immediately after such dividend or distribution.
The provisions of this subsection (c) shall not apply under any of the
circumstances for which an adjustment is provided in subsections (a) or (b).
(d) Issuance of Additional Capital Shares. If the Company, at any time
while this Warrant is unexpired and not exercised in full, shall issue any
additional Capital Shares ("Additional Capital Shares"), otherwise than as
provided in the foregoing subsections (a) through (c) above, at a price per
share less, or for other consideration lower, than the Bid Price in effect
immediately prior to such issuance, or without consideration, then upon such
issuance the Exercise Price shall be reduced to that price determined by
multiplying the Exercise Price in effect immediately prior to such event by a
fraction:
1. the numerator of which shall be the number of Outstanding Capital
Shares immediately prior to the issuance of the Additional Capital Shares plus
the number of Capital Shares that the aggregate consideration for the total
number of such Additional Capital Shares so issued would purchase at the then
effective Bid Price, and
2. the denominator of which shall be the number of Outstanding Capital
Shares immediately after the issuance of the Additional Capital Shares.
The provisions of this subsection (d) shall not apply under any of the
circumstances for which an adjustment is provided in subsections (a), (b) or
(c). The provisions of this subsection (d) shall not apply to the issuance of
any Additional Capital Shares that are issued pursuant to the exercise of any
warrants, options or other subscription or purchase rights or pursuant to the
exercise of any conversion or exchange rights in any convertible or exchangeable
securities.
(e) Issuance of Warrants, Options or Other Rights. If the Company, at any
time while this Warrant is unexpired and not exercised in full, shall issue any
warrants, options or other rights to subscribe for or purchase any Additional
Capital Shares and the price per share for which Additional Capital Shares may
at any time thereafter be issuable pursuant to such warrants, options or other
rights shall be less than the Bid Price in effect immediately prior to such
issuance, then upon the issuance of such options, warrants or other rights, the
Exercise Price shall be adjusted as provided in subsection (d) hereof on the
basis that:
1. the maximum number of Additional Capital Shares issuable on the
date of determination (subject to adjustment on the date(s) of exercise)
pursuant to all such warrants, options or other rights shall be deemed to have
been issued as of the date of actual issuance of such warrants, options or other
rights, and
2. the aggregate consideration for such maximum number of Additional
Capital Shares issuable pursuant to such warrants, options or other rights,
shall be deemed to be the consideration received by the Company for the issuance
of such warrants, options, or other rights plus the minimum consideration to be
received by the Company for the issuance of Additional Capital Shares pursuant
to such warrants, options, or other rights.
Page 6
<PAGE>
(f) Issuance of Convertible or Exchangeable Securities. If the Company, at
any time while this Warrant is unexpired and not exercised in full, shall issue
any securities convertible into or exchangeable for Capital Shares and the
consideration per share for which Additional Capital Shares may at any time
thereafter be issuable pursuant to the terms of such convertible or exchangeable
securities shall be less than the Bid Price in effect immediately prior to such
issuance, then upon the issuance of such convertible or exchangeable securities,
the Exercise Price shall be adjusted as provided in subsection (d) hereof on the
basis that:
1. the maximum number of Additional Capital Shares necessary on the
date of determination (subject to adjustment on the date(s) of conversion or
exchange) to effect the conversion or exchange of all such convertible or
exchangeable securities shall be deemed to have been issued as of the date of
issuance of such convertible or exchangeable securities, and
2. the aggregate consideration for such maximum number of Additional
Capital Shares shall be deemed to be the consideration received by the Company
for the issuance of such convertible or exchangeable securities plus the minimum
consideration received by the Company for the issuance of such Additional
Capital Shares pursuant to the terms of such convertible or exchangeable
securities.
No adjustment of the Exercise Price shall be made under this subsection (f) upon
the issuance of any convertible or exchangeable securities that are issued
pursuant to the exercise of any warrants, options or other subscription or
purchase rights therefor, if the issuance of such warrants, options or other
rights was subject to subsection (e) hereof.
(g) Adjustment of Number of Shares. Upon each adjustment of the Exercise
Price pursuant to any provisions of this Section 6.1, the number of Warrant
Shares issuable hereunder at the option of the Warrant Holder shall be
calculated, to the nearest one hundredth of a whole share, multiplying the
number of Warrant Shares issuable prior to an adjustment by a fraction
1. the numerator of which shall be the Exercise Price before any
adjustment pursuant to this Section 6.1; and
2. the denominator of which shall be the Exercise Price after such
adjustment.
(h) Liquidating Dividends, Etc. If the Company, at any time while this
Warrant is unexpired and not exercised in full, makes a distribution of its
assets or evidences of indebtedness to the holders of its Capital Shares as a
dividend in liquidation or by way of return of capital or other than as a
dividend payable out of earnings or surplus legally available for dividends
under applicable law or any distribution to such holders made in respect of the
sale of all or substantially all of the Company's assets (other than under the
circumstances provided for in the foregoing subsections (a) through (g)) while
an exercise is pending, then the Warrant Holder shall be entitled to receive
upon such exercise of the Warrant in addition to the Warrant Shares receivable
in connection therewith, and without payment of any consideration other
Page 7
<PAGE>
than the Exercise Price, an amount in cash equal to the value of such
distribution per Capital Share multiplied by the number of Warrant Shares that,
on the record date for such distribution, are issuable upon such exercise of the
Warrant (with no further adjustment being made following any event which causes
a subsequent adjustment in the number of Warrant Shares issuable), and an
appropriate provision therefor shall be made a part of any such distribution.
The value of a distribution that is paid in other than cash shall be determined
in good faith by the Board of Directors of the Company.
(i) Other Provisions Applicable to Adjustments Under this Section. The
following provisions will be applicable to the making of adjustments in a
Exercise Price hereinabove provided in this Section 6.1:
1. Computation of Consideration. To the extent that any Additional
Capital Shares or any convertible or exchangeable securities or any warrants,
options or other rights to subscribe for or purchase any Additional Capital
Shares or any convertible or exchangeable securities shall be issued for a cash
consideration, the consideration received by the Company therefor shall be
deemed to be the amount of the cash received by the Company therefor, or, if
such Additional Capital Shares or convertible or exchangeable securities are
offered by the Company for subscription, the subscription price, or, if such
Additional Capital Shares or convertible or exchangeable securities are sold to
or through underwriters or dealers for public offering without a subscription
offering, the initial public offering price, in any such case excluding any
amounts paid or incurred by the Company for and in the underwriting of, or
otherwise in connection with the issue thereof. To the extent that such issuance
shall be for a consideration other than cash, then, the amount of such
consideration shall be deemed to be the fair market value of such consideration
at the time of such issuance as determined in good faith by the Company's Board
of Directors. The consideration for any Additional Capital Shares issuable
pursuant to any warrants, options or other rights to subscribe for or purchase
the same shall be the consideration received by the Company for issuing such
warrants, options or other rights, plus the additional consideration payable to
the Company upon the exercise of such warrants, options or other rights. The
consideration for any Additional Capital Shares issuable pursuant to the terms
of any convertible or exchangeable securities shall be the consideration paid or
payable to the Company in respect of the subscription for or purchase of such
convertible or exchangeable securities, plus the additional consideration, if
any, payable to the Company upon the exercise of the right of conversion or
exchange in such convertible or exchangeable securities. In case of the issuance
at any time of any Additional Capital Shares or convertible or exchangeable
securities in payment or satisfaction of any dividend upon any class of stock
preferred as to dividends in a fixed amount, the Company shall be deemed to have
received for such Additional Capital Shares or convertible or exchangeable
securities a consideration equal to the amount of such dividend so paid or
satisfied.
2. Readjustment of Exercise Price. Upon the expiration of the right to
convert or exchange any convertible or exchangeable securities, or upon the
expiration of any rights, options or warrants, the issuance of which convertible
or exchangeable securities, rights, options or warrants effected an adjustment
in Exercise Price, if any such convertible or exchangeable securities shall not
have been converted or exchanged, or if any such rights, options or warrants
shall not have been exercised, the number of Capital Shares deemed to be
Page 8
<PAGE>
issued and Outstanding by reason of the fact that they were issuable upon
conversion or exchange of any such convertible or exchangeable securities or
upon exercise of any such rights, options, or warrants shall no longer be
computed as set forth above, and such Exercise Price shall forthwith be
readjusted and thereafter be the price that it would have been (but reflecting
any other adjustments in the Exercise Price made pursuant to the provisions of
this Section 6.1 after the issuance of such convertible or exchangeable
securities, rights, options or warrants) had the adjustment of the Exercise
Price made upon the issuance or sale of such convertible or exchangeable
securities or issuance of rights, options or warrants been made on the basis of
the issuance only of the number of Additional Capital Shares actually issued
upon conversion or exchange of such convertible or exchangeable securities, or
upon the exercise of such rights, options or warrants, and thereupon only the
number of Additional Capital Shares actually so issued, if any, shall be deemed
to have been issued and only the consideration actually received by the Company
(computed as set forth in sub-subsection (i) hereof) shall be deemed to have
been received by the Company. If the purchase price provided for in any rights,
options or warrants, or the additional consideration (if any) payable upon the
conversion or exchange of any convertible or exchangeable securities, or the
rate at which any convertible or exchangeable securities are convertible into or
exchangeable for Capital Shares changes at any time (other than under or by
reason of provisions designed to protect against dilution), the Exercise Price
in effect at the time of the change shall be adjusted to the Exercise Price that
would have been in effect at such time had such rights, options, warrants or
convertible or exchangeable securities still outstanding provided for such
changed purchase price, additional consideration or conversion rate, as the case
may be, at the time initially granted, issued or sold.
3. Other Action Affecting Capital Shares. In case after the date
hereof the Company shall take any action affecting the number of Outstanding
Capital Shares, other than an action described in any of the foregoing
subsections (a) through (h) hereof, inclusive, which in the opinion of the
Company's Board of Directors would have a materially adverse effect upon the
rights of the Warrant Holder at the time of exercise of the Warrant, the
Exercise Price shall be adjusted in such manner and at such time as the Board or
Directors on the advice of the Company's independent public accountants may in
good faith determine to be equitable in the circumstances.
(j) No Adjustments. No adjustments to the Exercise Price shall be made
whatsoever as a result of (i) warrants and stock options granted or reserved for
issuance to employees and directors as described in the SEC Documents on file
with the Commission as of the date of this Agreement, (ii) pursuant to an
Employee Stock Purchase Plan qualified under Section 423 of the Internal Revenue
Code as of the date of this Agreement (iii) the purchase and sale of the Put
Shares hereunder, (iv) the Warrant, (v) the Supplemental Warrant, or (vi) any
Common Stock issuable upon conversion or exercise of any of the foregoing.
(k) In the event the Company shall, at a time while the Warrant is
unexpired and outstanding, take any action which pursuant to subsections (a)
through (g) of this Section 6.1 may result in an adjustment of the Exercise
Price, the Company shall give to the Warrant Holder at its last address known to
the Company written notice of such action ten (10) days in
Page 9
<PAGE>
advance of its effective date in order to afford to the Warrant Holder an
opportunity to exercise the Warrant prior to such action becoming effective.
Section 6.2 Notice of Adjustments. Whenever the Exercise Price or number of
Warrant Shares shall be adjusted pursuant to Section 6.1 hereof, the Company
shall promptly make a certificate signed by its President or a Vice President
and by its Treasurer or Assistant Treasurer or its Secretary or Assistant
Secretary, setting forth in reasonable detail the event requiring the
adjustment, the amount of the adjustment, the method by which such adjustment
was calculated (including a description of the basis on which the Company's
Board of Directors made any determination hereunder), and the Exercise Price and
number of Warrant Shares purchasable at that Exercise Price after giving effect
to such adjustment, and shall promptly cause copies of such certificate to be
mailed (by first class and postage prepaid) to the Holder of the Warrant.
In the event the Company shall, at any time while the Warrant is unexpired and
not exercised in full, take any action that pursuant to subsections (a) through
(g) of Section 6.1 may result in an adjustment of the Exercise Price, the
Company shall give to the Holder of the Warrant at its last address known to the
Company written notice of such action ten (10) days in advance of its effective
date in order to afford to the Holder of the Warrant an opportunity to exercise
the Warrant prior to such action becoming effective.
Section 7. No Impairment. The Company will not, by amendment of its Articles of
Incorporation or By-Laws or through any reorganization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of
the terms of this Warrant, but will at all times in good faith assist in the
carrying out of all such terms and in the taking of all such action as may be
necessary or appropriate in order to protect the rights of the Warrant Holder
against impairment. Without limiting the generality of the foregoing, the
Company (a) will not increase the par value of any Warrant Shares above the
amount payable therefor on such exercise, and (b) will take all such action as
may be reasonably necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable Warrant Shares on the exercise of
this Warrant.
Section 8 Rights As Stockholder. Prior to exercise of this Warrant, the Warrant
Holder shall not be entitled to any rights as a stockholder of the Company with
respect to the Warrant Shares, including (without limitation) the right to vote
such shares, receive dividends or other distributions thereon or be notified of
stockholder meetings. However, in the event of any taking by the Company of a
record of the holders of any class of securities for the purpose of determining
the holders thereof who are entitled to receive any dividend (other than a cash
dividend) or other distribution, any right to subscribe for, purchase or
otherwise acquire any shares of stock of any class or any other securities or
property, or to receive any other right, the Company shall mail to each Warrant
Holder, at least 10 days prior to the date specified therein, a notice
specifying the date on which any such record is to be taken for the purpose of
such dividend, distribution or right, and the amount and character of such
dividend, distribution or right.
Page 10
<PAGE>
Section 9. Replacement of Warrant. Upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of the
Warrant and, in the case of any such loss, theft or destruction of the Warrant,
upon delivery of an indemnity agreement or security reasonably satisfactory in
form and amount to the Company or, in the case of any such mutilation, on
surrender and cancellation of such Warrant, the Company at its expense will
execute and deliver, in lieu thereof, a new Warrant of like tenor.
Section 10. Choice of Law. This Agreement shall be construed under the laws of
the State of New Jersey, without giving effect to provisions regarding conflicts
of law or choice of law.
Section 11. Entire Agreement; Amendments. This Warrant, the Registration Rights
Agreement, and the Agreement contain the entire understanding of the parties
with respect to the matters covered hereby and thereby. No provision of this
Warrant may be waived or amended other than by a written instrument signed by
the party against whom enforcement of any such amendment or waiver is sought.
Section 12. Restricted Securities.
(a) Registration or Exemption Required. This Warrant has been issued in a
transaction exempt from the registration requirements of the Securities Act in
reliance upon the provisions of Section 4(2) promulgated by the SEC under the
Securities Act. This Warrant and the Warrant Shares issuable upon exercise of
this Warrant may not be resold except pursuant to an effective registration
statement or an exemption to the registration requirements of the Securities Act
and applicable state laws.
(b) Legend. The Warrant and any Warrant Shares issued upon exercise
thereof, shall bear the following legend:
"THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
U.S. SECURITIES ACT OF 1933, AS AMENDED (THE"ACT" OR THE "SECURITIES ACT"), OR
ANY OTHER APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN
EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH
OTHER SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION
HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED,
HYPOTHECATED OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO A TRANSACTION
WHICH IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION. THE HOLDER OF THIS
CERTIFICATE IS THE BENEFICIARY OF CERTAIN OBLIGATIONS OF THE COMPANY SET FORTH
IN A PRIVATE SECURITIES SUBSCRIPTION AGREEMENT BETWEEN NUWAVE TECHNOLOGIES, INC.
AND PROFUTURES SPECIAL EQUITIES FUND, L.P. DATED AS OF FEBRUARY 6, 1998. A COPY
OF THE PORTION OF THE
Page 11
<PAGE>
AFORESAID AGREEMENT EVIDENCING SUCH OBLIGATIONS MAY BE OBTAINED FROM THE
COMPANY'S EXECUTIVE OFFICES."
(a) No Other Legend or Stock Transfer Restrictions. No legend other than
the one specified in Section 12(b) has been or shall be placed on the share
certificates representing the Common Stock and no instructions or "stop transfer
orders," so called, "stock transfer restrictions," or other restrictions have
been or shall be given to the Company's transfer agent with respect thereto
other than as expressly set forth in this Section 12.
(b) Assignment. Assuming the conditions of Section 12(a) above regarding
registration or exemption have been satisfied, the Warrant Holder may sell,
transfer, assign, pledge or otherwise dispose of this Warrant, in whole or in
part. The Warrant Holder shall deliver a written notice to Company,
substantially in the form of the Assignment attached hereto as Exhibit C,
indicating the person or persons to whom the Warrant shall be assigned and the
respective number of warrants to be assigned to each assignee. The Company shall
effect the assignment within ten (10) days, and shall deliver to the assignee(s)
designated by the Warrant Holder a Warrant or Warrants of like tenor and terms
for the appropriate number of shares.
(c) Investor's Compliance. Nothing in this Section 12 shall affect in any
way the Investor's obligations under any agreement to comply with all applicable
securities laws upon resale of the Common Stock.
(d) Collateral. Notwithstanding any provision herein to the contrary, the
Investor may pledge such Registrable Securities as Investor may hold as
collateral for a revolving credit note pursuant to a loan and security agreement
with a lending institution.
Section 13. Notices. All notices, demands, requests, consents, approvals, and
other communications required or permitted hereunder shall be in writing and
shall be (i) personally served, (ii) deposited in the mail, registered or
certified, return receipt requested, postage prepaid, (iii) delivered by
reputable air courier service with charges prepaid, or (iv) transmitted by hand
delivery, telegram, telex or facsimile, addressed as set forth below or to such
other address as such party shall have specified most recently by written
notice. Any notice or other communication required or permitted to be given
hereunder shall be deemed effective (a) upon hand delivery or delivery by
facsimile (with accurate confirmation generated by the transmitting facsimile
machine) at the address or number designated below (if delivered on a business
day during normal business hours where such notice is to be received), or the
first business day following such delivery (if delivered other than on a
business day during normal business hours where such notice is to be received)
or (b) on the second business day following the date of mailing by express
courier service, fully prepaid, addressed to such address, or upon actual
receipt of such mailing, whichever shall first occur. The addresses for such
communications shall be:
Page 12
<PAGE>
If to NUWAVE Technologies, Inc.: Jeremiah O'Brien
Chief Financial Officer
One Passaic Avenue
Fairfield, New Jersey 07004
Telephone (973) 882-8810 ext. 212
Facsimile (973) 882-8812
with a copy to: Fredric Klink, Esq.
(shall not constitute notice) Dechert, Price & Rhoads
30 Rockefeller Plaza, 23rd Floor
New York, New York 10112
Telephone (212) 698-3537
Facsimile (212) 698-3599
If to the Investor: Gary D. Halbert
President
ProFutures Special Equities Fund, L.P.
1310 Highway 620 South, Suite 200
Austin, TX 78734
Telephone (512) 263-3800
Facsimile (512) 263-3459
with a copy to: John Gray, Esq.
(shall not constitute notice) Fishman, Jones, Walsh & Marsh, P.C.
1310 Highway 620 South, Suite 200
Austin, TX 78734
Telephone (512) 263-8057
Facsimile (512) 263-8058
Either party hereto may from time to time change its address or facsimile number
for notices under this Section 13 by giving at least ten (10) days' prior
written notice of such changed address or facsimile number to the other party
hereto.
Section 14. Miscellaneous. This Warrant and any term hereof may be changed,
waived, discharged or terminated only by an instrument in writing signed by the
party against which enforcement of such change, waiver, discharge or termination
is sought. This Warrant shall be construed and enforced in accordance with and
governed by the laws of the State of New Jersey. The headings in this Warrant
are for purposes of reference only, and shall not limit or otherwise affect any
of the terms hereof. The invalidity or unenforceability of any provision hereof
shall in no way affect the validity or enforceability of any other provision.
Page 13
<PAGE>
IN WITNESS WHEREOF, this Warrant was duly executed on the date first
written above.
NUWAVE TECHNOLOGIES, INC.
By:
------------------------------------------
Gerald Zarin
Chairman and Chief Executive Officer
Attested
By:
------------------------------------------
Jeremiah F. O'Brien
Secretary and Chief Financial Officer
Page 14
<PAGE>
EXHIBIT A TO THE WARRANT
NUWAVE TECHNOLOGIES, INC.
CASH EXERCISE
The undersigned hereby irrevocably exercises the right to purchase
__________________ shares of Common Stock of NUWAVE Technologies, Inc., a
Delaware corporation, evidenced by the attached Warrant, and herewith makes
payment of the Exercise Price with respect to such shares in full in the form of
[wire transfer, cash or check in the amount of $___], [_____ Warrant Shares
which represent the amount of Warrant Shares as provided in the attached Warrant
to be canceled in connection with such exercise], all in accordance with the
conditions and provisions of said Warrant.
The undersigned requests that stock certificates for such Warrant
Shares be issued, and a Warrant representing any unexercised portion hereof be
issued, pursuant to this Warrant in the name of the registered Holder and
delivered to the undersigned at the address set forth below.
Dated:
--------------------------------------
- ---------------------------------------------
Signature of Registered Holder
- ---------------------------------------------
Name of Registered Holder (Print)
- ---------------------------------------------
- ---------------------------------------------
Address of Registered Holder (Print)
NOTICE
The signature to the foregoing Exercise Form must correspond to the name as
written upon the face of the attached Warrant in every particular, without
alteration or enlargement or any change whatsoever.
<PAGE>
EXHIBIT B TO THE WARRANT
NUWAVE TECHNOLOGIES, INC.
NET EXERCISE
The undersigned hereby irrevocably exercises the right to exchange the
attached Warrant for a number of shares of Common Stock of NUWAVE Technologies,
Inc., a Delaware corporation, as determined by multiplying the number of shares
as to which the Warrant is being exercised by the Per Share Warrant Value and
dividing the product by the Bid Price as the Trading Day immediately preceding
the Date of Exercise as set forth below:
No. of Shares for which this Warrant is exercised:
--------------------
Per Share Warrant Value $
--------------------
Bid Price (as of preceding Trading Day) $
--------------------
No. of Shares to be sent to Warrant Holder
--------------------
The undersigned requests that stock certificates for such Warrant
Shares be issued, and a Warrant representing any unexercised portion hereof be
issued, pursuant to this Warrant in the name of the registered Holder and
delivered to the undersigned at the address set forth below.
Dated:
------------------------------------
- -------------------------------------------
Signature of Registered Holder
- -------------------------------------------
Name of Registered Holder (Print)
- -------------------------------------------
- -------------------------------------------
Address of Registered Holder (Print)
NOTICE
The signature to the foregoing Exercise Form must correspond to the name as
written upon the face of the attached Warrant in every particular, without
alteration or enlargement or any change whatsoever.
<PAGE>
EXHIBIT C TO THE WARRANT
NUWAVE TECHNOLOGIES, INC.
ASSIGNMENT
(To be executed by the registered Warrant Holder desiring to transfer the
Warrant) FOR VALUED RECEIVED, the undersigned Warrant Holder of the attached
Warrant hereby sells, assigns and transfers unto the persons below named the
right to purchase ______________ shares of the Common Stock of NUWAVE
TECHNOLOGIES, INC. evidenced by the attached Warrant and does hereby irrevocably
constitute and appoint ______________________ attorney to transfer the said
Warrant on the books of the Company, with full power of substitution in the
premises.
Dated:
--------------------------------------
- ---------------------------------------------
Signature of Registered Holder
- ---------------------------------------------
Name of Registered Holder (Print)
- ---------------------------------------------
- ---------------------------------------------
Address of Registered Holder (Print)
NOTICE
The signature to the foregoing Exercise Form must correspond to the name as
written upon the face of the attached Warrant in every particular, without
alteration or enlargement or any change whatsoever.
Coopers & Lybrand [LOGO]
February 16, 1998
Securities and Exchange Commission
450 5th Street, N.W.
Washington, D.C. 20549
Gentlemen:
We have read the statements made by NuWave Technologies, In. (copy attached),
which we understand will be filed with the Commission, pursuant to Item 4 of
Form 8-K as part of the Company's Form 8-K report for the month of February
1998. We agree with the statements concerning our Firm in such Form 8-K.
Very truly yours,
Coopers & Lybrand L.L.P.
NUWAVE TECHNOLOGIES ANNOUNCES $6 MILLION COMMITMENT FOR EQUITY
FUNDING FROM PROFUTURES SPECIAL EQUITIES
FAIRFIELD, NEW JERSEY, FEBRUARY 10, 1998 - NUWAVE Technologies, Inc. (Nasdaq:
WAVE), a leader in state of the art video enhancing technology, announced today
that it has entered into an agreement with ProFutures Special Equities Fund,
L.P. which will provide the Company with up to $6 million of operating capital.
The funds will be used to complete the design and production of its ASIC
(Application Specific Integrated Circuit) chip for inclusion in consumer
electronics products pursuant to forthcoming Original Equipment Manufacturer
agreements, as well as other products incorporating the Company's revolutionary
video enhancement technology.
This agreement consists of the sale of $1 million of common stock and provides
up to $5 million in additional equity funding under certain terms and
conditions. Under the terms of the agreements, beginning later this year. NUWAVE
shall have the right to draw up to $5 million in cash at any time for the
subsequent two years. The decision to make draws, and the timing and amount of
such draws are solely at the Company's discretion, subject to certain
conditions. More detail regarding the terms of the financing will be available
in the filings to be made by NUWAVE with the Securities and Exchange Commission.
"We are very pleased to enter into this arrangement which will provide us with
additional capital as we complete the design and begin the manufacturing of our
ASIC chip for the OEM Market and for inclusion in products aimed at the retail
consumer and professional markets," said Gerald Zarin, NUWAVE's President and
Chairman. "This arrangement grants NUWAVE the flexibility to draw funds if
needed at the time most appropriate to the Company's requirements."
ProFutures Special Equities Fund, L.P. is a part of the ProFutures Group of
Companies in Austin, Texas. ProFutures has over 4,000 individual and
institutional clients who have allocated over $200 million to ProFutures for
management. ProFutures will be working with NUWAVE to raise awareness of the
Company's technology business.
"ProFutures looks forward to a long-term, prosperous relationship with NUWAVE
Technologies, Inc." said Marte Anderson, principal of a general partner of
ProFutures Special Equities Fund, L.P. "We are especially happy to be able to
introduce this unique investment opportunity to our current client base of high
net worth individuals and institutions."
Founded in July 1995, NUWAVE Technologies, Inc. is a leading designer,
developer, and marketer of state-of-the-art video enhancing technology, which
dramatically improves video pictures with clearer, sharper details and more
vibrant colors. NUWAVE's proprietary ASIC chip enhances video images at
breakthrough price points and is geared towards all video output products in the
rapidly expanding and converging multibillion-dollar video marketplace. NUWAVE's
unprecedented technology is recognized by Original Equipment Manufacturer
<PAGE>
(OEM) industry leaders as a superior video enhancement technology and one which
could significantly influence the choice consumers make in the selection of
video products.
The Company's products are positioned to sell to OEMs of products such as VCRs;
television sets, DVDs; camcorders and digital cameras; satellite and cable
set-top boxes; home theater devices. Additional markets include security and
surveillance; medical imaging; sports and entertainment; government and
military; science and technology; video duplication; corporate presentation and
HDTV.
Certain statements in this release are forward-looking statements that involve a
number of risks and uncertainties including those unforeseen events which could
delay or interfere with the Company's ability to make draws against the line of
credit. Among the important factors that could cause actual results to differ
materially from those indicated by such forward-looking statements are delays in
product development, competitive pressures, general economic conditions, risks
of intellectual property litigation, and the risk factors detailed from time to
time in the Company's annual report on form 10ksb and other materials filed with
the Securities and Exchange Commission.
